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ABSTRACT 
 
Engineering of protein with new modifications essentially expands the protein 
functions which provide powerful tools for investigating significant biological questions. 
New modifications also offer scientists the ability to handle protein activity at will. 
Therefore, development of facile and robust protein modification protocol is highly 
desirable in almost every aspect of biological research. In combination with chemistry 
and biology principles, the genetic code expansion technology has emerged as an 
effective strategy for manipulating proteins and interrogating biological systems. In this 
regard, the overall objective of the presented research is to expand the chemical biology 
toolbox based on noncanonical amino acid incorporation and bioorthogonal chemistry.   
During my graduate study, I was focused on methodology development to 
genetically incorporate defined, homogeneous native protein posttranslational 
modifications and new chemical/biophysical probes into proteins for biological 
investigations, particularly for epigenetic applications. I have established the protocol to 
incorporate various native lysine acylations into proteins including crotonylation, 
propionylation and butyrylation. In addition, I also developed a chemical biology 
approach to study epigenetics, coined “chemical antibody”. This approach allows high 
throughput fluorescent detection of posttranslational modifications without the use of 
antibodies. I genetically encoded native lysine posttranslational modification surrogates, 
such as acryloyllysine, into proteins. Coupled with the bioorthogonal chemistry 
development, the site-specific detection of the posttranslational modifications was 
 iii 
 
accomplished, essentially offering an alternative route for understanding epigenetic 
enzyme network. Following the same line of approach, in order to study protein long 
chain fatty acid acylation, I incorporated long chain unstrained alkene into proteins as 
chemical reports that are able to be selectively labeled via tetrazine-based bioorthogonal 
reaction. This development also generates a new direction of research in studying the 
long chain fatty acid metabolic acylome using chemical biology approach. Lastly, the 
site-specific incorporation of fluorine-containing noncanonical amino acid probes into 
proteins was also developed. Fluorine is referred to as “magic bullet” in medicinal 
organic chemistry and biochemistry. Introducing fluorine into protein allows generating 
an unrivalled unique probe in a protein without any structural perturbation. The site-
specific incorporation of perfluorinated probes is an invaluable tool for the study of 
noncovalent protein interactions as well as the application on protein designs. 
Overall, the collective work presented has extensively improved our ability of 
handling site-specific protein modifications with native biological PTMs and handy 
chemical/ biophysical probes for diverse medical and biological applications. 
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CHAPTER I 
INTRODUCTION 
 
Advances in Site-Specific Protein Modifications  
Protein is nature’s most versatile and fascinating class of biomolecules due to 
their diverse properties of function and structure. While proteins are comprised of only 
twenty canonical amino acids with relatively simple functional groups, they sustain the 
entire normal life of a living organism where proteins are responsibility for almost all 
aspect of biological activities, such as catalysis, structure, signal transduction, gene 
regulation etc. 
1-5
 Engineering of protein with desirable handles essentially provides an 
exclusive ability to manipulation of protein behavior, in turn to probe, regulate and 
understand the entire living system. Accordingly, development of methodology for 
specific protein modification has emerged as an invaluable tool for investigation of 
protein associated biological questions including protein functions, architectures, as well 
as metabolism and interactive network. The chemical modification of amino acid side 
chains can be backtracked to 100 years ago, whereas today a variety of bioconjugation 
reactions are developed and applied routinely to alter the proteins properties as dictated 
by the application or analysis method at hand.
6, 7
 Each of these approaches allows new 
protein targets to be addressed, leading to advances in biological understanding, new 
protein-drug conjugates, targeted medical imaging agents and hybrid materials with 
complex functions. 
 2 
 
 
Figure 1-1. Classic methods for protein modification 
 
Early methods of protein functionalization exploited the reactivity of endogenous 
functional groups. All functional groups of a protein have different pKa values and 
therefore their reactivity can be controlled by adjustment of pH in a buffer. This fact 
allows a selective reaction on one type of amino acid residue as mostly applied for 
modification strategies to the amine group of the lysines or the N-terminus of a protein 
and the thiol group of cysteines (Figure 1-1). Lysine has a side chain amine with pKa ~ 
10.5 and is a common modification target due to a variety of reactions are accessible for 
selective primary amines modification.
8
 By treating the protein with excess amine-
reactive reagents such as N-hydroxysuccinimidyl esters or isothiocyanates, selective 
protein labeling is achieved (Figure 1-1A). The N-terminus of a protein has a unique 
amine which is slightly more acidic than that of lysine side chain with the pKa around 
8.
8
 Therefore, the N-terminus of protein offers the opportunity for single-site protein 
modification. Cystein is a rare residue in whole proteome and makes it a precious native 
A B
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chemical handle for protein derivatization. The modification of cysteine can be 
accomplished via disulfide linkage or through thiol nucleophilic addition to the thiol-
reactive reagents such as maleimides probes or haloacetamides (Figure 1-1B).
9, 10
 In 
addition to lysine and cysteine modifications, methods have also been developed to 
chemically modify tyrosine and aspartate or glutamate residues.
9
 These classic methods 
are convenient and actively been used for quick qualitative protein modifications. 
However, their chemoselectivity become the hurdle when site-specific modification is 
desired.  
To achieve site-specific, engineering or external assistance from the non-native 
reagents are required. A traditional approach has relied on the creation of fusion proteins 
of the protein of interest with green fluorescent proteins (GFP). With the advances of 
molecular biology technologies, this approach can conveniently introduce a GPF tag at 
the genetic level. However, the GFP tagging is limited to the two terminal ends of a 
protein. Moreover, the size of GFP (26 kDa) may risk in perturbing the native state of 
the protein of interest.
11
 
The complementary use of both genetic and chemical methods has provided a 
large toolbox that allows the preparation of almost unlimited protein constructs with 
either natural or synthetically modified residues. Numerous milestones were established 
in the past twenty years in contributing to the advances of site-specific protein 
modification. These milestones include click chemistry, bioorthogonal reaction, native 
chemical ligation, expressed protein ligations as well as genetic code expansion and will 
be summarized extensively but not exhaustively in the following sections. 
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Click Chemistry and Bioorthogonal Reactions 
Given the high environmental constrains in physiological and cellular setting, it 
requires unique chemistry in order to handle and control manipulate the behavior of 
biomolecule of interest. Therefore, the pressing need promotes the development of click 
chemistry and bioorthogonal reactions in the past decades.
12
 Described and termed by 
Sharpless and coworkers in 1999, the “click chemistry” concept defines a new group of 
chemical reactions that are modular, highly selective and efficient and can be performed 
at mild ambient condition in physiological solutions.
13, 14
 Since it was first introduced, in 
past decade the development of click chemistry has had an enormous impact on 
substantially every fields of chemical science and technology, ranging from medicine, 
material science, polymer chemistry to chemical biology, biomolecule engineering and 
bionanotechnology. Due to their robustness, superb selectivity and versatility, click 
reactions allow the assembly of fundamental fragments into sophisticated but valuable 
targets under a benign condition with decent reaction rate. Broad utilization of click 
chemistry in various subjects enables scientist to achieve multidisciplinary research, 
effectively bridging discrete worlds into one.  
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Early focus of click chemistry centered on the Cu(I)-catalyzed azide-alkyne 
cycloaddition (CuAAC) reaction (Figure 1-2). Due to the biologically inert nature, azide 
and alkyne have become unrivaled chemical tools, broadly incorporated into 
biomacromolecules and applied in in vitro biochemical studies. Applications of CuAAC 
in chemical biology include activity-based protein profiling and selective biomolecule 
labeling. However, one pitfall of using CuAAC in living systems is the detrimental 
effect of copper ions and reducing agent formulation which raise concerns about protein 
damage or precipitation as well as the reactivity oxygen-induced cytotoxicity.
15
 Thereby, 
considering the complexity of living system that is composed of interacting biopolymers, 
ions and metabolites,  further methodology development on the basis of click chemistry 
in complying to the cellular constrains are in pressing need and prevailing in chemical 
biology filed. To this end, the pursuit of chemical reactions with outstanding 
bioorthogonality falls into the development of bioorthogonal reactions. 
1
 
Bioorthogonal reactions defined a new category of chemical reactions that can 
occur in living systems without interfering with native biochemical processes and have 
emerged as highly specific tools that can be used for investigation the dynamics and 
function of biomolecules in living system. Typical bioorthogonal reactions include 
Straudinger ligation, Strained-promoted azide-alkyne cycloaddition, and 
hydrazone/oxime conjugates from aldehyde/ketone-hydrazide/alkoxylamine pair. The 
Staudinger ligation is based on the classic Staudinger reaction between azide and 
triarylphosphine, developed by Bertozzi and coworkers in 2000 for the selective 
glycoprotein labeling.
16
 The reaction was later been used in studying protein 
 7 
 
glycosylation both with live cells and live mice.
17
 Shortly after the Staudinger ligation, a 
new variant was described referred as “traceless” Staudinger ligation, where the final 
amide-linked product is freed from the phosphine oxide moiety and gives a native amine 
linkage.
18, 19
 Staudinger launched the field of bioorthogonal chemistry as the first 
reaction with completely abiotic functional groups although it is less widely used due to 
its relatively slow reaction rate (~ 10
-3
 M
-1
 s
-1
). 
20
 
Aldehyde and ketone are two of the most versatile groups in synthetic organic 
chemistry and were among the first functionalities to be explored as bioorthogonal 
chemical reporters. Under acidic conditions (pH 4-6), the carbonyl groups are 
preferentially form a reversible Schiff base with the equilibrium favoring the free 
carbonyl form. The use of strong electron donating group at -substituent of amine, such 
as hydrazide or alkoxyamines, shifts the equilibrium in favor of the hydrazone and 
oxime product, though the reaction kinetics is slow (10
-4
-10
-3
 M
-1
 s
-1
). The use of 
nucleophilic catalyst aniline will facilitate the condensation and boost up the reaction 
rate (170 M
-1
 s
-1
 for hydrazone and 8.2 M
-1
 s
-1
 for oxime). Application of 
aldehyde/ketone-hydrazide/alkoxyamine includes glycoprotein and cell surface receptor 
labeling
20
. 
Azide and alkyne are ideal bioorthogonal chemical reports. Although the use of 
copper limits CuAAC, the development of copper-free methods will circumvent the 
limitation.   Cu(I) catalyst can be avoided by strain-promoted azide-cyclooctyne 
cycloaddition (SPAAC) (Figure 1-2). Driven by the ring strain, the cyclooctyne triple 
bond has an elevated energy state and therefore reacts spontaneously with an organic 
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azide under mild, aqueous conditions, elegantly sidestepping the use of Cu(I) catalyst. 
Although originally described as a relative slow reaction, cyclooctyne derivatives that 
show improved SPAAC reaction kinetics developed. The pursuit of other fast catalyst-
free click reactions that can be applied in living systems for labeling biomolecules under 
biologically relevant conditions has recently revitalized one celebrated reaction, namely 
the Diels-Alder [4+2] cycloaddition (DA). Not only is DA rapid, selective and 
chemically accessible, but also DA is highly aqueous friendly, giving augment reaction 
kinetics up to hundred-fold in aqueous media in comparison to in organic solvents. In 
particular, Diels-Alder reaction with inverse electron demand (DAinv) of 1,2,4,5-
tetrazines with strained cyclic dienophiles is exceptionally fast in aqueous buffer (Figure 
1-2).
21, 22
 1,2,4,5-tetrazines react with dienophiles such as including norbornene, trans-
cyclooctene, cyclooctyne, cyclobutene, and cyclopropene very selectively, irreversibly 
giving dihydropyridazine products and release very benign dinitrogen byproduct. 
Another copper-free click reaction that has been recently explored but not yet highly 
appreciated is the 1,3-dipolar cycloaddition (1,3-DC) between nitrile imine (Figure 1-
2).
23
 Compared to tetrazine and cyclooctyne that stably exist in aqueous conditions, 
nitrilimine reacts with water and therefore needs to be formed transiently. Two methods 
are generally used to transiently form nitrile imine. One is the photolysis of tetrazole and 
the other is the ionization of hydrazonyl halide. Lin et al. have extended the first 
approach for photoclick protein labeling in living cells.
24, 25
 The second approach was 
recently utilized for the fluorescent turn-on labeling of proteins incorporated with 
norbornene, cyclopropene, and acrylamide moieties.
26-28
 Both reactions display rapid 
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kinetics when a strained alkene/alkyne is involved. Applications of these two reactions 
include labeling biomolecules in cells and cancer diagnostics.
26, 29-32
 
Bioorthogonal chemistry directed biomolecule conjugation has shown 
widespread applications attributed to their unique features of selectivity, 
biocompatibility and reaction kinetics in physiological conditions. The use of 
bioorthogonal chemistry typically proceeds with two steps. First, a cellular substrate is 
modified with a bioorthogonal functional group (chemical reporter) and introduced to 
the cell; substrates include metabolites, enzyme inhibitors, etc. The chemical reporter 
must not alter the structure of the substrate dramatically to avoid affecting its bioactivity. 
Secondly, a probe containing the complementary functional group is introduced to react 
and label the substrate. To introduce the chemical reporter into the proteins, current 
advances involve solid phase synthesis, native chemical ligation, expressed protein 
ligation, as well as enzymatic modification and genetic code expansion for ncAA 
incorporation. 
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Figure 1-3. Protein semisynthesis approaches. Schematic representation of A) solid 
phase peptide synthesis; B) native chemical ligation; C) the mechanism of intein 
chemistry; D) expressed protein ligation.  
 
 
Protein Semisynthesis, Native Chemical Ligation and Expressed Protein Ligation 
Chemical synthesis has long term been used to manipulate functionality 
transformation and allows custom implementation of any chemical reporter on the target 
molecules. In addition, synthetic chemicals are easily scalable and economical. 
Therefore, to achieve the production of medical significant or biological relevant 
biomacromelecules, organic chemist have attempted to develop means in efficient 
assembly of basic biological elements such as the synthesis from amino acids to peptides 
and functional proteins. To this end, peptide synthesis was developed at this regard. One 
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critical milestone in the development history is solid phase peptide synthesis (SPPS) 
which greatly simplifies the tedious purification steps and boosts up the synthesis 
productivity.
33
 SPPS has established routine protocols generally involving repeatedly 
deprotection, activation and coupling three steps to bring together each amino acids into 
peptide chain. Followed by one step deprotection and cleavage from resin, the synthesis 
of peptide with chemical reporter or PTM incorporated can be accomplished (Figure 1-
3A). SPPS is straightforward and can be applied to synthesize proteins/peptides with 
diverse chemical reporters and PTMs. However, given the fact that this approach lies on 
the amide bond formation with chemical reactions, it suffers from low yield when the 
target polypeptide is larger than 50 amino acid residues.
34
 For instance, if each amino 
acid addition has a 90% yield then the overall yield of the synthesis of a 50 amino acids 
polypeptide is merely 0.5%. Since a functional protein is normally greater than 100 
amino acids, the low yield of SPPS is a conspicuous pitfall limiting the generally 
application in synthesis of large proteins. Although modern SPPS instrumentation has 
greatly optimize the coupling and deprotection yields to greater than 99%, leading to an 
overall yield of greater than 90% for a 50 amino acids polypeptide. To overcome the 
limitations, the methods to glue polypeptide from SPPS were therefore developed, which 
was referred as chemical ligation.
35
 
There were numerous chemical ligation protocols developed and intended to 
assemble SPPS peptide fragments, whereas the created non-native linkages were 
concerns when native protein is required.
35
 Not until the development of native chemical 
ligation (NCL), chemical ligation became routine protocol in protein semisynthesis. 
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Since it was reported by Kent and coworkers in 1994, NCL has been emerged as one of 
the major strategy to the semisynthesis of proteins with desired chemical reporters and 
PTMs modifications at programmed site.
34
 It allows unprotected peptide fragments to be 
chemoselectively ligated together with native amide bond which greatly extends the size 
limitations of SPPS that chemist can reach. NCL relies on the reaction between the C-
terminus thioester of one synthesized peptide fragment and the N-terminus cysteine 
residue of the other. The thiol group in the cysteine reacts to the thioester by means of 
reversible thiol/thioester exchange to afford the new thioester-linked conjugated peptide. 
Followed by irreversible intramolecular S- to N-acyl transfer rearrangement, full length 
native protein with more than 100 residues can be afforded in single NCL step (Figure 
1-3B).
34
 Since two peptide fragments are synthesized separately, NCL not only promotes 
the efficiency and extend the size limitation of SPPS but also allows the synthesis 
chemical reporter functionalized protein at desirable site of a protein. Specifically, when 
the ncAA locates in the N-terminal peptide fragment, the C-terminal peptide can be 
synthesized by recombinant DNA-based protein expression. This method offers a 
solution to synthesize larger proteins with ncAAs incorporated close to N-terminus.
35, 36
 
Another notable milestone of semisynthesis is the development of expressed 
protein ligation (EPL). While the installation of ncAAs at N-terminus of protein was 
realized readily through NCL, the synthesis of protein with ncAAs incorporated at C-
terminus became the remaining challenge. Unlike the C-terminal end of a peptide 
fragment, the N-terminal fragment contains a thioester tail which cannot be 
recombinantly produced in simple protocol. Therefore, a method to produce a peptide 
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fragment with C-terminal end thiolester through perhaps recombinant protein expression 
was in high demand. Protein splicing is a posttranslational process, involving a series of 
intramolecular rearrangement to precisely remove an internal sequence (intein) and 
ligate the two flanking segments (extein) via a reversible transesterification and a S- to 
N-acyl shift mediated by an adjacent asparagine, resulting in the formation of an native 
amide linkage (Figure 1-3C).
37
 Mutation of the C-terminal asparagine residue within the 
intein to an alanine blocks the final step in protein splicing. Proteins expressed as in-
frame N-terminal fusions to such mutant inteins can be cleaved by excessive thiols, such 
as dithiotheitol, -mercatoethanol or thiolphenol, to give the corresponding protein -
thioester derivatives (Figure 1-3D). Commercial expression vectors are available that 
allow the generation of recombinant intein fusion proteins containing chitin binding 
domain (CBD) affinity purification tags where the cleaved intein corpses are removed 
from -thioester protein by chitin-immobilized beads. The obtained recombinant protein 
-thioester can then react with a N-terminal cysteine containing peptide (either synthetic 
or recombinant) via NCL to afford a semisynthetic target protein (Figure 1-3D). 
Expressed protein ligation refers to the combination of the intein thiolysis and native 
chemical ligation steps.
36, 38, 39
 EPL successfully offers a solution for the semisynthesis 
of proteins with C-termius ncAAs incorporated. SPPS is essentially able to synthesize 
the peptides with any desired chemical reporter or PTM. The advances of NCL and EPL 
allow the semisynthesisi of theoretically any proteins functionalized with chemical 
reporter or biological significant PTMs for in vivo and in vitro studies.  
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SPPS, NCL in combined with EPL have provided a powerful semisynthetic 
toolbox and have greatly expanded the realm of available proteins that can be 
synthesized. Nonetheless, “the big three” are not invincible due to their intrinsic 
limitations. In order to perform the transthioesterification steps, the introduction of 
terminal cysteine is required. A cysteine scar remains within the ligated product and the 
cysteine mutation may not be desirable in following studies. Although current advances 
have developed the desulfurization methodologies, the compatibility of the extra step 
remains a concern. In addition, the biophysical parameters of the protein-intein-CBD 
fusion need to be taken into account at protein expression. The three component 
chimeric protein may cause unexpected solubility and stability during recombinant 
protein expression and expression processes.
36
 
 
Enzymatic Installation of Chemical Reporter 
The nature have evolved enzyme to be highly specific to its native substrates in 
order to ensure the catalytic function and tight regulation within the complex biological 
network, thereby to sustain normal life of an organism. The outstanding selectivity of 
enzymes has inspired the development of enzymatic protein labeling approach. Site-
specific protein labeling is essentially artificial modification on protein with new 
chemical entities at the posttranslational stage. Based on the analogy between protein 
labeling and protein posttranslational modification, enzymatic tools are with high 
potential in developing efficient protocol for programmable labeling of target proteins 
with chemical probes of diverse structures and functionalities.
40, 41
 Enzymatic reactions 
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are selective and catalytic within the cellular environment, therefore protein labeling use 
this approach are typically low background, efficient and biocompatible. Generally, this 
method relies on first installation of an enzyme-specific “tag” on the target where the tag 
can be introduced at genetic level, followed by enzymatically transforming the tag to or 
with desired chemical reporters (Figure 1-4A). De novo synthesis of substrates or 
cofactors with bioorthogonal functionality is normally required in order to incorporate 
chemical reporters into target proteins. Also, engineering of the cognate enzyme against 
unnatural substrates to assure the specificity is inevitable prior to the practical utilization. 
The engineering effort is tedious and cumbersome therefore at present there are only 
handful protocols available. Recent developed and more generally adapted are 
summarized as follows. 
Transglutaminase (TGase) catalyzes protein crosslinking in the cell by the 
formation of an isopeptide bond between glutamine and lysine residues. Gunea pig liver 
TGase (gpTGase) demonstrates high specificity for Gln containing proteins as the acyl 
doners and low specificity for Lys containing substrate as acyl acceptors. This feature 
makes it possible to use gpTGase in protein labeling with amine functionalized synthetic 
probes. A short XXQXX peptide tag (Q-tag, X denotes any residues) is fused to the 
target protein and expressed as a fusion protein. Followed by TGase-catalyzed 
conjugation, the probes are covalently tagged the target protein via isopeptide linkage.
40
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Figure 1-4. Enzymatic protein modifications. A) General scheme for introduction of 
chemical reporters via engineered enzyme. B) Available enzymatic tool sets for site-
specific protein modification. 
 
Sortase is a transpeptidase which catalyzes a transpeptidase reaction between a 
specific internal sequence of a protein and an amino group present on the N-terminus of 
polyglycines. The S. aureus sortase, SrtA, recognizes LPXTG motif and cleave the 
peptide bond between threonine and glycien and form a new peptide bone with 
pentaglycine-containing peptide. Site-specific labeling of target protein can be achieved 
by genetically introducing the LPXTG motif onto the C-terminus of target protein of 
interest. Followed by SrtA-mediated conjugation with oligoglycine-functionalized probe, 
the target protein is modified with desired chemical reporoters.
41, 42
 The advances of 
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sortase method have been utilized for cell surface protein imaging as well as the 
development of N-terminus oligoglycine tagging protocol.
40, 41
 
Formylglycine-generating enzyme (FGE) is involved in the maturation of 
sulfatase and catalyzes a molecular oxygen-mediated oxidation of cysteine in the 
LCTPSR peptide, generating formylglycine as product and hydrogen peroxide as 
byproduct. The consensus 6-mer LCTPSR tag can be genetically encoded next to the 
target protein either at N- or C-terminus. After enzymatic oxidation, the afforded 
aldehyde can easily be functionalized with hydrazide or alkoxyamine probe. Engineering 
of the cell to overexpress FGE has allowed the in situ generation of aldehyde on the 
target protein and enabled in vivo cell imaging applications.
40, 43, 44
 
Biotin ligase catalyzes the protein posttranslational biotinylation. E. coli biotin 
ligase BirA, together with ATP, modifies the lysine residue of a15-mer consensus motif 
(AP tag) to biotinylated lysine. The biotinylated tagged-protein can be further enriched 
or detected using streptavidin resin or probes. Moreover, the engineering of BirA has 
allowed the incorporation of biotin analogues with bioorthogonal functionalities 
implemented including the ketone, azide and alkyne, which can be further functionalized 
via bioorthogonal reactions on the target protein.
40, 45, 46
 
Similar to biotin ligase, lipoic acid ligase catalyzes ATP-dependent protein lysine 
posttranslational modification with lipoic acid. E. coli lipoic acid ligase LplA recognizes 
a 22-residue peptide (LAP tag) and engineered LplA is able to utilize azide-containing 
lipoic acid analogue. Expression of LAP-protein fusion followed by LplA-mediated 
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modification, the target protein is modified with azide and allows further 
functionalization with probe.
40, 47
 
Phosphopantetheinyl transferase (PPTase) has been recently developed as a 
useful tool for protein labeling due to their broad substrate specificity with CoA 
conjugated small molecules. PPTase transfers 4’-phosphopantetheinyl group (PPant) of 
CoA to a conserved serine residue to an acyl carrier protein (ACP) or peptidyl carrier 
protein (PCP). Because PPTase only recognize the 3’-5’-ADP moiety of CoA at the 
active site, various CoA analogue probes have been reported incorporation by PPTase. 
To adopt PPTase catalyzed protein labeling, ACP or PCP domains are expressed as a 
fusion to the target protein, thereby to incorporate chemical reporters. Performed PPase 
directed evolution and the evolved mutant is able to pair with simplified CP with only 
12-residues, which greatly promotes the practical utilization of this protocol. 
40
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Figure 1-5. The ncAA incorporation strategy derived from the pyrrolysine incorporation 
machinery. 
 
 
Genetic Incorporation of ncAAs 
Pioneered by Schultz and coworkers, the side-specific incorporation of non-
canonical amino acid (ncAA) into a protein was first accomplished in 1989.
48
 This 
methodology makes use of an orthogonal tRNA, namely the tRNA does not have cross-
reactivity with any of the endogenous aminoacyl-tRNA synthetase (aaRS). Additionally, 
the original anticodon of the tRNA is substituted to CUA so as to match up with UAG 
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codon on mRNA, translationally read through the mRNA amber stop codon. Because the 
tRNA is capable of reading through mRNA amber stop codon, it is also coined as amber 
suppressor tRNA. To charge desired ncAA, the tRNA is manipulated in vitro and ligated 
with a chemically synthesized deoxyribonucleotide-ncAA hybrid using DNA ligase, 
generating an full-length aminoacylated amber suppressor tRNA. Then the suppressor 
tRNA is subjected to a cell-free translation system in response to programmed mRNA 
amber codon site, in turn to biosynthetically produce ncAA-incorporated protein of 
interest. Though technically challenging, this approach has been very useful in the study 
of protein structure and function. Examples include the incorporation of ncAAs with 
modified side chines, fluorophores, native PTMs, photo-cross-linkers as well as 
chemically reactivity functionalities.
49, 50
  In coupled with microinjection or 
electrotransfection technology, the chemically synthesized suppressor can be transferred 
into cells and undergo protein translation in vivo. Nevertheless, this approach is limited 
by poor protein yielding for  two major reasons, first the accessibility and stability of the 
aminoacyl-tRNA adducts and second the bad molecule economy due to the 
stoichiometric use of the aminoacylated tRNAs that cannot be constantly delivered.
3
 
An alternative route was further developed by Schultz and coworkers in 2001 to 
circumvent aforementioned limitations of using a chemically aminoacylated suppressor 
tRNA.
51, 52
 The idea is to create an in vivo biosynthetic machinery in host cell in which 
the designated aminoacylated suppressor tRNA is continuously supplied within the 
expression organism during protein translation. This can be achieved by importing a 
foreign orthogonal tRNA/synthetase pair from a different organism if cross-species 
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aminoacylation is inefficient and the anticodon loop is not a key determinant of 
synthetase recognition. An eligible orthogonal tRNACUA/aaRS pair MjTyrRS-
MjtRNACUA
Tyr
 derived from Methanococcus jannaschii was introduced into E. coli that 
enabled the genetic incorporation of O-methyltyrosine at programmed amber stop codon 
site. The orthogonal synthetase was engineered to specifically recognize the designated 
ncAA, preventing aaRS cross-interaction with endogenous amino acids. By engineering 
the MjTyrRS active site through rational design or directed evolution, the evolved 
MjTyrRS mutants have greatly expanded ncAA substrate scope, containing mostly 
tyrosine or phenylalanine derivatives with diverse chemical or biophysical properties. 
However, in spite of the success of incorporation of ncAAs into proteins in E. coli, this 
method is not applicable to eukaryotes since the MjTyrRS/tRNACUA
Tyr
 fails to achieve 
orthogonality in eukaryotic systems. Therefore, to further extend this method in other 
organisms, in particular in mammalian cells, development of new aaRS/tRNA pair is 
highly desirable. 
The opportunity was later been found after the discovery of pyrrolysine (Pyl), the 
22
nd
 genetic encoded amino acid.
53, 54
 Derived from certain methanogenic archaea and 
Gram positive bacterium, Pyl’s natural cognate tRNApyl (PylT) uses CAU as anticodon 
in response to UAG amber codon on mRNA to incorporate Pyl during protein translation 
perhaps for its methyltransferase activity.
53, 54
 This natural incorporation mechanism is 
equivalent to the genetic code expansion methodology using engineered 
MjTyrRS/MjtRNACUA
Tyr
 pair. Moreover, both Pyl’s cognate tRNA and aaRS, pyrrolysyl-
tRNA synthetase (PylRS), are orthogonal to the bacteria and eukaryote systems.  Pyl 
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system essentially fulfills the requirement of genetic ncAA incorporation methodology, 
consequently, PylRS/tRNACUA
pyl
 pair is optimal to incorporation ncAA in both bacteria 
and eukaryotic cells. Interestingly, unlike the MjTyrRS/MjtRNACUA
Tyr
pair, the anticodon 
region of tRNACUA
pyl
barely affects its binding to PylRS, which allows mutations on the 
anticodon to make an alternative suppressor other than amber codon. It not only enables 
an opportunity to use a sense codon to encode ncAAs, which can boost up the 
suppression efficiency, but also makes it possible to incorporation two different ncAAs 
into proteins with the combination of the MjTyrRS/Mj tRNACUA
Tyr
pair.
55
 Structurally, 
PylRS has a large cavity at the catalytic site which allows PylRS to accommodate 
diverse lysine analogues substrates without any engineering. Along the same line of 
thought, further expand the substrate diversity can be achieved by active site engineering 
through rational design or directed evolution. At present, there are more than 50 ncAAs 
including lysine and phenylalanine derivatives have been incorporated.
50, 56
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CHAPTER II  
GENETICALLY ENCODED ACRYLAMIDE FUNCTIONALITY* 
 
Introduction 
Selective labeling has its great utility as a tool to interrogate physiological 
functions of proteins and develop biotechnological applications. To label a protein of 
interest site-specifically, the genetic noncanonical amino acid (ncAA) incorporation 
approach has drawn great attention due to its potentially broad applications.
51,57
 Many 
ncAAs have been genetically incorporated into proteins in bacteria, yeast, mammalian 
cells and even animals.
50, 51, 58-61
 Of these ncAAs, a few bioorthogonal functionalities are 
available, including ketone, alkyne, and azide that undergo biocompatible reactions such 
as hydrazone/oxime formation and azide-alkyne cycloaddition reactions for site-
selective protein modifications.
62-71
 Although ketone, alkyne, and azide are involved in 
diverse organic reaction types beyond the aforementioned bioorthogonal reactions, most 
of these reactions either cannot be realized in physiological conditions or lack selectivity 
in the biological system. A genetically encoded and simple chemical moiety that 
undergoes multiple types of biocompatible and selective reactions could have broad 
implications for selective labeling strategies in vitro and in vivo. One functional group 
that shows many facets of organic reactivity is the carbon-carbon double bond. Given 
the versatility in organic transformation, olefins have found extensive application in 
*Reprinted with permission from Lee, Y. J., Wu, B., Raymond, J. E., Zeng, Y., Fang, 
X., Wooley, K. L., and Liu, W. R. (2013) A genetically encoded acrylamide 
functionality, ACS Chem. Biol. 8, 1664-1670. Copyright 2013 American Chemical 
Society. 
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synthetic organic chemistry. Various biocompatible olefin reactions have been 
demonstrated elsewhere. These include 1,4-addition, olefin metathesis, thiol-ene click, 
Diels-Alder, and 1,3-dipolar cycloaddition reactions.
10, 72
 The olefin functionality has 
been genetically incorporated into proteins. Using an evolved amber-suppressing 
aminoacyl-tRNA synthetase-tRNA pair that was derived from Methanocaldococcus 
jannaschii tyrosyl-tRNA synthetase-tRNA
Tyr
 pair, Zhang et al. were able to incorporate 
O-allyl-L-tyrosine into proteins in E. coli.
73
 The same ncAA and two other aliphatic 
olefin-containing tyrosine analogs were also genetically encoded in E. coli using a 
mutant pyrrolysyl-tRNA synthetase (PylRS)-tRNACUA
Pyl
 pair.
74
 A photoclick reaction that 
exploits the nitrile imine-alkene cycloaddition reaction was applied to fluorescently label 
proteins with O-allyl-L-tyrosine incorporated in E. coli, albeit the labeling efficiency 
was low.
29
 Five other aliphatic olefin-containing NAAs have also been encoded in 
Saccharomyces cerevisiae and used to undergo olefin metathesis on proteins.
75
 In 
general, these aliphatic olefin-containing NAAs have low reactivity toward nitrile imine 
and are not capable of performing 1,4-addition under physiological conditions. Recently, 
several groups have used wild-type and evolved PylRS- tRNACUA
Pyl
 pairs to site-
specifically install ncAAs with a strain-promoted alkene into proteins.
27, 28, 76-79
 Reacting 
rapidly with tetrazine or a tetrazole photo-cleavage product, these ncAAs contain a 
norbornene, transcyclooctene, or cyclopropene moiety that is a relatively large 
functional group. These NAAs may not be optimal options when minimal structural 
perturbation of proteins is necessary. Acrylamide is a small electron deficient olefin that 
undergoes several potentially biocompatible reactions, e.g., those shown in Scheme 2-1. 
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Here, we wish to report its genetic incorporation and its mediated diverse reactions for 
protein modifications. We envision that the acrylamide moiety would serve as a user-
defined multifunctional chemical handle for different purposes of applications.  
 
 
 
 
 
Scheme 2-1. Potential biocompatible reactions for acrylamide. 
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Results and Discussion 
Due to the electrophilic nature of acrylamide, one may suspect it undergoes 1,4-
addition with thiol nucleophiles such as intracellular glutathione. The kinetics of 1,4-
addition of -mercaptoethanol (-ME) to acrylamide was investigated. -ME instead of 
glutathione was used in our study due to the simple NMR spectrum of its 1,4-addition 
product with acrylamide. At pH 7.4, the second order rate constant determined was 
0.0040 ± 0.0003 M-1s-1 (Figure 2-1) that is twice a reported rate constant (0.002 M-1s-1) 
of the reaction between glutathione and acrylamide at the same pH.
80
 Providing the 
intracellular reduced glutathione concentration at 5 mM,
81
 acrylamide will have at least a 
half-life of 10 h that is ample for protein expression. A parallel kinetic analysis at pH 8.0 
inferred a second order rate constant of 0.013±0.001 M-1 s-1 (Figure 2-1), indicating a 
linear dependence of the logarithm of the rate constant on pH. Therefore, an acrylamide-
containing protein could be produced in cells and then modified at slightly alkali 
conditions in vitro. Encouraged by the initial kinetic studies, we synthesized N
ε
-acryloyl-
L-lysine (AcrK) and N
ε
-crotonyl-L-lysine (CrtK) whose structures are shown in Figure 
2-3A and then searched mutant PylRS-tRNACUA
Pyl
 pairs for their genetic encoding in E. 
coli. Two more stable analogous NAAs, N
ε
-propionyl-L-lysine (PrK) and N
ε
-butyryl-L-
lysine (BuK), were also synthesized and used during the initial search of mutant PylRS-
tRNACUA
Pyl
 pairs. Due to the structural similarity between N
ε
-acetyl-L-lysine (AcK), PrK 
and AcrK, MmAcKRS1 that was evolved from Methanosarcina mazei PylRS for the 
AcK incorporation also recognizes PrK and AcrK.
82
 To improve its efficiency, we 
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constructed a single-site MmAcKRS1 library that randomized Y384. Mutations at Y384 
have been shown in mutant PylRS variants for other lysine derivatives.
83, 84
 Clones from 
this library were screened against PrK using a protocol described previously.
85
 Most of 
the positive clones converged to a same MmAcKRS1 variant that has the Y384W 
mutation and is coined as PrKRS. The following testing with AcrK indicated that the 
PrKRS-tRNACUA
Pyl
 pair also mediates a high-level incorporation of AcrK at an amber 
codon (Figure 2-2). It was demonstrated previously that wild-type PylRS recognizes 
CrtK albeit at a low level. 
86, 87
 To improve the binding, a single site PylRS library with 
randomization at Y384 was constructed. Clones of this library were screened against 
BuK. Most positive clones converged to a single PylRS variant that has the Y384W 
mutation and is defined as BuKRS. BuKRS also recognizes CrtK (Figure 2-2). 
 
 
Figure 2-1. (A) The Michael addition reaction between acrylamide and -ME 
characterized by NMR. The indicated chemical shift at 3.88 ppm is from protons on the 
 carbon of the product. Signals for this chemical shift were integrated and drawn 
against time shown in (B) and (C). (B) The time dependence of the Michael addition 
product formation at pH 7.4. (C) at pH 8.0. The data were fitted to the equation 𝑝 =
𝐴1 − 𝐴2𝑒
−𝑘×𝑡, where p represents the integrated chemical shift at 3.88 ppm, A1 the final 
integrated chemical shift at 3.88 ppm, A1-A2 the initial integrated chemical shift at 3.88 
ppm, and k the apparent pseudo first order reaction constant. 
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Figure 2-2. (A) Screening of the pBK-MmAcKRS1 plasmid library. The PrK Plate 
contained GMML agar/CKT, and PrK (2 mM). The control plate on the left had no PrK 
supplement. (B) Screening results of the pBK-PylRS plasmid library. The BuK Plate 
contained GMML agar/CKT, and BuK (2 mM). The CrtK plate contained CrtK (2 mM) 
instead of BuK. The control plate on the left had no NNA supplement. CKT denotes 
Cam (68 ug/mL), Kan (50 ug/mL), Tet (25 ug/mL). 
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Figure 2-3: (A) Structures of AcK, PrK, AcrK, BuK, and CrtK. (B) The site-selective 
incorporation of AcrK and CrtK at the S2 position of sfGFP. (C) ESI-MS of the purified 
proteins. 
 
For further characterization of the genetic incorporation of AcrK and CrtK, 
PrKRS and BuKRS genes were cloned separately into an optimized pEVOL vector 
under control of an araBAD promoter to afford plasmids pEVOL-PrKRS and pEVOL-
BuKRS that also contain a tRNACUA
Pyl
 gene under control of the proK promoter. 
Transforming BL21(DE3) cells that contained a reporter plasmid pET-sfGFP2TAG with 
pEVOL-PrKRS or pEVOL-BuKRS afforded cell strains for further protein expression. 
PET-sfGFP2TAG has a His-tagged superfolder green fluorescent protein (sfGFP) gene 
that contains an amber mutation at its S2 position and is under control of a IPTG-
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inducible T7 promoter.
74
 Growing cells and inducing with the addition of 0.2% 
arabinose, 1 mM IPTG, and 2 mM AcrK or CrtK resulted in the overexpression of 
sfGFP. When AcrK or CrtK is absent, only a very small amount of sfGFP could be 
observed (Figure 2-3B). Purified proteins were then subjected to electrospray ionization 
mass spectrometry (ESI-MS) analysis that showed the expected molecular weights (For 
AcrK, calculated: 27,764 Da; detected: 27,762 Da. For CrtK, calculated: 27,778 Da; 
detected:  27,778 Da). Although proteins were expressed for 8 h at 37 
o
C, there was no 
apparent 1,4-addition product that could be detected by ESI-MS, indicating intracellular 
stability for both AcrK and CrtK (Figure 2-3C). 
 
 
Figure 2-4. ESI-MS analysis of the -ME modified sfGFP-AcrK. The red spectrum is 
for the product without further DTT treatment; the blue spectrum is for the product 
with further DTT treatment. The theoretical molecular weight of -ME modified 
sfGFP-AcrK is 27,842 Da. 
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To demonstrate 1,4-addition for protein labeling, we chose to work with sfGFP 
that had AcrK incorporated at S2 (sfGFP-S2AcrK), due to the known steric effect of the 
methyl group to hinder the addition of a thiol nucleophile to CrtK. sfGFP-S2AcrK (39 
M) was incubated with -ME (40 mM) at 37 oC overnight. pH 8.8 was used to elevate 
the reaction rate. The reaction proceeded smoothly with little original sfGFP-S2AcrK 
left after an overnight incubation (Figure 2-4). Besides the expected -ME addition 
adduct, the ESI-MS spectrum also displayed two additional peaks that are 76 and 151 Da 
greater than the expected product, indicating that one and two additional -ME 
molecules were covalently linked to sfGFP-S2AcrK. Since the -ME adducts of proteins 
through the disulfide bond linkage were observed previously
82
 and sfGFP-S2AcrK has 
two cysteine residues, these two additional peaks clearly resulted from the disulfide 
covalent linkage of -ME to sfGFP-S2AcrK. These extra -ME additions could be 
removed by further treatment with 5 mM dithiothreitol (DTT) for 1 h (Figure 2-4). A 
similar reaction was carried out to covalent link sfGFP-S2AcrK to methoxypolyethylene 
glycol thiol 5 kDa (mPEGSH5k). sfGFP-S2AcrK (50 M) was incubated with 
mPEGSH5k (40 mM) at pH 8.8, 37 
o
C for 8 h and then treated with DTT (5 mM) for an 
additional hour. The following SDS-PAGE analysis showed two protein bands, with one 
around 5 kDa larger than the other. The relative intensities of the two protein bands 
indicated roughly 50% conversion (Figure 2-5). The same reaction with wild-type (WT) 
sfGFP did not lead to a modified protein with a significant signal that could be detected 
by SDS-PAGE. 
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Figure 2-5: SDS-PAGE analysis of WT sfGFP and sfGFP-S2AcrK before and after their 
reactions with mPEGSH5k. 
 
Radical polymerization has been applied to undergo selective protein 
modifications in physiological conditions.
88, 89
 One typical chemical moiety for radical 
polymerization is acrylamide. To demonstrate that the acrylamide moiety in sfGFP-
S2AcrK can serve as a monomer for radical polymerization, a copolymer hydrogel was 
prepared by mixing sfGFP-S2AcrK (110 M), acrylamide (15%), and bis-acrylamide 
(0.5%) and initiating polymerization with the addition of tetramethylethylenediamine 
(0.3%) and ammonium persulfate (3%). The reaction solution was loaded to a well of a 
native PAGE gel and allowed to solidify. By this process, sfGFP-S2AcrK was 
covalently immobilized in the hydrogel and did not migrate during the following 
electrophoresis process (Figure 2-6). However, a similar test with WT sfGFP showed 
that the majority of the protein did not form covalent linkages with hydrogel. Moreover, 
as indicated by the fluorescence maintenance of the immobilized sfGFP-S2AcrK, this 
radical copolymerization reaction is compatible with preservation of the native protein 
state of sfGFP. 
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Figure 2-6: A native PAGE analysis of coimmobilized sfGFP-S2AcrK in an acrylamide 
hydrogel. WT sfGFP was loaded to the first lane to serve as the standard. 
 
It was demonstrated previously that olefin reacts with diaryl nitrile imine to 
generate a fluorescent pyrazoline at an appreciable rate in mild aqueous conditions.
25
 
Using a hydrazonoyl chloride 1 as a precursor that undergoes rapid dissociation in water 
to form a diaryl nitrile imine (2), Kaya et al. demonstrated a genetically encoded 
norbornene moiety could be used to fluorescently label proteins.
27
 However, a 
systematic kinetic investigation of the olefin reaction with diaryl nitrile imine is absent. 
1 was synthesized according to the literature procedures. Reactions of 1 (5 M) with 
acrylamide were examined by detecting the fluorescent emission from the product. The 
time-dependent fluorescent emission increase at different acrylamide concentrations is 
presented in Figure 2-7A. They all show single exponential curvatures. The determined 
apparent reaction rate constants have a linear dependence on the acrylamide 
concentrations with a significant y-axis intercept (Figure 2-7B). The reactions between 
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1 and other olefins shown in Figure 2-7C all display equivalent kinetic features 
(Figures 2-5 - 2-11). Figure 2-7A also shows very different fluorescent intensities for 
the final products at different acrylamide concentrations. All these observations indicate 
that 2 underwent two parallel reactions in an aqueous buffer, one with olefin and the 
other with water (Figure 2-7C).
25
 Based on the mechanism in Figure 2-7C, the 
pyrazoline formation follows the kinetic Equation 2-1, where k1 is the second order rate 
constant of the reaction between 2 and an olefin, k2 the hydrolysis rate constant of 2, [O] 
the olefin concentration, and [NI] the concentration of 2. Using this equation to analyze 
all the data resulted in k1 and k2 for various olefins shown in the table in Figure 2-7C. 
All determined k2 values are similar, supporting the parallel reaction mechanism. The 
results also indicated that acrylamide reacted with diaryl nitrile imine much faster than 
with all the other tested olefins, specifically 3 times faster than norbornene. This 
observation is consistent with a previous report.
90
 The hydrolysis of 2 was also analyzed 
by examining the UV absorbance decay of 2 at 315 nm in a buffer that contained 
acetonitrile and PBS with a ratio of 1:1 (Figure 2-13) and gave a first order rate constant 
of 0.00034 ± 0.00001 s-1, similar to the k2 values shown in Figure 2-7C. 
 
Equation 2-1 
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Figure 2-7: (A) The pyrazoline formation in reactions between 5 μM 1 and varying 
concentrations of acrylamide. Reactions were monitored by fluorescence emission at 480 
nm, with an excitation light at 318 nm. (B) The linear dependence of apparent rates of 
the reaction between 1 and acrylamide on the acrylamide concentrations. (C) 
Mechanism of the reaction between 1 and olefin in aqueous conditions and the finally 
determined rate constants for different olefins. 
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Figure 2-8. (A) The formation of pyrazoline from the reaction between 5 M 1 and 
varying concentrations of norbornene monitored by the fluorescence increase at 480 nm. 
Samples were excited at 318 nm. (B) The linear dependence of apparent rates of the 
reaction between 1 and norbornene on the norbornene concentrations. 
 
 
  
Figure 2-9. (A) The formation of pyrazoline from the reaction between 5 M 1 and 
varying concentrations of crotonamide monitored by the fluorescence increase at 480 
nm. Samples were excited at 318 nm. (B) The linear dependence of apparent rates of the 
reaction between 1 and crotonamide on the norbornene concentrations. 
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Figure 2-10. (A) The formation of pyrazoline from the reaction between 5 M 1 and 
varying concentrations of allyl alcohol monitored by the fluorescence increase at 480 
nm. Samples were excited at 318 nm. (B) The linear dependence of apparent rates of the 
reaction between 1 and allyl alcohol on the allyl alcohol concentrations. 
 
 
 
Figure 2-11. (A) The formation of pyrazoline from the reaction between 5 M 1 and 
varying concentrations of hydroxyethyl vinyl ether monitored by the fluorescence 
increase at 480 nm. Samples were excited at 318 nm. (B) The linear dependence of 
apparent rates of the reaction between 1 and hydroxyethyl vinyl ether on the 
hydroxyethyl vinyl ether concentrations. 
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Figure 2-12. (A) The formation of pyrazoline from the reaction between 5 M 1 and 
varying concentrations of 3-buten-1-ol monitored by the fluorescence increase at 480 
nm. Samples were excited at 318 nm. (B) The linear dependence of apparent rates of the 
reaction between 1 and 3-buten-1-ol on the 3-buten-1-ol concentrations. 
 
 
 
Figure 2-13. Hydrolysis of nitrile imine in the ACN/PBS (1:1) buffer monitored by UV 
absorption decrease at 315 nm. 
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Figure 2-14: (A) Fluorescent labeling of sfGFP variants with 1. The image at the top 
panel was the Coomassie blue stained gel; the bottom panel was the fluorescent image of 
the same gel before Coomassie blue staining. The image was detected by BioRad 
ChemiDoc XRS+ system under UV irradiation. (B) The ESI-MS spectra of the original 
(in red) and labeled (in blue) sfGFP-S2AcrK proteins. 
 
 
Figure 2-15. Simulated fluorescent labeling of 1 M proteins with different olefins 
incorporated with 500 M 1.  
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To demonstrate the nitrile imine-olefin cycloaddition for the fluorescent protein 
labeling, we expressed sfGFP variants that were incorporated with AcrK, CrtK, and 
three other olefin-containing tyrosine analogs, illustrated in Figure 2-14A as 3-5, at the 
sfGFP S2 position. The genetic incorporation of 3 and 4 was demonstrated previously 
using a rationally designed PylRS mutant.
74
 This same mutant also recognizes 5. sfGFP 
variants (14 M) were incubated with 1 (70 M) in a Tris-HCl buffer (pH 7.4) at RT for 
1 h, fully denatured, and then analyzed by SDS-PAGE. The cyclization product of 
sfGFP-S2AcrK and sfGFP with CrtK incorporated at S2 (sfGFP-S2CrtK) displayed 
detectable fluorescent emission when irradiated by UV light (Figure 2-14A). The signal 
from sfGFP-S2CrtK is relatively weak and was estimated as 17% of that from sfGFP-
S2AcrK. This was consistent with the simulation results for reactions of 1 with 
acrylamide and crotonamide (Figure 2-15). However, sfGFP variants incorporated with 
3-5 did not show significant fluorescent signals after their reactions with 1. Prolonging 
the reaction time did not appreciably improve the labeling efficiency. Giving the low 
cyclization reactivity of 3-5 with 1, 1 preferentially underwent hydrolysis, leading to low 
labeling efficiency (Figure 2-15). To verify the cyclization product of sfGFP-S2AcrK, it 
was subjected to ESI-MS analysis. The major detected peak (28,085 Da) agrees well 
with the calculated labeling product (28,083 Da) (Figure 2-14B). The original protein 
could be barely detected. 
To explore the possibility of labeling the acrylamide moiety with 1 in living 
cells, plasmid pETDuet-OmpXTAG was constructed for expressing the E. coli outer 
membrane protein OmpX incorporated with AcrK (OmpX-AcrK). The OmpX gene in 
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pETDuet-OmpXTAG has an AAAAXAA (A denotes alanine; X denotes an amber 
mutation) insertion between its two extracellular OmpX residues S53 and S54. 
Transforming BL21(DE3) cells with pEVOL-PrKRS and pETDuet-OmpXTAG and 
growing the transformed cells in LB medium supplemented with 1 mM IPTG and 5 mM 
AcrK afforded OmpX-AcrK overexpression (Figure 2-16A). Incubating the lysate of 
cells expressing OmpX-AcrK with 1 (0.5 mM) at RT for 1 h led to a detectable 
fluorescent band in a SDS-PAGE gel that corresponded well with the Coomassie blue 
stained OmpX-AcrK in the same gel. While many proteins in the lysate were present at 
higher expression levels, in-gel fluorescence imaging showed that only the expressed 
OmpX-AcrK could be specifically labeled, giving nearly no detectable background 
(Figure 2-16A). With the success of the cell lysate labeling, experiments were 
conducted to fluorescently label living cells with 1 by incubating the PBS-washed E. coli 
that overexpressed OmpX-AcrK with 1 (0.5 mM) at RT for 1 h. The cells were then 
washed with an isotonic saline solution and subjected to confocal microscopy imaging. 
E. coli cells expressing OmpX-AcrK showed detectable fluorescence (Figure 2-16B), 
indicating the cycloaddition is biocompatible and highly selective. The low variation in 
florescence lifetime profiles for all cells indicates a uniformity of dye states consistent 
with single-site covalent binding of the dye to the cell membrane and not of multiple dye 
environments typical of electrostatically bound or internalized dyes (Figure 2-17). We 
also noticed that the labeled OmpX-AcrK is not uniformly distributed on the E. coli cell 
membrane. This preferential accumulation of OmpX at the two poles of E. coli needs to 
be further investigated. The same reaction to label E. coli cells without OmpX-AcrK did 
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not yield any fluorescent cells that could be detected by confocal fluorescent microscopy 
(Figure 2-18). 
 
 
  
Figure 2-16: (A) Labeling OmpX-AcrK in a cell lysate with 1. The first lane shows a 
control without expressed OmpX-AcrK. (B) Confocal fluorescent imaging of cells 
overexpressing OmpX-AcrK and labeled with 1. The top left image shows the 
fluorescent imaging of multiple cells; the top right is the corresponding DIC image; the 
bottom right is the DIC image of a single cell; the bottom left is the overlay of the DIC 
and the confocal fluorescent image of a single E. coli. 
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Figure 2-17. (A) DIC images of a ca. 100 individual labeled E. coli. (B) FLIM imaging 
overlaid on DIC.  Note the low variation in lifetime profiles for all cells present, 
indicating a uniformity of dye states consistent with single site binding and not 
indicative of multiple dye environments typical of electrostatically bound or internalized 
dyes. 
 
 
 
Figure 2-18. Fluorescence confocal and DIC image of single E. coli from the control 
group, which is not expressing OmpX-AcrK.  Fluorescence collection parameters 
were similar to the OmpX-AcrK provided in figure 2-16B with identical scan rates, 
excitation power and monochrometer settings.  Fluorescence intensity was not 
above background nor was it co-localized with the E. coli control group. 
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Figure 2-19. (A) The genetic incorporation of AcrK and PrK into the S2 position of 
sfGFP. Proteins were expressed in cells that contained pEVOL-PrKRS and pET-
sfGFPS2TAG and were grown in LB media supplemented with 1 mM AcrK or PrK. (B) 
The genetic incorporation of BuK and CrtK into the sfGFPS2 position. Proteins in third 
and fourth lanes were expressed in cells that contained pEVOL-BuKRS and pET-
sfGFPS2TAG and were grown in LB media supplemented with 1 mM BuK or CrtK. The 
first two lanes indicated the sfGFP expression levels using wild type PylRS. (C) ESI-MS 
spectra of sfGFP2 with PrK incorporated at S2 (sfGFPS2-PrK) and sfGFP with BuK 
incorporated at S2 (sfGFPS2-BuK). Calculated molecular weights are 27,766 Da for 
sfGFPS2-PrK and 27,780 Da for sfGFPS2-BuK. 
 
 
 
Figure 2-20. ESI-MS spectrum of sfGFPS2 incorporated with NAA 5.  The theoretical 
molecular weight of sfGFPS2-NAA5 is 27,874 Da. 
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Conclusion 
In summary, we report a method for the genetic installation of a small electron 
deficient olefin, acrylamide, into recombinant proteins in E. coli. Being a multifaceted 
chemical group for functionalizing proteins, the acrylamide moiety is relatively stable in 
physiological conditions and undergoes a number of biocompatible and unique reactions. 
We demonstrate that acrylamide-containing AcrK can be genetically encoded using an 
evolved PrKRS-tRNACUA
Pyl
 pair and the genetically incorporated AcrK mediated efficient 
1,4-addition, radical copolymerization, and 1,3-diplor cycloaddition reactions on 
proteins. These unique reactions provide a direct route to applications that include 
synthesizing PEGylated therapeutic proteins for disease intervention and generating 
protein-immobilizing hydrogels for ELISA, microarray/microfluidic detections. One 
reaction is proven viable for site-selective protein labeling in living cells for protein 
functional investigations. The 1,4- addition reaction to PEGylate an acrylamide in a 
protein produces a selective and simple thioether linkage that is likely well tolerated in 
the biological system, potentially providing an advantage over the existing PEGylation 
techniques. The nitrile imine-acrylamide cycloaddition reaction presented in this study 
displays fast kinetics and high selectivity and is performed without catalyst or light 
activation. This reaction can be potentially used as an excellent alternative for in vivo 
protein labeling to the most popular click reaction type, the azide-alkyne cycloaddition 
that requires a Cu(I) catalyst and therefore may disrupt certain cellular functions.
14, 91
 
The current study also identified mutant PylRS variants that allow the synthesis of 
proteins incorporated with PrK, BuK, and CrtK. Propionylation, butylation, and 
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crotonylation are naturally existing posttranslational lysine modifications of proteins.
92, 
93
 In line with others,
86, 87, 94
 we have provided approaches that can be applied to 
investigate these novel posttranslational modifications. 
 
Experimental Section 
Kinetic Analysis of Acrylamide-Thiol 1,4-Addition Reaction 
Reaction conditions: In a NMR tube, 5 mM acrylamide in 0.1 M sodium 
phosphate buffer (pH 7.4 or pH 8.0) was added 30 mM -ME solution. A trace amount 
of acetonitrile was added as the internal 1H standard. The reaction was maintained at RT 
and subjected to 1H NMR analysis at different times. NMR spectra were acquired every 
5 minutes during the first 2 h and acquired every 10-30 minutes after the first 2 h. The 
appearance of a chemical shift at 3.88 ppm represents the sp
3
 protons on the carbon of 
the product. Signals from this chemical shift were integrated and drawn against time 
shown in SI Figures 1 & 2. These time-dependent chemical shift signal increase data 
were fitted to a single exponential equation to give pseudo first order reaction rate 
constants as 0.000120 ± 0.000009 s
-1
 at pH 7.4 and 0.00038 ± 0.00002 s
-1
 at pH 8.0. 
Since k’ = k × [-ME], where k’ is the pseudo first order rate constant, k the second 
order rate constant, [-ME] the -ME concentration (30 mM), the first calculated second 
order rate constants are 0.0040 ± 0.0003 s
-1
 at pH 7.4 and 0.013 ± 0.001 s
-1
 at pH 8.0. If 
the acrylamide-thiol 1,4-addition reaction followed the reaction mechanism shown in 
Scheme 1, the logarithm of the determined second order rate constants between 
acrylamide and -ME at different pH values would be linearly dependent on pH. Based 
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on this assumable linear dependence, theoretically the second order rate constant at pH 
8.0 would be 4 times of that at pH 7.4, which is close to the 3.1 times difference 
determined experimentally. 
 
 
Scheme 2-2. The pH dependent acrylamide-thiol 1,4-addition reaction. 
 
Identification of PylRS Mutants 
Library Construction 
The plasmid pBK-MmAcKRS1 was derived from pBK-MmPylRS plasmid 
reported previously.
85
 The gene MmAcKRS1 was amplified from pAraCB2
82
 using a 5’-
end primer containing a NdeI site:  5'-gaatcccatatggataaaaaaccactaaacactctg-3' and a 3’-
end primer containing a NsiI site: 5'-gtttgaaaatgcatttacaggttggtagaaatccc-3'. The 
amplified gene was cloned into pBK plasmid to replace the original synthetase gene. The 
resulting plasmid, pBK-MmAcKRS1, has synthetase expression under the control of 
constitutive E. coli glnS promoter and terminator.  
To identify mutant synthetases specific for recognizing AcrK and CrtK, a 
MmAcKRS1 library was constructed with randomization at Y384. Two primers 
mAcKRS-Y384NNK-F: 5’-gattcctgcatggctNNKggggatacccttgatg-3’ and mAcKRS-
Y384NNK-R: 5’-catcaagggtatccccMN Ngaccatgcaggaatc-3’ (N=A/C/T/G; T, K=G/T; 
M=C/A) were used to amplify pBK-MmAcKRS1. The PCR product was phosphorylated 
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with T4 PNK, ligated with T4 DNA ligase and heat killed before transformation. The 
same primers were used to create a pBK-MmPylRS plasmid library with randomization 
at Y384 of its encoded MmPylRS gene. 
 
Library Screening 
The pBK-MmAcKRS1 or pBK-MmPylRS plasmid library and the positive 
selection plasmid pY+ were used to cotransform E. coli Top10 cells.  The plasmid pY+ 
encodes the tRNACUA
Pyl
 gene (PylT), a chloramphenicol acetyltransferase gene with an 
amber mutation at position D112, a T7 RNA polymerase gene with two amber mutations 
at its N-terminus, and a green fluorescent protein (GFP) gene under control of a T7 
promoter.
85
 The transformed cells were plated on LB agar plates supplemented with 
kanamycin (Kan, 50 μg/ mL) and tetracycline (Tet, 25 μg/ mL). The afforded single 
colonies were transferred to 96-well plates in which each well contains LB broth with 50 
ug/mL Kan and 25 ug/mL Tet and incubated at 37
o
C to allow cell propagation. After 6 
hours, the cells on the 96-well plate were dotted on a screening plate containing GMML 
agar, Cam (68 μg/mL), Kan (50 μg/mL), Tet (25 μg/mL) and a NAA (2 mM). A plate 
without NAA served as the control. Plates were incubated at 37
o
C for overnight. The cell 
phenotypic differences of viability and fluorescence intensity were analyzed and 
photographed. The clones with strong fluorescence on the NAA-containing plate and 
low viability and fluorescence on the control plate were selected as the active clones and 
were amplified from the corresponding wells in the 96-well plate. The pBK plasmid of 
 49 
 
the active clones was isolated and sequenced. Most of the active clones were converged 
to contain a Y384W mutation (Figure 2-2). 
 
sfGFP Protein Expression and Purification 
DNA Sequence of sfGFP 
atgtagaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaatgggcacaaattttctgtcc
gtggagagggtgaaggtgatgctacaaacggaaaactcacccttaaatttatttgcactactggaaaactacctgttccgtggcc
aacacttgtcactactctgacctatggtgttcaatgcttttcccgttatccggatcacatgaaacggcatgactttttcaagagtgcc
atgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggacctacaagacgcgtgctgaagtcaagtttgaa
ggtgatacccttgttaatcgtatcgagttaaagggtattgattttaaagaagatggaaacattcttggacacaaactcgagtacaac
tttaactcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaacgttgaag
atggttccgttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagacaaccattacctgt
cgacacaatctgtcctttcgaaagatcccaacgaaaagcgtgaccacatggtccttcttgagtttgtaactgctgctgggattaca
catggcatggatgagctctacaaaggatcccatcaccatcaccatcactaa 
 
Protein sequence of sfGFP: 
MASKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKL
PVPWPTLVTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTY
KTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGI
KANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKR
DHMVLLEFVTAAGITHGMDELYKGSHHHHHH 
*The ncAA incorporation site is highlighted in red. 
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Plasmid pEVOL-PylT-PrKRS Construction 
The pEVOL-PylT-PrKRS plasmids were derived from the pEVOL-PylT plasmid 
reported previously. The PrKRS gene was PCR amplified from the identified pBK-
PrKRS plasmids using primers pEVOL-PylRS-SpeI-F: 5’-
gaggaaactagtatggataaaaaaccactaaacactctg-3’ and pEVOL-PylRS-SalI-R: 5’-
tgatggtcgactcacaggttggtagaaatcccgtt-3’. The PCR product was digested by SpeI and SalI 
restriction enzymes, and ligated to a similarly digested pEVOL-PylT plasmid. 
 
Plasmid pEVOL-PylT-BuKRS Construction 
The pEVOL-PylT-BuKRS plasmid was derived from the pEVOL-PylT plasmid 
reported previously.74 The BuKRS gene was PCR amplified from the identified pBK-
BuKRS plasmids using primers pEVOL-PylRS-SpeI-F: 5’-
gaggaaactagtatggataaaaaaccactaaacactctg-3’ and pEVOL-PylRS-SalI-R: 5’-
tgatggtcgactcacaggttggtagaaatcccgtt-3’. The PCR product was digested by SpeI and 
SalI restriction enzymes, and was ligated to a similarly digested pEVOL-PylT 
plasmid. 
 
Protein Expression in E. coli and Protein Purification  
The plasmid pET-sfGFPS2TAG reported previously
 
was used to express sfGFP 
proteins for NAA incorporation and characterization.
74
 E. coli BL21(DE3) cells were 
transformed with pEVOL-pylT-AcrKRS and pET-sfGFPS2TAG and plated on LB agar 
plate containing chloramphenicol (Cam) (34 μg/mL) and ampicillin (Amp) (100 μg/mL). 
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A 5 mL o/n culture was prepared from a single colony. This overnight culture was used 
to inoculate 500 mL of LB medium supplemented with Cam and Amp. Cells were grown 
at 37 
o
C in an incubator (250 r.p.m.) and the protein expression was induced with 1 mM 
IPTG, 0.2% arabinose and 2 mM AcrK when OD600 reached 0.6. After 8h induction, 
cells were harvested, resuspended in a lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 
mM imidazole, pH 8.0), and sonicated  in an ice/water bath four times (4 min each, 10 
min interval to cool the suspension below 10 
o
C between each pulse). The cell lysate was 
centrifuged (60 min, 11,000 g, 4 
o
C). The supernatant was incubated with 3 mL Ni-NTA 
resin (Qiagen) (2 h, 4 
o
C). The slurry was then loaded to a column and the protein-bound 
resin was washed with 30 mL of the wash buffer. Protein was finally eluted by the lysis 
buffer with 250 mM imidazole. Eluted fractions were collected, concentrated and buffer 
exchanged to 10 mM ammonium bicarbonate using an Amicon Ultra-15 Centrifugal 
Filter Devices (10k MWCO cut, Millipore). The protein purity was analyzed by 15% 
SDS-PAGE. sfGFP
 
proteins incorporated with CrtK (sfGFP-CrtK) was similarly 
expressed and purified by supplementing 5 mM CrtK in the growth medium. 
 
sfGFPS2AcrK Protein Labeling with -Mercaptoethanol via 1,4-Addition 
-Mercaptoethanol (40 mM) was added to the solution of sfGFP-AcrK (40 μM) 
in 0.1 M Tris-HCl buffer (pH 8.8). The solution was incubated at 37 
o
C for 8h. DTT 
(5mM) was then added and incubated at RT for an additional 1h. The sample was further 
treated by Zip-tip (Millipore) before subjected to the ESI-MS analysis (Figure 2-4).  
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sfGFPS2AcrK Protein PEGylation 
Methoxypolyethylene glycol thiol 5k (Nanocos Inc.) (50 mM) was added into the 
solution of sfGFP-AcrK (40 M) in 0.1 M Tris-HCl buffer (pH 8.8). The solution was 
incubated at 37 
o
C for 8h. The solution was then added DTT (5 mM) and was incubated 
at RT for an additional 1h before subjected to the SDS-PAGE analysis. An equal amount 
of wild-type sfGFP was treated in parallel as the control experiment. 
 
sfGFPS2AcrK Protein Immobilization on Hydrogel via Radical Copolymerization  
To the solution of sfGFP (5 g) in PBS buffer (15 L) was added equal volume 
of 30% acrylamide/bis-acrylamide solution (29:1) and -ME (0.5% of final conc.). 
N,N,N’,N’-tetramethylenylenediamine (TEMED) (0.1 L) and ammonium persulfate (1 
L) was added into the mixture before loaded into the sample well of a 15% native 
polyacrylamide gel. The gel was left on bench top for 30 min to allow completion of the 
copolymerization. The gel was then applied under electrophoresis conditions with native 
running buffer (5 mM Tris-HCl, 30 mM glycine, pH 8.6). An equal amount of wild-type 
sfGFP was loaded next to immobilized wild-type sfGFP hydrogel as the control. After 
electrophoresis, the whole gel was visualized under blue light and photographed. 
 
Kinetics Analysis of Nitrile Imine-Olefin Cycloaddition 
The reactions between 5 M 1 and varying concentrations of olefins in a 2 mL 
buffer that contained PBS and acetonitrile (1:1) were fluorescently monitored using a 
PTI QM-40 fluorescent spectrophotometer. The fluorescence increment from the 
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cyclized pyrazoline product was monitored with excitation at 315 nm and emission at 
480 nm. Measurements were stopped once the signal reaches maximum mostly 60 to 90 
min. The fluorescent increment data were fitted to a single exponential increase equation 
𝐹 = 𝐹1 − 𝐹2 × 𝑒
(−𝑘′×𝑡), where F is the detected fluorescent signal at a give time, F1 the 
final fluorescence, F1-F2 the background fluorescent signal, and k’ the apparent pseudo 
first order reaction rate constant. The resulted values for k’ were plotted against olefin 
concentrations and fitted to equation 𝑘′ = 𝑘1 × [𝑜𝑙𝑒𝑓𝑖𝑛] + 𝑘2, where k1 is the second 
order rate constant for the reaction between an olefin and nitrile imine 2 and k2 is the 
hydrolysis rate constant of 2. All the data are shown in Figures 2-8 - 2-12. 
 
Hydrolysis of Nitrile Imine 
The UV absorbance decay of 50 M 1 in a 2 mL buffer that contained PBS and 
acetonitrile (1:1) was monitored at 315 nm for about 4 h (Figure 13). The curve shows a 
single exponential decay with a k value as 0.0034 ± 0.00001 s
-1
. 
 
Simulation of Nitrile Imine Labeling of Proteins with Olefin Incorporated 
The simulation was carried out using the program COPASI. The starting reagents 
were set as 500 M for the hydrazonoyl chloride 1 and 1 M for a corresponding olefin. 
The reaction time was set as 2 h. The simulation data are shown in Figure 2-15. 
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In vitro Fluorescent Protein Labeling with Hydrazonoyl Chloride 1 
Compound 1 was added to a solution of sfGFP-AcrK in 0.1 M phosphate buffer 
(pH 7.4) and incubated at RT for 1 h. The protein was quickly purified using Ni-NTA 
resin and was subjected to SDS-PAGE analysis. In-gel fluorescence was detected by 
BioRad ChemiDoc XRS+ system under UV irradiation. All other sfGFPs incorporated 
with CrtK, 3, 4, or 5 were treated in parallel. 
 
OmpX-AcrK Expression and Fluorescent Labeling 
pETDuet-OmpX plasmid Construction 
OmpX gene with C-terminal 6xHis Tag was amplified from BL21 (DE3) cells 
using an 5’-end primer containing an NdeI site: 5’-
aggtggttcatatgaaaaaaattgcatgtctttcagcactgg-3’ and a 3’-end primer with a KpnI site: 5’-
caaagtgaggtaccttagtgatggtgatggtgatggaagcggtaa ccaacaccggcaat-3’. The PCR product 
was cloned into the NdeI and KpnI sites of pETDuet-1 to afford pETDuet-OmpX. The 
pETDuet-OmpXTAG was generated by Phusion high fidelity DNA polymerase-based 
site-directed mutagenesis with primer pairs 5’-aagccgtactgcaagcg 
ccgcagccgcataggccgcagcttctggtgactacaac-3’ and 5’-ttctcggtgtaagtgaaagaaccgatc-3’. The 
pETDuet-OmpXTAG has an AAAAXAA (A denotes alanine; X denotes an amber 
mutation) insertion between its coded OmpX residues S53 and S54. 
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Fluorescent Protein Labeling on Cell Lysates 
BL21(DE3) cell was transformed to carry two plasmids pEVOL-PylT-PrKRS 
and pETDuet-OmpXTAG. The OmpX-AcrK protein was overexpressed in LB medium 
supplemented with IPTG (1 mM) and AcrK (5 mM) at 30 
o
C for 10 h. The cell pellet 
was washed with PBS 3 times and lysed. The cell lysate was incubated with 1 (0.5 mM) 
at RT for 1 h and subject to SDS-PAGE analysis. In-gel fluorescence was detected by 
BioRad ChemiDox XRS+ system under UV irradiation. The cell culture without AcrK 
supplement in the medium served as the control. 
 
Fluorescent Protein Labeling on Living Cell 
BL21(DE3) cell was transformed to carry plasmids pEVOL-PylT-PrKRS and 
pETDuet-OmpXTAG. The OmpX-AcrK protein was overexpressed in LB medium 
supplied with IPTG (1 mM) and AcrK (5 mM) at 30 
o
C for 10 h. The cell pellet was 
washed with PBS 3 times and incubated with 1 (0.5 mM) at RT for 1 h. The cell pellet 
was then washed with isotonic saline solution 3 times and subjected to the confocal 
microscopy imaging. The cell culture without AcrK supplement in the medium served as 
the control and treated following the same protocol. 
 
Confocal Imaging 
An IX-81 base (Olympus) housing a full spectral FV-1000 (Olympus) was used 
to image the fluorescently labeled E. coli and confirm a lack of autofluorescence in the 
unlabeled E. coli.  A 405 nm ps-pulsed diode laser was used for the excitation of the 
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sample, with collection being obtained through the use of a monochrometer as a band 
pass filter (420-520 nm) followed by a photomultiplier tube (PMT).  A 20x UPlanSApo 
(na 0.75, infinity corrected) objective was used for all measurements.  Scan rates varied 
from 1 to 20 μm per second based on field of view and maximization of S/N (Figure 2-
16).  The unlabeled cells were unable to be observed via confocal fluorescence.  For 
additional confirmation of targeted binding, the E. coli cells were also imaged by 
fluorescence lifetime imaging microscopy (FLIM) (Figure 2-17).  This was 
accomplished using the same excitation regime and a time correlated single photon 
counting system (Picoquant) for detection, consisting of a gated PMT and a band-pass 
filter (470 ±35 nm) and with an laser repetition rate of 40 MHz and analyzed via the 
PicoHarp software package (Picoquant). 
 
Chemical Synthesis 
Materials and General Experimental 
Unless otherwise noted, synthetic reagents were purchased from general 
chemical manufactures including Sigma-Aldrich, TCI, Alfa Aesar, and Chem-Impex and 
were used as received without further purification. Anhydrous DMF and methanol were 
purchased from Sigma-Aldrich in sealed bottles and transferred into reaction systems by 
using air-free technique. All reactions involving moisture sensitive reagents were 
conducted in oven-dried glassware under argon atmosphere. Thin layer chromatography 
(TLC) was performed on silica 60 F-254 plates. Visualization of TLC was accomplished 
by UV irradiation at 254 nm or stained with p-anisaldehyde in acidic ethanol. Flash 
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column chromatography was performed with silica gel (particle size 32-63 μm) from 
Dynamic Adsorbents Inc. (Atlanta, GA). 
All 
1
H and 
13
C NMR spectra were obtained on Varian Mercury-300, INOVA-300 
and INOVA-500 MHz spectrometers. NMR spectra chemical shifts were reported in 
parts per million (ppm) and referenced to solvent peaks: chloroform (7.27 ppm for 
1
H 
and 77.23 ppm for 
13
C) or water (4.8 ppm for 
1
H). A minimal amount of 1,4-dioxane 
was added as the reference standard (67.19 ppm for 
13
C) for carbon NMR spectra in 
deuterium oxide. 
1
H NMR spectra are tabulated as follows: chemical shift, multiplicity 
(s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
number of protons, and coupling constant(s). Mass spectra were obtained at the 
Laboratory for Biological Mass Spectrometry at Department of Chemistry, Texas A&M 
University. 
 
 
Scheme 2-3  
 
Synthesis of N
ε
-acryloyl-L-lysine (AcrK) – Scheme 2-3  
N-Succinimidyl acrylate (6): To a solution of N-hydroxysuccinimide (NHS) 
(2.6 g, 22.6 mmol) and N,N-diisopropylethylamine (DIPEA) (3.1 mL, 17.8 mmol) in 
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anhydrous dichloromethane (50 mL) was added acryloyl chloride (1.5 mL, 18.5 mmol) 
dropwise in ice bath. The mixture was warmed to RT and stirred for 8h. The reaction 
was then diluted with ethyl acetate, washed with saturated aqueous ammonium chloride, 
brine, and dried over anhydrous MgSO4. After filtration, the filtrate was concentrated 
under reduced pressure to give a clear oil (3.4 g) that was subjected to next step without 
further purification.  
N
ε
-acryloyl-L-lysine (AcrK): Copper(II) sulfate pentahydrate (2.5 g, 10 mmol) 
in water was added into a aqueous solution of lysine hydrochloride (3.7 g, 20 mmol) and 
sodium bicarbonate (4.7 g, 56 mmol). The blue mixture was stirred at RT for 15 min, 
and then 6 from previous step (40 mL) was added as a solution in acetone. The reaction 
was stirred at RT for 8h. The blue suspension was then filtered and washed with water 
and acetone. To the afforded blue solid was added water and chloroform in equal amount 
(200 mL). The solution was stirred vigorously at RT. Solid 8-hydroxyquinoline (4.1 g, 
28 mmol) was added in one portion. The mixture was gradually turned green and the 
solution was stirred at RT for additional 30 min. The resulted in heterogeneous green 
mixture was filtered. The filtrate was washed with chloroform, concentrated in vacuo 
and further purified by ion-exchange chromatography to give a white powder as the 
desired product (3 g, 74% for two steps). 
1
H NMR (D2O, 300 MHz) δ 6.2-5.43 (m, 2H), 
5.59 (dd, 1H, J = 11.4, 1.8 Hz), 3.58 (t, 1H, J = 6 Hz,), 3.13 (t, 2H, J = 6.9 Hz), 1.71 (m, 
2H), 1.46 (m, 2H), 1.24 (m, 2H). 
13
C NMR (75 MHz, D2O) δ 175.4, 169.1, 130.6, 127.7, 
55.3, 39.6, 30.7, 28.6, 22.4. HRMS (ESI) calcd. for C9H17N2O3 [M+H]
+
 201.1234, found 
201.1241. 
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Scheme 2-4 
 
Synthesis of N

-crotonyl-L-lysine (CrtK) – Scheme 2-4 
Boc-Lys-OMe: To a solution of Boc-Lys(Cbz)-OMe (3.9 g, 10 mmol) in 
methanol was added palladium on activated carbon (Pd 10%, 0.6 g, 0.6 mmol) and the 
suspension was stirred with hydrogen bubbled through for 3 h. The product was filtered 
with celite and concentrated to be an almost colorless oil. The product was directly used 
in the next step without further purification. 
Boc-Lys(Crt)-OMe: To a solution of Boc-Lys-OMe (2.6 g, 10 mmol) in 
dichloromethane (40 mL, dried with calcium hydride) was added crotonic acid (1.76 g, 
20 mmol), followed by 4-dimethylaminopyridine (50 mg, 0.4 mmol) and N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC, 2.5 g, 13 mmol) in 
dichloromethane (10 mL) dropwise. The reaction mixture was stirred at RT under a 
balloon of argon overnight. The product was extracted by ethyl acetate ( 100 mL) and 
washed with water (60 mL twice), brine (60 mL), dried with sodium sulfate, 
concentrated and chromatographed (EtOAc/hexanes, 1:3) to give a colorless oil (2.8 g, 
85%).
1
H NMR (CDCl3, 300 MHz) δ 6.83 (m, 1H), 5.79 (d, 1H, J = 15.0 Hz), 5.66 (s, 
1H), 5.13 (d, 1H, J = 8.1 Hz), 4.26 (m, 1H), 3.72 (s, 3H), 3.29 (quart, 2H, J = 6.3 Hz), 
1.83 (dd, J = 6.9, 1.8 Hz, 3H), 1.69-1.43 (m, 4H), 1.41 (s, 9H), 1.39 (m, 2H). 
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N

-Crotonyl-L-lysine (CrtK): To a solution of Boc-Lys(Crt)-OMe (2.8 g,  8.5 
mmol) in THF (4 mL) was added sodium hydroxide solution (2 M, 20 mL, 40 mmol) 
dropwise in an ice bath. The reaction mixture was stirred at 0 
o
C for 1h then at RT for 
another 2h. The organic impurities were washed by ethyl acetate (40 mL twice) and then 
the pH of the aqueous layer was adjusted to 3 with 3 M aqueous HCl. Then the product 
was extracted by ethyl acetate (60 mL then another 20 mL), washed with water (40 mL 
twice), brine (40 mL), dried with anhydrous sodium sulfate, and concentrated to give a 
sticky colorless oil, which was then dissolved in dioxane (5 mL). Hydrochloric acid in 
dioxane (4 M, 5 mL, 20 mmol) was then added and the reaction mixture was stirred at 
RT for 1h. The solvent was removed to give an almost colorless oil (1.7g, 94%). The 
product was applied to biological studies without further purification. 
1
H NMR (D2O, 
300 MHz) δ 6.78 (m, 1H), 5.93 (d, 1H, J = 15.0 Hz), 4.01 (t, 1H, J = 6.3 Hz), 3.26 (t, 2H, 
J = 6.6Hz), 1.95 (m, 2H,), 1.85 (dd, 3H, J = 6.9, 1.5 Hz), 1.59 (m, 2H), 1.46 (m, 2H). 
13
C 
NMR (75 MHz, D2O) δ 175.8, 169.6, 142.2, 124.5, 55.3, 39.5, 30.9, 28.7, 22.4, 17.7. 
HRMS (ESI) calcd. for C10H19N2O3 [M+H]
+
 215.1390, found 215.1387. 
 
 
Scheme 2-5 
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Synthesis of N

- Propionyl-L-lysine (PrK) – Scheme 2-5 
Boc-Lys-OH: To a solution of Boc-Lys(Cbz)-OH (3.8 g, 10 mmol) in methanol 
(50 mL) was added palladium on activated carbon (Pd 10%, 0.6 g, 0.6 mmol) and the 
suspension was stirred with hydrogen bubbled through for 3 h. The product was filtered 
with celite and concentrated to be almost colorless oil. The product was directly used in 
the next step without further purification.  
Boc-Lys(Pr)-OH: Boc-Lys-OH (2.4 g, 9.8 mmol) was dissolved in the solution 
of sodium carbonate (0.5 M, 40 mL) and then propionic anhydride (2.0 mL, 15.7 mL) 
was added dropwise into the solution. The reaction mixture was stirred at RT for 2h. 
Sodium hydroxide (2 M, 20 mL) solution was added and the excessive propanoic 
anhydride was extracted by ethyl acetate. Then the pH of the aqueous phase was 
adjusted by hydrochloric acid to pH 3. The product was extracted by ethyl acetate (80 
mL) and concentrated to give a colorless oil. The product was directly used in the next 
step without further purification. 
N

- Propionyl-L-lysine (PrK): To a solution of Boc-Lys(pr)-OH (2.8 g, 9.3 
mmol) in dioxane (5 mL) was added hydrochloric acid in dioxane (4 M, 5 mL, 20 
mmol). The reaction mixture was stirred at RT for 2h. A white sticky solid precipitated 
out as the reaction went. The liquid was filtered off and the solid was washed with 
excess ethyl acetate (200 mL). The product was then dried under oil pump overnight to 
afford a slightly yellow solid (1.7 g, 90%).  
1
H NMR (D2O, 300 MHz) δ 4.05 (t, 1H, J = 
6.3 Hz), 3.16 (t, 2H, J = 6.9Hz), 2.20 (quart, 2 H, J=7.8Hz,), 1.93 (m, 2H), 1.52 (m, 2H), 
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1.44 (m, 2H). 
13
C NMR (75 MHz, D2O) δ 175.6, 173.0, 53.6, 39.3, 30.0, 29.8, 28.5, 
22.1, 10.3. HRMS (ESI) calcd. for C9H19N2O3 [M+H]
+
 203.1390, found 203.1403. 
 
 
Scheme 2-6 
 
Synthesis of N

- butyryl-L-lysine (BuK) – Scheme 2-6 
N

- Butyryl-L-lysine (BuK) was prepared in the same manner as PrK except that 
a cation exchange column was applied to purify the final product. 
1
H NMR (D2O, 300 
MHz) δ 3.72 (t, 1H, J = 6.3 Hz), 3.20 (t, 2H, J = 6.9 Hz), 2.21 (t, 2H, J = 7.5 Hz,), 1.87 
(m, 2H), 1.59 (m, 4H), 1.42 (m, 2H), 0.90 (t, 2H, J = 7.5 Hz). 
13
C NMR (75 MHz, D2O) 
δ 177.6, 175.3, 55.3, 39.5, 38.3, 30.7, 28.7, 22.4, 19.7, 13.3. HRMS (ESI) calcd. for 
C10H21N2O3 [M+H]
+
 217.1547, found 217.1550. 
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Scheme 2-7 
 
Synthesis of Hydrazonoyl Chloride 1 – Scheme 2-7 
Hydrazonoyl chloride 1 was synthesized according to a literature procedure.
27
  
Hydrazone 7: To commercially available 3,4-dimethoxybenzaldehyde (0.59 g, 
3.6 mmol) in 20 mL of benzene was added 4-methoxyphenylhydrazine hydrochloride 
(0.62 g, 3.6 mmol) at RT. The solution was stirred for 12 hours. The resulting 
heterogeneous mixture was concentrated to give a brownish solid 7 which was used in 
the next step without further purification. 
Hydrazonoyl chloride 1: To a solution of N-chlorosuccinimide (NCS) (0.71 g, 
5.3 mmol) in anhydrous dichloromethane (15 ml) was added dimethyl sulfide (DMS) 
(0.78 mL, 10.6 mmol) slowly in an ice bath. The mixture was stirred at 0
°
C for 20 min 
and cooled to -78
°
C. A solution of 7 in anhydrous dichloromethane was then added 
slowly. After complete addition, the solution was stirred for an additional 3h at the same 
temperature. The solvent-free crude product was purified by flash column 
chromatography (10% EtOAc/Hexane) to give a white powder as the desired product. 
1
H 
NMR (300 MHz, CDCl3) δ 8.27 (s, 1H), 7.45-7.52 (m, 3H), 6.92 (d, 1H, J = 2.76), 6.89 
(d, 1H, J = 8.27), 6.87 (dd, 1H, J = 8.97, J = 2.77), 3.98 (s, 3H), 3.94 (s, 3H), 3.80 (s, 
3H). 
13
C NMR (75 MHz, CDCl3) δ 154.1, 150.6, 149.0, 134.1, 127.4, 126.5, 120.1, 
118.5, 115.6, 114.8, 114.6, 110.8, 109.3, 56.2, 56.2, 56.1. 
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Scheme 2-8 
 
Synthesis of Crotonamide 8 – Scheme 2-8 
Crotonamide 8: To a solution of crotonic acid (0.5 g, 5.8 mmol), glycine ethyl 
ester hydrochloride (0.87 g, 6.2 mmol), and 4-dimethylaminopyridine (DMAP) (30 mg, 
0.25 mmol) in anhydrous dichloromethane was added 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) (1.8 g, 9.4 mmol) in an ice 
bath. The reaction mixture was warmed to RT and stirred for 8 h. The solution was 
quenched with a dichloromethane/water mixture. The organic layer was collected, 
washed with water, brine, dried over anhydrous Na2SO4 and concentrated. The crude 
product was subjected to flash column chromatography (eluted at 25% EtOAc/hexane) 
to afford a yellowish solid as the desired product. 
1
H NMR (300 MHz, CDCl3) δ 6.90-
6.80 (m, 1 H), 6.11 (bs, 1H), 5.88 (dq, 1H, J = 15, 3 Hz), 4.22 (q, 2H, J = 6 Hz), 4.09 (d, 
2H, 3 Hz), 1.87 (dt, 2H, J = 9, 3 Hz), 1.29 (t, 3H, 6 Hz). 
13
C NMR (75 MHz, CDCl3) δ 
170.4, 166.1, 141.0, 124.6, 61.7, 41.6, 18.0, 14.3. 
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CHAPTER III 
GENETICALLY ENCODED UNSTRAINED OLEFINES FOR LIVE CELL 
LABELING WITH TETRAZINE DYES* 
 
Introduction 
Owing to its high selectivity, fast reaction kinetics, and non-catalytic nature, the 
inverse electron-demand Diels-Alder cycloaddition reaction between a tetrazine and an 
olefin has emerged as a state-of-the-art approach for selective bioconjugation in live 
cells.
31, 95-99
 Previous efforts focused on applications of strained cyclic olefins or alkynes 
that react rapidly with tetrazines.
21, 22, 30, 56, 76-79, 100-104
 However, similar applications with 
unstrained olefins have been largely overlooked except a recent report of metabolic 
glycan labeling,
105
 due to the common notion that the reaction between an unstrained 
olefin and a tetrazine is not kinetically favored. Here, we systematically analysed 
unstrained olefin-tetrazine reactions and showed that several unstrained olefins readily 
reacted with a tetrazine dye and a number of unstrained olefin-bearing ncAAs can be 
genetically incorporated into proteins in Escherichia coli for selective labeling with 
tetrazine dyes. 
 
 
*Reprinted with permission from Lee, Y. J., Kurra, Y., Yang, Y., Torres-Kolbus, J., 
Deiters, A., and Liu, W. R. (2014) Genetically encoded unstrained olefins for live cell 
labeling with tetrazine dyes, Chem. Commun. 50, 13085-13088. Copyright 2014 Royal 
Society of Chemistry. 
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Results and Discussion 
We first characterized the reaction kinetics between a tetrazine dye 10 (Figure 3-
1) and a number of unstrained olefins in phosphate buffered saline (PBS) at ambient 
temperature. Three alkenyl alcohols (allyl alcohol, 3-buten-1-ol, and 4-penten-1-ol) and 
ncAAs 5-8 (Figure 3-1) were chosen to undergo kinetic analysis. The alkenyl alcohols 
were used instead of their corresponding ncAAs 1-3 due to their high solubility in PBS 
buffer. Both 2 and 3 could hardly dissolve to more than 5 mM in PBS buffer. With this 
low solubility, their reactions with 10 were too long for reliable data collection. To test 
whether terminal and non-terminal olefins react differently with 10, 2-buten-1-ol was 
also included in the analysis. Since the inverse electron-demand Diels-Alder reaction is 
highly influenced by the dienophile electron density, vinyl ethers with electron-rich 
olefins, 2-hydroxyethyl vinyl ether that corresponds to ncAA 4, and 9 were also selected 
to undergo assays with 10. Conjugation of fluorescein to a tetrazine moiety such as in 10 
inherently quenches the fluorescence from the fluorophore.
31
 Cycloaddition of the 
tetrazine moiety and an olefin abolishes this intrinsic quenching effect, leading to the 
rescue of fluorescence that can be readily detected with a fluorospectrometer. The 
reactions of all olefins with 10 were carried out in pseudo-first-order conditions in which 
the olefin concentration was at least 20-fold higher than the concentration of 10 (Figures 
3-2 - 3-11). The determined second-order reaction rate constants are presented in Table 
3-1.   
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Figure 3-1. (A) The tetrazine-olefin reaction. (B) Unstrained olefin-bearing ncAAs. (C) 
Two fluorescein-tetrazine dyes used in this study.  
 
 
A)
B)
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Table 3-1. Determined second-order reaction rate constants between various olefin 
dienophiles and 10. 
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Figure 3-2. Kinetics analysis of the inverse electron demand Diels-Alder reaction 
(DAinv) between tetrazine 10 and allyl alcohol dienophile in PBS buffer at RT. The 
fluorescence increase at 521 nm was monitored as excited at 493 nm. The inset plot 
presents the linear dependence of the reaction apparent rate (kobs) with the concentration 
of dienophile. 
 
 
 
Figure 3-3. Kinetics analysis of the DAinv between tetrazine 10 and 2-buten-1-ol 
dienophile in PBS buffer at RT. The fluorescence increase at 521 nm was monitored as 
excited at 493 nm. The inset plot presents the linear dependence of the reaction apparent 
rate (kobs) with the concentration of dienophile. 
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Figure 3-4 Kinetics analysis of the DAinv between tetrazine 10 and 3-buten-1-ol 
dienophile in PBS buffer at RT. The fluorescence increase at 521 nm was monitored as 
excited at 493 nm. The inset plot presents the linear dependence of the reaction apparent 
rate (kobs) with the concentration of dienophile. 
 
 
 
Figure 3-5 Kinetics analysis of the DAinv between tetrazine 10 and 4-penten-1-ol 
dienophile in PBS buffer at RT. The fluorescence increase at 521 nm was monitored as 
excited at 493 nm. The inset plot presents the linear dependence of the reaction apparent 
rate (kobs) with the concentration of dienophile. 
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Figure 3-6 Kinetics analysis of the DAinv between tetrazine 10 and 2-hydroxyethyl 
vinyl ether dienophile in PBS buffer at RT. The fluorescence increase at 521 nm was 
monitored as excited at 493 nm. The inset plot presents the linear dependence of the 
reaction apparent rate (kobs) with the concentration of dienophile. 
 
 
 
Figure 3-7 Kinetics analysis of the DAinv between tetrazine 10 and ncAA 5 in PBS 
buffer at RT. The fluorescence increase at 521 nm was monitored as excited at 493 nm. 
The inset plot presents the linear dependence of the reaction apparent rate (kobs) with the 
concentration of dienophile. 
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Figure 3-8 Kinetics analysis of the DAinv between tetrazine 10 and ncAA 6 in PBS 
buffer at RT. The fluorescence increase at 521 nm was monitored as excited at 493 nm. 
The inset plot presents the linear dependence of the reaction apparent rate (kobs) with the 
concentration of dienophile. 
 
 
 
Figure 3-9 Kinetics analysis of the DAinv between tetrazine 10 and ncAA 7 in PBS 
buffer at RT. The fluorescence increase at 521 nm was monitored as excited at 493 nm. 
The inset plot presents the linear dependence of the reaction apparent rate (kobs) with the 
concentration of dienophile. 
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Figure 3-10 Kinetics analysis of the DAinv between tetrazine 10 and ncAA 8 in PBS 
buffer at RT. The fluorescence increase at 521 nm was monitored as excited at 493 nm. 
The inset plot presents the linear dependence of the reaction apparent rate (kobs) with the 
concentration of dienophile. 
 
 
 
Figure 3-11 Kinetics analysis of the DAinv between tetrazine 10 and ncAA 9 in PBS 
buffer at RT. The fluorescence increase at 521 nm was monitored as excited at 493 nm. 
The inset plot presents the linear dependence of the reaction apparent rate (kobs) with the 
concentration of dienophile. 
  
3 10
5
3.5 10
5
4 10
5
4.5 10
5
5 10
5
5.5 10
5
6 10
5
0 1000 2000 3000 4000 5000 6000
R
e
l.
 F
lu
. 
In
t.
 (
A
U
)
t (s)
0.0004
0.0005
0.0006
0.0007
0.0008
0.0009
0.035 0.04 0.045 0.05 0.055 0.06 0.065
k
o
b
s
 (
M
-1
 s
-1
)
HeK (8) Conc. (M)
R2= 0.9915
Dienophile: 
4 10
5
4.5 10
5
5 10
5
5.5 10
5
6 10
5
6.5 10
5
0 1000 2000 3000 4000
R
e
l.
 F
lu
. 
In
t.
 (
A
U
)
t (s)
0.0005
0.001
0.0015
0.002
0.0025
0.02 0.04 0.06 0.08 0.1 0.12 0.14
k
o
b
s
 (
M
-1
 s
-1
)
 (9) Conc. (M)
R2= 0.9857
Dienophile: 
 74 
 
As shown in Table 3-1, all tested unstrained olefins reacted readily with 10 with 
second-order rate constants more than 0.001 M
-1 
s
-1
. Both inductive and resonance 
effects of an olefin substituent significantly influence its reactivity with respect to 10.
106, 
107
 Electron withdrawing effects of the hydroxyl group and the amide group gradually 
diminish, correlating well to gradually improved reactivities from allyl alcohol to 4-
penten-1-ol and 6 to 8, respectively. Two vinyl ethers, 2-hydroxyethyl vinyl ether and 9, 
display relatively higher reactivities toward 10 in comparison to other tested olefins due 
to the strong electron donating resonance effect of the vinyl ether oxygen atom. The 
sluggish reaction between 5 and 10 is attributed to the electron withdrawing resonance 
effect of the amide group. In comparison to the allyl alcohol, 2-buten-1-ol reacts 
significantly slower with 10, indicating that the methyl substituent adds steric hindrance. 
Although our kinetic analysis indicates much slower reactions with a tetrazine for 
unstrained olefins compared to strained ones,
98
 the determined second-order rate 
constants are comparable to those of the Staudinger ligation (k = 0.002 M
-1
s
-1
)
16
 and the 
copper-free dibenzocyclooctyne-azide  cycloaddition (k = 0.0565 M
-1
s
-1
),
108-112
 two 
reactions that have been well adopted for bioconjugation in live cells. In comparison to 
strained olefins, unstrained olefins can be more easily prepared and are generally more 
stable toward cellular nucleophiles (except 5).
113
 Their genetic installation in proteins 
followed by selective bioconjugation with tetrazine dyes can potentially provide a simple 
and readily adoptable protein labeling approach in live cells. 
Encouraged by our kinetic analysis, we proceeded to recombinantly synthesize 
proteins carrying site-specifically incorporated unstrained olefins in E. coli. We 
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previously reported that a rationally designed pyrrolysyl-tRNA synthetase (PylRS) 
mutant with two mutations, N346A and C348A, (PylRS(N346A/C348A)) together with 
tRNACUA
Pyl
 is able to mediate the genetic incorporation of 1-4 into proteins at an amber 
codon in E. coli.
70, 74, 114, 115
 This system was applied to synthesize four superfolder green 
fluorescent protein (sfGFP) variants with 1, 2, 3, or 4 incorporated at their S2 positions 
(sfGFP-1, sfGFP-2, sfGFP-3, and sfGFP-4). To synthesize the sfGFP variant with 5 
incorporated at its S2 site (sfGFP-5), a previously evolved PylRS mutant PrKRS 
together with tRNACUA
Pyl
 was used.
26
 Although systems for the genetic incorporation of 6-
9 has not been described in the literature, our studies indicated that another previously 
evolved PylRS mutant BuKRS is able to recognize them as substrates.
26
 BuKRS together 
with tRNACUA
Pyl
 was therefore applied for the synthesis of sfGFP variants with 6, 7, 8, and 9 
at their S2 positions (sfGFP-6, sfGFP-7, sfGFP-8, and sfGFP-9) and the site-specific 
incorporation of 6-9 was verified by electrospray ionization mass spectrometry (ESI-
MS) analysis (Figures 3-17 - 3-20). The sfGFP variants were purified and then subjected 
to the fluorescent labeling with 10 at physiological pH in PBS buffer before they were 
denatured and analyzed by SDS-PAGE. Direct in-gel fluorescence detection showed 
strong fluorescent labeling of sfGFP-2, sfGFP-3, sfGFP-7, and sfGFP-8 (Figure 3-12). 
Labeling of sfGFP-1, sfGFP-5, and sfGFP-6 could be barely detected and, importantly, 
no labeling was observed for wild-type sfGFP. This labeling observation is consistent 
with the kinetic results in which 3-buten-1-ol, 4-penten-1-ol, 7, and 8 react more 
favorably with 10 compared to allyl alcohol, 5, and 6. Although 2-hydroxyethyl vinyl 
ether displayed fast kinetics when reacted with 10, sfGFP-4 did not show detectable 
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labeling with 10 on the gel. This is likely due to the cleavage of the cycloaddition 
product from sfGFP-4 to generate an aromatized 1,2-diazine-fluorescein final product 
and a sfGFP-4 derivative with its vinyl group removed.
106, 107
 Although a similar diazine 
formation reaction that followed the reaction between sfGFP-9 and 10 would retain the 
1,2-diazine-fluorescein moiety to sfGFP-9, we did not observed fluorescein-labeled 
sfGFP-9 on the gel. Since a fluorescent small molecule band was detected in the gel 
(Figure 3-13), we suspect that the final fluorescein-labeled sfGFP-9 was not stable and 
hydrolysed during the SDS-PAGE analysis that required harsh treatments such as 
heating at 100 degree for 5 min. In gels, sfGFP-2 and sfGFP-7 displayed integrated 
fluorescence intensities that were about 40% and 80% in comparison to sfGFP-3 and 
sfGFP-8 after their labeling with 10. The labeled sfGFP-3 was further subjected to the 
ESI-MS analysis that indicated close to 50% labeling efficiency (Figure 3-14). 
 
 
 
Figure 3- 12 Labeling of sfGFP variants with 10. The top panel shows Coomassie blue 
stained gels and the bottom panel presents the fluorescent imaging of the same gels 
before they were stained with Coomassie blue.  Each protein (35 μM) was incubated 
with 0.5 mM of 10 in a 50 mM Tris-Cl buffer at pH 7.4 for 8 h before they were 
precipitated in 10% TFA, fully denatured with heating at 100 °C for 5 min, and then 
analyzed by SDS-PAGE. sfGFP with no ncAA incorporated was used as a control. 
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Figure 3-13 Labeling sfGFP variants with 10. The top: Coomassie blue stained gel and 
the bottom: the fluorescent imaging of the same gel before they were stained with 
Coomassie blue. sfGFP with no ncAA incorporated was used as a control. The 
fluorescent signal of the gel indicated that sfGFP-3 and sfGFP-8 were fluorescently 
labeled with 10. sfGFP-9 did not show fluorescent signal at its corresponding sfGFP 
protein band. However, a fluorescent signal was observed at low molecule weight region 
suggesting the decomposition of the product after the reaction between sfGFP-9 and 10. 
 
 
Figure 3-14. ESI-MS analysis of the sfGFP-3 modified with tetrazine dye 10. Calculated 
mass for unmodified sfGFP-3: 27826 Da; found: 27827 Da. Calculated mass for sfGFP-
3 and tetrazine 10 conjugate: 28431 Da; found: 28432 Da. 
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Figure 3-15. Selective labeling of E. coli cells expressing OmpX-3 and OmpX-8. 
Labeling reactions were carried out in the presence of 0.5 mM 10 or 11 in the PBS 
buffer at pH 7.4 for 8 h. E. coli cells grown in corresponding media without NCAA 
supplemented served as controls (Ctrls). The left panels show bright-field images of E. 
coli cells, the middle panels show green fluorescent images of the same cells, and the 
right panels shows composite images of bright-field and fluorescent images. Scale bars 
represent 10 um. 
 
 
 
 79 
 
With the demonstration of the tetrazine reaction of unstrained alkenes for protein 
labeling in vitro, we then proceeded to test this reaction to label proteins bearing 
unstrained alkenes in live cells. Two previously constructed plasmids pEVOL-pylT-
PylRS(N346A/C348A)
70
 and pETDuet-OmpXTAG
26
 were used to transform E. coli 
BL21 cells to express an E. coli outer membrane protein OmpX with 3 incorporated at 
its extracellular domain (OmpX-3). Plasmid pEVOL-pylT-PylRS(N346A/C348A) 
carried genes for PylRS(N346A/C348A) and tRNACUA
Pyl
 and plasmid pETDuet-
OmpXTAG contained a gene coding OmpX with an AAAXAA (A denotes alanine and 
X denotes an amber mutation) insertion between two extracellular residues 53 and 54. 
The transformed cells were grown in M9 minimal medium supplemented with 1% 
glycerol, 1 mM IPTG, 0.2% arabinose, and 5 mM 3 to express OmpX with 3 
incorporated. After the expression of OmpX-3, cells were washed with PBS buffer and 
incubated with 10 (0.5 mM) in PBS buffer at room temperature for 8 h. The residual dye 
was removed by washing cells with isotonic saline. Finally the labeled cells were 
subjected to fluorescent microscope imaging. E. coli cells expressing OmpX-3 showed 
detectable fluorescence (Figure 3-15). In contrast, control cells that were grown in the 
absence of 3 did not display any fluorescence. A similar labeling reaction was carried 
out to label E. coli cells that expressed OmpX with 8 incorporated (OmpX-8). To 
express OmpX-8, plasmids pEVOL-pylT-BuKRS and pETDuet-OmpXTAG were used 
to transform E. coli BL21 cells. Plasmid pEVOL-pylT-BuKRS carried genes coding 
BuKRS and tRNACUA
Pyl
. OmpX-8 was expressed similarly as OmpX-3 except that the 
expression was done in LB medium. Since we noticed some background reaction 
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between 10 and bovine serum albumin, we employed another tetrazine-fluorescein dye 
11 that displayed a much lower reactivity toward cysteine than 10 for the following cell 
labeling analysis (Figure 3-16). Cells were incubated with 11 (0.5 mM) for 8h, washed 
with isotonic saline, and then subjected to fluorescent microscope imaging. Cells 
expressing OmpX-8 displayed strong green fluorescence. However, cells grown in the 
absence of 8 were not visibly labeled with 11. These results indicate that the unstrained 
alkene labeling reaction with a tetrazine is biocompatible and highly selective. 
 
 
 
Figure 3-16. Labeling of sfGFP variants and bovine serum albumin (BSA) mixture with 
10. The left panel shows Coomassie blue stained gel and the right panel presents the 
fluorescent imaging of the same gel before it was stained with Coomassie blue. Each  
mixture of 35 uM sfGFP and 30 ug BSA (Thermo-Fisher Scientific Inc., Rockford, IL, 
USA) was incubated with 0.5 mM 10 in 50 mM Tris-HCl buffer at pH 7.4 for 8 h before 
they were precipitated in 10% TFA, fully denatured with heating at 100 oC for 5 min, 
and then analyzed by SDS-PAGE. 
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Figure 3-17 ESI-MS analysis of the purified sfGFP incorporated with NCAA 6 (sfGFP-
6). Top panel is the protein charge ladder and the bottom panel is the corresponding 
deconvoluted mass spectrum. Calcd. mass 27776 Da, found 27779 Da. 
 
 
 
Figure 3-18 ESI-MS analysis of the purified sfGFP incorporated with NCAA 7 (sfGFP-
7). Top panel is the protein charge ladder and the bottom panel is the corresponding 
deconvoluted mass spectrum.  Calcd. mass 27790 Da, found 27793 Da. 
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Figure 3-19 ESI-MS analysis of the purified sfGFP incorporated with NCAA 8 (sfGFP-
8). Top panel is the protein charge ladder and the bottom panel is the corresponding 
deconvoluted mass spectrum. Calcd. mass 27804 Da, found 27807 Da. 
 
 
 
Figure 3-20 ESI-MS analysis of the purified sfGFP incorporated with NCAA 9 (sfGFP-
9). Top panel is the protein charge ladder and the bottom panel is the corresponding 
deconvoluted mass spectrum. Calcd. mass 27792 Da, found 27794 Da. 
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Conclusion 
In summary, we demonstrate that an unstrained olefin can react with a tetrazine 
dye with an appreciable reaction rate that allows selective labeling of proteins on the 
surface of live bacterial cells. Given its small size, easy preparation, and high stability, 
an unstrained olefin provides a significant advantage over a strained olefin in promoting 
the general adoption of the tetrazine labeling approach for cell biology studies. With a 
size comparable to alkyne and azide, an unstrained olefin can be similarly integrated into 
metabolic surrogates for cell labeling.
16, 105, 116-119
 Its biocompatible reaction with a 
tetrazine probe potentially provides an alternative tool for metabolic labeling research. 
That can be applied to investigate the temporal and spatial synthesis of DNA, RNA, 
proteins, and carbohydrates in live cells. 
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Experimental Section 
Kinetic analysis of DAinv between tetrazine and acyclic alkenes 
Kinetic analysis of the inverse electron demand Diels-Alder reaction (DAinv) 
was performed on a PTI QM-40 spectrofluorometer (PTI, Edison, NJ, USA). The 
fluorescence increase at 521 nm was monitored as exciting the mixed reaction solution at 
493 nm in PBS buffer at room temperature. The reaction was set to be performed in 
pseudo first order kinetics manner, namely the dienophile concentration is at least 20 
times higher than that of the diene. Specifically, 0.1 mM of tetrazine 10 was mixed with 
each acyclic alkene at designated concentration (ranging from 20 mM to up to 0.5 M). 
For each diene and dienophile pair, at least three experiments with different 
concentration of subjected alkene were carried out. The measurement was stopped when 
the fluorescence reached saturation, generally in 2-3h. The fluorescent increment data 
were fitted to a single exponential increase equation 𝐹 = 𝐹1 − 𝐹2 × 𝑒
(−𝑘′×𝑡), where F is 
the detected fluorescent signal at a given time, F1 the final fluorescence, F2 the 
background fluorescent signal, and k’ the apparent pseudo first order reaction rate 
constant. The resulted values for k’ were plotted against alkene concentrations and fitted 
to equation 𝑘′ = 𝑘 × [𝑑𝑖𝑒𝑛𝑜𝑝ℎ𝑖𝑙𝑒] + 𝐶, where k is the second order rate constant for the 
reaction between an olefin and tetrazine 10. All the data are shown in Figures 3-2 - 3-11. 
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Genetic incorporation of ncAAs into sfGFP and protein expression 
Proteins Sequences 
sfGFP: 
MASKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKL
PVPWPTLVTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTY
KTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGI
KANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKR
DHMVLLEFVTAAGITHGMDELYKGSHHHHHH 
*The ncAA incorporation site is highlighted in red. 
 
Incorporation of ncAA-1, -2, -3, -4, and -5 into sfGFP 
A previously reported protocol was followed to genetically incorporate ncAA-1, 
-2, -3, -4, -5 into sfGFP.
74
 Briefly, E. coli BL21(DE3) cells were transformed with 
plasmids pET-PylT-sfGFPS2TAG and pEVOL-PylT-PylRS(N346A/C348A). The 
transformed cell was used to inoculate the LB media and was grown at 37°C with 
agitation until the OD600 reached 1.0-1.2. Then the cells were pelleted and washed with 
PBS buffer (x3). After medium shift to a minimal medium supplemented with 5 mM 
ncAA, 1 mM IPTG, and 0.2% arabinose, the cells were incubated at 37
o
C with agitation 
for 8h. All ncAAs were purchased from Chem-Impex International Inc. (Wood Dale, IL, 
USA) and used without further purification. After centrifugation, the cell pellet was 
resuspended in ice cold lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
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imidazole, pH 8.0) and lysed by sonication. The lysate was centrifuged (10000 xg, 4
o
C, 
1h) and the supernatant was subjected to Ni-NTA affinity chromatography according to 
manufacturer’s protocol. The supernatant was incubated with Ni-NTA resin (Qiagen) 
(2h, 4
o
C). The slurry was then loaded to a column and the protein-bound resin was 
washed with washing buffer (50 mM NaH2PO4, 300 mM NaCl, 45 mM imidazole, pH 
8.0) followed by eluting the bound protein with elution buffer (50 mM NaH2PO4, 300 
mM NaCl, 250 mM imidazole, pH 8.0). The eluted protein was conducted buffer 
exchange to Tris-HCl buffer (50 mM, pH 7.4) and concentrated using an Amicon Ultra-
15 Centrifugal Filter (10 kD MWCO, Millipore). The quality of the purified protein was 
analyzed by SDS-PAGE and ESI-MS. The sfGFP concentration was quantified by UV 
absorbance at 485 nm using the literature reported molar extinction coefficient 8.33x10
4
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.
120
  
 
Incorporation of ncAA-6, -7, -8, -9 into sfGFP 
A previously reported protocol was followed to genetically incorporate ncAA 6, 
7, 8, 9 into sfGFP.
26
 Briefly, E. coli BL21(DE3) cells were transformed with plasmids 
pET-PylT-sfGFPS2TAG and pEVOL-PylT-BuKRS. The transformed cell was used to 
inoculate LB media and was grown at 37 °C with agitation until the OD600 reached 0.6-
0.8. The medium was then supplemented with 5 mM ncAA, 1 mM IPTG, and 0.2% 
arabinose, followed by incubating the cells at 37 
o
C with agitation for 8 h for protein 
expression. The purification procedures are the same as described above.  
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Protein labeling with tetrazine dye on sfGFP-ncAA mutants 
sfGFP (WT or incorporated with ncAA, 20 ug) and tetrazine 10 (0.5 mM) in 
Tris-HCl buffer (50 mM, pH 7.4) were incubated at room temperature for 8 h. After the 
reaction time, protein was precipitated down using aqueous trichloroacetic acid (TCA) 
solution, followed by centrifugation to remove excessive dyes in the supernatant. The 
obtained protein pellet was further washed with ice-cold acetone, dried and resuspended 
in 1x SDS-PAGE sample loading buffer (250 mM TrisHCl pH 6.8, 250 mM DTT, 2.5% 
SDS, 10% glycerol). After fully heat-denatured, the protein was then subjected to the 
SDS-PAGE analysis. In-gel fluorescence detection was performed before coomassie 
blue staining on a Bio-Rad ChemiDoc XRS+ system (Bio-Rad, Hercules, CA, USA) 
under UV irradiation.  
 
E. Coli OmpX-ncAA mutants protein expression and protein labeling with tetrazine 
dye 
The construction of OmpX expression plasmid pETDuet-OmpXTAG was 
described previously.
26  
The expression of the OmpX with ncAA incorporation followed 
the same reported procedure with minor modification for expression optimization. 
 
OmpX-ncAA-5 Protein Expression   
BL21(DE3) cells transformed to carry plasmid pEVOL-PylT-
PylRS(N346A/C348A) and pETDuet-OmpXTAG were grown in LB medium until 
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OD600 reached 1.0. Then the cells were pelleted and washed with PBS buffer (x3). After 
medium shift to minimal medium supplemented with 5 mM ncAA, 1 mM IPTG, and 
0.2% arabinose, the cells was incubated at room temperature with agitation for 16h. 
After centrifugation, the pelleted cells were washed with PBS (x3), resuspended in PBS 
and subjected to the subsequent cell labeling procedure. The cell culture without ncAA 5 
supplement in the medium served as the control.  
 
OmpX-ncAA-8 Protein Expression 
BL21(DE3) cells transformed to carry plasmid pEVOL-PylT-BuKRS and 
pETDuet-OmpXTAG were grown in LB medium until OD600 reached 0.6-0.8. The 
medium was then supplemented with 5 mM ncAA 8, 1 mM IPTG, and 0.2% arabinose, 
followed by incubating the cells at room temperature with agitation for 16 h. After 
centrifugation, the pelleted cells were washed with PBS (x3), resuspended in PBS and 
subjected to the subsequent cell labeling procedures. The cell culture without ncAA 8 
supplement in the medium served as the control. 
 
Fluorescent E. coli OmpX-ncAA Mutants Labeling with Tetrazine Dyes 
Aforementioned E. coli cells expression OmpX-3 or OmpX-8 and tetrazine dye 
(10 for OmpX-3 and 11 for OmpX-8) (0.5 mM) in Tris-HCl buffer (50 mM, pH 7.4) 
were incubated at room temperature for 8 h with homogeneous mixing. After 
centrifugation to remove the excessive dye in the solution, the resulting cell pellet was 
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resuspended in PBS and incubated at room temperature for another 1-2 h. The cell was 
once again pelleted and washed with PBS or isotonic saline (x5), resuspended in PBS or 
isotonic saline then subjected to epifluorescence microscopy imaging. The cell culture 
without ncAA supplemented in the medium was treated with the same protocol and 
served as control experiment. 
 
Microscopy 
Microscopy was performed using an Olympus IXA81 inverted microscope 
(Olympus America, Center Valley PA, USA) equipped with UPLSAPO 100x/1.4 oil 
immersion objective, a Rolera XR CCD camera (Qimaging, Surrey BC, Canada) and a 
Proscan H117 motorized XY stage (Prior Scientific, Rockland, MA, USA) controlled by 
the µManager freeware (http://www.microAmanager.org). A field lens of 1.6x 
magnification was used to achieve Nyquist sampling for imaging. The following 
fluorescence filter sets (Chroma technology Corp., Bellows Falls, VT, USA) were used, 
with the central wavelength and bandwidth of the excitation and emission filters as 
indicated: FITC (Ex. 470/40; Em. 525/50). 
 
Chemical synthesis 
General Experimental 
All reactions involving moisture sensitive reagents were conducted in oven-dried 
glassware under an argon atmosphere. Anhydrous solvents were obtained through 
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standard laboratory protocols. Analytical thin-layer chromatography (TLC) was 
performed on EMD Millipore silica gel 60 F254 plates. Visualization was accomplished 
by UV irradiation at 254 nm or by staining with ninhydrin (0.3% w/v in glacial acetic 
acid/n-butyl alcohol 3:97). Flash column chromatography was performed with flash 
silica gel (particle size 32-63 m) from Dynamic Adsorbents Inc (Atlanta, GA).  
Proton and carbon NMR spectra were obtained on Varian 300 and 500 MHz 
NMR spectrometers. Chemical shifts are reported as  values in parts per million (ppm) 
as referenced to the residual solvents: chloroform (7.27 ppm for 
1
H and 77.23 ppm for 
13
C) or water (4.80 ppm for 
1
H). A minimal amount of 1,4-dioxane  was added as the 
reference standard (67.19 ppm for 
13
C) for carbon NMR spectra in deuterium oxide, and 
a minimal amount of sodium hydroxide pellet or concentrated hydrochloric acid was 
added to the NMR sample to aid in the solvation of amino acids which have low 
solubility in deuterium oxide under neutral conditions. 
1
H NMR spectra are tabulated as 
follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet), number of protons, and coupling constant(s). Mass 
spectra were obtained at the Laboratory for Biological Mass Spectrometry at the 
Department of Chemistry, Texas A&M University. 
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Scheme 3-1 
 
Synthetic of N

-3-Buteenoyl-L-lysine (6) – Scheme 3-1 
3-Butenoic acid succinimidyl ester (S1):  To the solution of 3-butenic acid (0.5 
mL, 5.9 mmol) in anhydrous dichloromethane (50 mL) was cooled to 0
o
C and was added 
EDC∙HCl (1.51 g, 7.9 mmol). The solution was stirred at 0oC for 10 min followed by 
addition of N-hydroxysuccinimide in one portion in an ice bath. The mixture was stirred 
at RT for 8h before the reaction was diluted with addition of water. After washing with 
water, brine, the combined organic layer was dried over anhydrous sodium sulfate, 
concentrated to afford a crude product which was further purified by flash column 
chromatography (eluted by 50% EA/Hexane) to give a white solid as the desired product 
(980 mg, 90.7%). 
1
H NMR (300 MHz, CDCl3):  6.71 (ddt, J = 10, 7, 4 Hz, 1H), 6.08-
5.99 (m, 2H), 2.84 (s, 4H), 2.20 (d, J = 7 Hz, 2H).  
N

-3-Butenoyl-L-lysine (6):  The mixture of Boc-Lys(Cbz)-OH (3.8 g, 10 
mmol) and palladium on activated carbon (10% Pd basis, 0.6 g, 5 mol%) in methanol 
(50 mL) was bubbled through hydrogen with stirring at RT for 3h. The solution was 
filtered through a celite cake before the flow through solution was concentrated. The 
 92 
 
afforded Boc-Lys-OH is clear oil and was directly used in the next step without further 
purification. To the solution of Boc-Lys-OH (1.36 g, 5.52 mmol) dissolved in THF (25 
mL) was added NaHCO3 aqueous solution (sat. in water, 25 mL) and cooled in an ice 
bath. 4-Pentenoic acid succinimidyl ester from previous step (851 mg, 4.6 mmol) was 
then added into the mixture in on portion and allowed to stir at RT. After 10h, the 
solution was acidified using 2 M HCl and the THF was removed in vacuo. The residue 
was dissolved in ethyl acetate and the solution was washed with water and brine, dried 
over anhydrous sodium sulfate and concentrated under reduced pressure. The crude 
product was further purified by silica gel flash chromatography (eluted at 5% 
MeOH/DCM) to give a colorless oil as the desired product (1.1 g, 76 %). The afforded 
product was then dissolved in dioxane (10 mL) and the solution was added hydrogen 
chloride solution (4 M in dioxane, 10 mL, 40.0 mmol). The mixture was stirred at RT for 
8h, and then the resulting white suspension was filtered and washed with diethyl ether to 
remove organic impurities. The afforded pale white solid was lyophilized overnight to 
yield the title compound as an HCl salt in quant. yield (875 mg).
 1
H NMR (300 MHz, 
D2O):  6.59 (m, 1H), 5.78 (dd, J = 15.4, 1.7 Hz, 1H), 5.68 (dd, J = 11.7, 1.7 Hz, 1H), 
3.55 (t, J = 4.9 Hz, 1H), 3.08 (t, J = 6 Hz, 2H), 1.81-1.63 (comp m, 4H), 1.48-1.33 (m, 
2H), 1.33-1.13 (m, 2H) 
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Scheme 3-2 
 
Synthetic of N

-4-Pentenoyl-L-lysine (7) – Scheme 3-2 
4-Pentenoic acid succinimidyl ester (S2):  To the solution of 4-pentenoyl 
chloride (0.2 mL, 1.8 mmol) and triethylamine (0.28 mL, 2 mmol) in anhydrous THF 
(10 mL) was added N-hydroxysuccinimide (229 mg, 2 mmol) in one portion in an ice 
bath. The mixture was warmed to RT and stirred for 10h. After removing the THF, the 
residue was dissolved in ethyl acetate then washed with water and brine. The organic 
layer was dried over anhydrous sodium sulfate and concentrated to give clear brownish 
oil that was triturated to give a white solid as the desired product (319 mg, 90%). The 
afforded product was subjected to the next step without further purification. 
1
H NMR 
(300 MHz, CDCl3):  5.84 (m, 1H), 5.19-4.96 (m, 2H), 2.81 (s, 4H), 2.63 (td, J = 4, 7 
Hz, 2H), 2.47 (m, 2H).  
N

-4-Pentenoyl-L-lysine (7):  The mixture of Boc-Lys(Cbz)-OH (3.8 g, 10 
mmol) and palladium on activated carbon (10% Pd basis, 0.6 g, 5 mol%) in methanol 
(50 mL) was bubbled through hydrogen with stirring at RT for 3h. The solution was 
filtered through a celite cake before the flow through solution was concentrated. The 
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afforded Boc-Lys-OH is clear oil and was directly used in the next step without further 
purification. To the solution of Boc-Lys-OH (1.3 g, 5.4 mmol) dissolved in THF (25 
mL) was added NaHCO3 aqueous solution (sat. in water, 25 mL) and cooled in an ice 
bath. 4-Pentenoic acid succinimidyl ester from previous step (880 mg, 4.5 mmol) was 
then added into the mixture in on portion and allowed to stir at RT. After 10h, the 
solution was acidified using 2 M HCl and the THF was removed in vacuo. The residue 
was dissolved in ethyl acetate and the solution was washed with water and brine, dried 
over anhydrous sodium sulfate and concentrated under reduced pressure. The crude 
product was further purified by silica gel flash chromatography (eluted at 5% 
MeOH/DCM) to give a colorless oil as the desired product (1.6 g, 96 %). The afforded 
product was then dissolved in dioxane (12 mL) and the solution was added hydrogen 
chloride solution (4 M in dioxane, 12 mL, 48.0 mmol). The mixture was stirred at RT for 
8h, and then the resulting white suspension was filtered and washed with diethyl ether to 
remove organic impurities. The afforded pale white solid was lyophilized overnight to 
yield the title compound in quant. yield (1.2 g). 
1
H NMR (300 MHz, D2O):  5.92-5.74 
(m, 1H), 5.11-4.97 (m, 2H), 3.70 (t, J = 6 Hz, 1H), 3.16 (t, J = 7 Hz, 2H), 2.34-2.29 (t, J 
= 7 Hz, 4H), 1.94-1.74 (m, 2H), 1.59-1.44 (m, 2H), 1.44-1.27 (m, 2H); 
13
C NMR (300 
MHz, D2O):  176.4, 174.7, 136.9, 115.6, 54.6, 38.8, 35.0, 30.0, 29.4, 28.0, 21.7. 
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Scheme 3-3 
 
Synthetic of N

-4-Hexenoyl-L-lysine (8) – Scheme 3-3 
5-Hexenoic acid succinimidyl ester (S3): To the solution of 5-hexenoic acid (2 
mL, 16.8 mmol) in anhydrous dichloromethane (80 mL) was added EDC∙HCl (4.2 g, 
21.9 mmol) and DMAP (107 mg, 0.9 mmol) in an ice bath. The solution was stirred for 
10 min and the resulting clear solution was added N-hydroxysuccinimide (2.5 g, 21.7 
mmol) in one portion in an ice bath. The reaction was warmed to RT and stirred under 
inert atmosphere for 8h before the reaction was diluted by the addition of water. The 
solution was then washed with water, brine, dried over anhydrous sodium sulfate and 
concentrated under reduced pressure. The resulting crude product was subjected to silica 
gel flash chromatography (eluted with 40% EA/Hexane) to afford an off-white crystal as 
the desired product (3.3 g, 94%). 
1
H NMR (300 MHz, CDCl3):  5.87-5.67 (m, 1H), 
5.15-5.08 (m, 1H), 5.08-4.96 (m, 1H), 2.84 (s, 4H), 2.63 (t, J = 6 Hz, 2H), 2.19 (app dd, 
J = 7 Hz, 2H), 1.86 (m, 2H). 
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N

-4-hexenoyl-L-lysine (8):  To the solution of lysine monohydrochloride (3.2 g, 
17.4 mmol) and sodium bicarbonate (5.4 g, 64.2 mmol) in H2O (40 mL) was added 
CuSO4∙5H2O aqueous solution (2.2 g, 8.8 mmol in 20 mL H2O) at room temperature. 
The resulting blue solution was stirred at room temperature for 15 minutes. The 
succinimidyl ester (S3) from previous step (3.5 g, 16.6 mmol) was dissolved in acetone 
(20 mL) and was added into the aforementioned blue solution dropwise. The mixture 
was stirred vigorously at room temperature for 10h to give a cloudy solution. After 
filtration, the pale blue solid was collected, washed with water (30 mL x3), acetone (30 
mL x3) and dried to give blue solid as the amino acid copper complex. To remove the 
copper, the blue solid was added to a 1:1 mixture of H2O and CHCl3 (160 mL), followed 
by addition of 8-hydroxyquinoline (3.6 g, 24.8 mmol) in one protein and vigorous 
stirring at room temperature for 1h. The resulting green suspension was filtered off 
under reduced pressure. The filtrate was washed with CHCl3 (100 mL x5) and 
concentrated under high vacuum pump to afford a white solid as the desired product (2.5 
g, 59% yield for three steps). 
1
H NMR (300 MHz, D2O):  5.96-5.74 (m, 1H), 5.13-4.94 
(m, 2H), 3.69 (t, J = 5.6 Hz, 1H), 3.17 (t, J = 6.7 Hz, 2H), 2.22 (t, J = 7 Hz, 2H), 2.05 
(app. q, J = 7 Hz, 2H), 1.92-1.76 (m, 2H), 1.76-1.59 (m, 2H), 1.59-1.45 (m, 2H), 1.45-
1.27 (m, 2H); 
13
C NMR (300 MHz, D2O):  176.7, 174.7, 138.4, 115.0, 54.6, 38.8, 35.0, 
32.2, 30.0, 27.9, 24.4, 21.7. 
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Scheme 3-4 
 
Synthetic of N

-(3-Methoxyacryloyl)-L-lysine (9) – Scheme 3-4 
3-Methoxyacrylic acid (S4): The mixed solution of 3-methoxyacrylic acid 
methyl ester (4 mL, 42.3 mmol) in THF (125 mL) and LiOH∙H2O aqueous solution (10.2 
g, 243 mmol in 50 mL H2O) was stirred at 65
o
C for 24h. After cooling the mixture to 
0
o
C, concentrated hydrochloric acid was added until pH = 3. The mixture was extracted 
with diethyl ether (120 mL x3), dried over anhydrous magnesium sulfate and 
concentrated under reduced pressure to give a white crystal as the desired product (3.1 g, 
72%). The afforded acid was subjected to the next step without further purification. ). 
1
H 
NMR (300 MHz, CDCl3):  7.65 (d, J = 13 Hz, 1H), 5.14 (d, J = 13 Hz, 1H), 3.68 (s, 
3H). 
3-Methoxyacrylic acid succinimidyl ester (S5) : To the solution of 3-
methoxyacrylic acid (3.1 g, 30.4 mmol) in anhydrous dichloromethane (100 mL) was 
added EDC∙HCl (7.7 g, 40.2 mmol) and DMAP (184 mg, 1.5 mmol) in an ice bath. The 
solution was stirred for 10 min and the resulting clear solution was added N-
hydroxysuccinimide (4.6 g, 40.0 mmol) in one portion in an ice bath. The reaction was 
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warmed to RT and stirred under inert atmosphere for 8h before the reaction was diluted 
by the addition of water. The solution was then washed with water, brine, dried over 
anhydrous sodium sulfate and concentrated under reduced pressure. The resulting crude 
product was subjected to silica gel flash chromatography (eluted with 40% EA/Hexane) 
to afford an off-white crystal as the desired product (3.4 g, 53%). 
1
H NMR (300 MHz, 
CDCl3):  7.81 (d, J = 12 Hz, 1H), 5.35 (d, J = 13 Hz, 1H), 3.78 (s, 3H), 2.81 (s, 4H). 
N

-(3-Methoxyacryloyl)-L-lysine (9) : To the solution of lysine 
monohydrochloride (3.2 g, 17.4 mmol) and sodium bicarbonate (5.4 g, 64.2 mmol) in 
H2O (40 mL) was added CuSO4∙5H2O aqueous solution (2.2 g, 8.8 mmol in 20 mL H2O) 
at room temperature. The resulting blue solution was stirred at room temperature for 15 
minutes. The succinimidyl ester (S5) from previous step (3.3 g, 16.6 mmol) was 
dissolved in acetone (20 mL) and was added into the aforementioned blue solution 
dropwise. The mixture was stirred vigorously at room temperature for 10h to give a 
cloudy solution. After filtration, the pale blue solid was collected, washed with water (30 
mL x3), acetone (30 mL x3) and dried to give blue solid as the amino acid copper 
complex. To remove the copper, the blue solid was added to a 1:1 mixture of H2O and 
CHCl3 (160 mL), followed by addition of 8-hydroxyquinoline (3.6 g, 24.8 mmol) in one 
protein and vigorous stirring at room temperature for 1h. The resulting green suspension 
was filtered off under reduced pressure. The filtrate was washed with CHCl3 (100 mL 
x5) and concentrated under high vacuum pump to afford a white solid as the desired 
product (2.5 g, 62% yield for three steps). 
1
H NMR (300 MHz, D2O):  7.44 (d, J = 12 
Hz, 1H), 5.38 (d, J = 12 Hz, 1H), 3.68 (app s, 4H), 3.22 (t, 6.7 Hz, 2H), 1.84 (m, 2H), 
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1.55 (m, 2H), 1.39 (m, 2H); 
13
C NMR (300 MHz, D2O):  175.0, 169.6, 160.2, 97.8, 
57.3, 54.6, 38.7, 30.1, 28.1, 21,7. 
 
 
Scheme 3-5 
 
Synthesis of Tetrazine Dye (10) – Scheme 3-5 
Tetrazine S6: 4-cyanobenzoic acid (0.5 g, 3.4 mmol), formamidine acetate salt 
(1.76 g, 17.0 mmol) and zinc (II) triflate (0.6 g, 1.7 mmol) were mixed together under 
nitrogen and cooled to 0 °C. Anhydrous hydrazine (4.2 mL, 136 mmol) was added 
slowly and the stirring reaction mixture was allowed to slowly warm to r.t. After 20 h, 
the dark brown mixture was cooled to 0 °C and an ice-cold, aqueous solution of sodium 
nitrite (2.3 g, 34.0 mmol) was added. This was followed by slow addition of ice-cold 2 
M HCl aq, during which toxic nitrogen oxide gases evolved and the mixture turned 
bright pink. The addition of aqueous HCl was continued until pH 2-3 and stirring was 
continued for another 30 min at this temperature. Ethyl acetate (20 mL) was added and 
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the phases were separated. The aqueous layer was extracted with four portions of EtOAc 
or until the last organic extract was faint pink in color. The organic layers were 
combined, washed with 1 M HCl, water and brine, dried over Na2SO4, and concentrated 
under reduced pressure. The obtained residue was purified by column chromatography 
on silica gel using DCM:acetone (3:1) to give tetrazine S6 (391.4 mg, 56%) as a bright 
pink solid. Analytical data matched previous literature values (Bioconjugate Chem. 
2011, 22, 2263). 
Tetrazine S7: Tetrazine S6 (100 mg, 0.49 mmol) was dissolved in a solution of 
DIPEA (0.21 mL, 1.22 mmol) in dry THF (7 mL). HATU (0.28g, 0.73 mmol) was added 
and the reaction mixture was allowed to stir at r.t. for 2 h under nitrogen before the 
addition of N-Boc-ethylenediamine (0.115 mL, 0.73 mmol). After 1 h, the reaction 
mixture was concentrated and the residue was dissolved in EtOAc (15 mL), washed with 
5% citric acid, water and brine, dried over Na2SO4, and concentrated under reduced 
pressure. The obtained residue was purified by column chromatography on silica gel 
using 20% acetone in DCM to afford tetrazine S7 (138 mg, 82%) as a bright pink solid. 
1
H NMR (CDCl3, 300 MHz) δ 10.25 (s, 1H), 8.68 (d, J = 8.4 Hz, 2H), 8.06 (d, J = 8.4 
Hz, 2H), 7.66 (m, 1H), 5.15 (t, J = 6.0 Hz, 1H), 3.59 (q, J = 4.8, 5.4 Hz, 2H), 3.45 (q, J = 
4.8, 5.4 Hz, 2H), 1.43 (s, 9H). 
13
C NMR (CDCl3, 75 MHz) δ 166.8, 166.1, 158.1, 138.3, 
134.2, 128.5, 128.1, 80.4, 42.9, 39.9, 28.5. ESI-MS (m/z): [M+K]
+
 calcd for C16H20N6O3 
383.4662, found 383.1213. 
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Tetrazine S8: Tetrazine S7 (90 mg, 0.26 mmol) was suspended in dry MeOH (4 
mL) and cooled to 0°C before the slow addition of 4N HCl in 1,4-dioxane (1.3 mL). The 
reaction mixture was stirred at r.t. for 45 min. The volatiles were removed under reduced 
pressure and the remaining residue was suspended in diethyl ether. The solvent was 
decanted and the procedure was repeated two more times. The pink solid was collected 
and dried under vacuum to yield tetrazine S8 (55.3 mg, 75%). The crude material was 
considered pure enough for subsequent reactions and the identity was confirmed by ESI-
MS (m/z): [M+H]
+
 calcd for C11H12N6O 245.1145, found 245.1142. 
Tetrazine dye (10): Tetrazine S8 (12 mg, 0.042 mmol) was dissolved in a 
solution of TEA (40 µL, 0.28 mmol) in dry MeOH and THF (2:1, 1.2 mL). The reaction 
mixture was cooled to 0 °C before adding fluorescein 5-isothiocyanate (FITC) (11 mg, 
0.028 mmol).  The reaction mixture was allowed to warm to rt and stirred overnight 
before concentrating and purifying by column chromatography on silica gel using a 
gradient of DCM:acetone:MeOH (80:15:5 to 45:50:5) to afford  10 (10 mg, 62%) as an 
orange solid. 
1
H NMR (Acetone-d6, 300 MHz) δ 10.45 (s, 1H), 9.57 (bs, 1H), 9.02 (bs, 
2H), 8.60 (d, J = 8.7 Hz, 2H), 8.43 (bs, 0.5H), 8.30 (bs, 0.5H), 8.16 (d, J = 8.7 Hz, 2H), 
8.05 (bs, 0.5H), 7.88 (bs, 0.5H), 7.19 (d, J = 8.1 Hz, 1H), 6.69-6.54 (m, 8H), 3.91 (m, 
2H), 3.76 (q, J = 6.0, 6.4 Hz, 2H). 
13
C NMR (Acetone-d6, 100 MHz) δ 182.2, 168.5, 
168.1, 159.6, 158.5, 152.7, 148.8, 141.3, 135.0, 130.6, 129.5, 128.5, 128.1, 124.5, 118.3, 
112.6, 111.1, 102.6, 54.8, 39.7, 31.3. ESI-MS (m/z): [M+H]
+
 calcd for C32H23N7O6S 
634.1503, found 634.1462. 
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Scheme 3-6 
 
Synthesis of tetrazine dye (11) – Scheme 3-6 
Tetrazine S9: 4-(6-(pyrimidin-2-yl)-1,2,4,5-tetrazin-3-yl)benzoic acid 
(synthesized  according to Chem. Commun. 2012, 48, 1736) (29 mg, 0.10 mmol) was 
dissolved in a solution of DIPEA (36 µL, 0.21 mmol) in dry DMF (0.6 mL). HATU (47 
mg, 0.12 mmol) was added and the reaction mixture was allowed to stir at r.t. for 1 h 
under nitrogen before the addition of N-Boc-ethylenediamine (20 µL, 0.12 mmol). After 
4 h, the reaction mixture was partitioned in EtOAc (10 mL) and water. The organic layer 
was washed with water (x3) and brine, dried over Na2SO4, and concentrated under 
reduced pressure. The obtained residue was purified by column chromatography on 
silica gel using 2-10% MeOH in DCM to afford tetrazine S9 (38 mg, 87%) as a purple 
solid. 
1
H NMR (CDCl3, 300 MHz) δ 9.12 (d, J = 4.5 Hz, 2H), 8.77 (d, J = 8.1 Hz, 2H), 
8.08 (d, J = 8.7 Hz, 2H), 7.64 (sb, 1H), 7.59 (t, J = 5.1 Hz, 1H), 5.12 (t, J = 4.2 Hz, 1H), 
3.60 (q, J = 4.5, 5.7 Hz, 2H), 3.44 (m, 2H), 1.42 (s, 9H). 
13
C NMR (CDCl3, 100 MHz) δ 
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166.8, 164.2, 163.3, 159.5, 158.6, 158.0, 138.5, 133.9, 129.0, 128.2, 122.7, 80.3, 42.8, 
39.9, 28.5. ESI-MS (m/z): [M+H]
+ 
calcd for C20H23N8O3 423.18876, found 423.19028.  
Tetrazine S10: Tetrazine S9 (28 mg, 0.066 mmol) was dissolved in dry MeOH 
(1.5 mL) and cooled to 0 °C before the slow addition of 4N HCl in 1,4-dioxane (0.5 
mL). The reaction mixture was stirred at rt for 45 min. The volatiles were removed under 
reduced pressure and the remaining residue was suspended in diethyl ether. The solvent 
was decanted and the procedure was repeated two more times. The purple solid was 
collected and dried under vacuum to yield tetrazine S10 (23 mg, 97%). The crude 
material was considered pure enough for subsequent reactions and the identity was 
confirmed by ESI-MS (m/z): [M+H]
+
 calcd for C15H15N8O 323.13633, found 323.13746. 
Tetrazine 11: Tetrazine S10 (13 mg, 0.036 mmol) was dissolved in a solution of   
TEA (39 µL, 0.28 mmol) in dry MeOH and THF (2:1, 1.2 mL). The reaction mixture 
was cooled to 0 °C before adding fluorescein 5-isothiocyanate (FITC) (11 mg, 0.028 
mmol).  The reaction mixture was allowed to warm to rt and stirred overnight before 
concentrating and purifying by column chromatography on silica gel using a gradient of 
DCM:acetone:MeOH (80:10:10 to 0:90:10) to afford  tetrazine 11 (10 mg, 50%) as an 
orange solid. 
1
H NMR (CD3OD, 400 MHz) δ 9.16 (d, 2H, J = 4.8 Hz), 8.75 (d, 2H, J = 
8.4 Hz), 8.12 (d, 2H, J = 8.4 Hz), 8.06 (d, br, 1H, J =2.4 Hz), 7.81 (t, 1H, J = 5.2 Hz), 
7.75 (d, br, 1H, J = 7.2 Hz), 7.14 (d, 2H, J = 8.0 Hz), 6.69-6.63 (m, 5H), 6.51-6.48 (m, 
3H), 3.95 (m, 2H), 3.72 (m, 2H). ESI-MS (m/z): [M+H]
+
 calcd for C36H26N9O6S 
712.17213, found 712.17463. 
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CHAPTER IV  
PHOSPHINE-ACRYLAMIDE 1,4-ADDITION AS NEW CLICK REACTION 
FOR SITE-SPECIFIC PROTEIN LABELING ON A GENETICALLY ENCODED 
ACRYLAMIDE FUNCTIONALITY 
 
Introduction 
Specifically target biomolecules in cellular context is crucial to the investigation 
of biological events. In particular, precisely probe and track the proteins of interest is 
essential to visualize, isolate and quantify the proteins from the complex biological 
mixture, in turn to understand protein dynamic, function and interactive network. 
10
 
Development of toolbox to specifically tag desired proteins accordingly has arisen to an 
emerging challenge to the research at chemistry-biology interface. Classic residue-
specific protein modification using cysteine or lysine chemistry appeared inadequate due 
to the non-specificity from identical residues of undesired proteins. Whereas, the 
approach of genetic introduction with a fluorescent protein tag, producing a traceable 
protein fusion, successfully circumvents the limitation. Though convenient, the large 
size of fluorescent protein may risk in perturbing native performance of the protein of 
interest. The development of small molecule based, highly selective, versatile and 
biocompatible methodology is high desirable. To this end, click chemistry directed 
bioorthogonal labeling has emerged as an all-around strategy for programmable protein 
engineering in living system. 
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Typical bioorthogonal reactions include Cu(I)-catalyzed or strain-promoted 
azide-alkyne cycloaddition, Staudinger ligation and hydrazide/oxime conjugates, that 
derive from functional groups of azide-alkyne, aryl phosphine-azide, and 
aldehyde/ketone-hydrazide/alkoxylamine. Despite there is strong demand on promoting 
bioorthogonal chemistry, however, there are merely handful functionalities in the 
inventory. The pressing need to develop new bioorthogonal reaction pairs is prevailing 
in chemical biology research. Recently alkene has drawn enormous emphasis in this 
regard because of alkene’s inter nature in biological system as well as high versatility 
that involves many types of organic transformations. Cyclic alkenes such as norbornene, 
trans-cyclooctene or cyclopropene react rapidly with tetrazine or nitrile imine.
121
 
Nonetheless, the stability, size and chemical accessibility of these strained alkenes are 
concerns and may not be optimal options when minimal structural perturbation of 
proteins is necessary. With regard to this, development of unstrained alkenes as clickable 
chemical reporter will be beneficial and expand the repertoire of available tools for 
bioconjugation.
26, 122
 Among the alkenyl chemical reporters, acrylamide has advantages 
over others in its small size and demonstrated multi-faceted reactivity in biological 
system.
26
 Acrylamide is essentially electron-deficient. Given that there is no 
electrophilic residue presented in canonical amino acids, an acrylamide-containing 
protein will be unique, serving as a specific acceptor for nucleophilic addition. On the 
other words, designing of a nucleophilic chemical probe to target acrylamide will 
potentially be an inimitable click reaction for bioconjugate applications. To explore this, 
we previously investigated the thiol nucleophilic 1,4-addition to acrylamide and 
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demonstrated the reaction kinetics (Scheme 4-1).
26
 While acrylamide is stable against 
thiols at pH 7.4, the thiol addition reactivity is promoted when pH is elevated to 8.8, 
which allowed achieving protein PEGylation site-specifically on the acrylamide-
incorporated protein. Although thiol-acrylamide 1,4-addition is capable of generating 
valuable bioconjugates in vitro, however, the slow kinetics is insufficient, impeding its 
application to complicated biological system or living cells due to the stringent reaction 
parameters. Therefore, the search and development of an alternative nucleophilic probe 
that gives accelerated kinetics onto the acrylamide at physiological pH is invaluable. 
Phosphine is a strong Lewis base and has superior reactivity toward -unsaturated 
compound via conjugate addition. Using trialkylphosphine as catalyst, the 
hydroalkoxylation of conjugated olefin as well as the nucleophilic thiol-ene reaction 
were accomplished, where phosphine addition to a -unsaturat alkene is kinetically 
favored.
123, 124
 Based on this observation, we proposed that the trialkylphosphine is an 
unrivaled candidate to execute the nucleophilic 1,4-addition to an acrylamide in aqueous 
buffer (Scheme 4-1). Here, we report the kinetics analysis and development of 
phosphine-acrylamide 1,4-addtion as unprecedented click reaction for bioconjugation 
applications. 
 
 
Scheme 4-1. Nucleophilic 1,4-addition to acrylamide with thiol and alkyl phosphine. 
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Figure 4-1. Kinetic analysis of nucleophilic 1,4-addition between tris(2-
carboxyethyl)phosphine (TCEP) and acrylamide by 
31
P and 
1
H NMR. (a) Reaction 
scheme. (b) Time-course 
31
P NMR experiment of phosphine 1,4-addition on acrylamide. 
The formation of the product was monitored by 
31
P NMR signal (c) 
1
H NMR experiment 
of acrylamide-phosphine reaction monitored at the proton peak at 5.83-5.74 ppm and 
6.35-6.10 ppm. The disappearances of signals were monitored. Integration of the protein 
signal was plotted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
CB
 108 
 
 
Figure 4-2. 
31
P NMR analysis of the phosphine nucleophilic 1,4-addition to acrylamide 
and demonstrated the air stability of TCEP. (A) 
31
P NMR spectrum of the reaction after 
20h reaction. The 1,4-addition product has chemical shift at 38.15 ppm. (B) 
31
P NMR 
spectrum of the reaction after 10h incubation, followed by addition of 1 uL H2O2 to 
induce TCEP oxidation where the phosphine oxide has the chemical shift at 57.58 ppm. 
 
 
 
 
 
Results and Discussion 
To test the 1,4-addition reactivity between alkyl phosphine and acrylic alkene in 
biological setup, we first look into the reaction kinetics of model reactants in aqueous 
buffer. An air-stable, aqueous-friendly and biocompatible phosphine is highly desirable 
and we found the tris(2-carboxyethyl)phosphine (TCEP) is an exceptionally felicitous 
and easy accessible candidate for initial study. Given the high solubility and stability in 
water, TCEP has been a well-adapted mild reductant employed in various biochemical 
assays both in vitro and on live cells. In coupled with acrylamide as the 1,4-addition 
t = 0
t = 10 h 
+ 1 uL 30% H2O2
t = 10 h
t = 4 h
t = 20 h
t = 1 min
t = 0 min
A B
17.30 ppm
38.15 ppm
17.30 ppm
17.30 ppm
17.30 ppm
38.17 ppm
57.58 ppm
17.30 ppm
17.30 ppm
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acceptor, the reaction between TCEP and acrylamide was investigated in aqueous buffer 
of physiological pH at room temperature (Figure 4-1A). Monitoring chemical reaction 
with phosphorus-31 nuclear magnetic resonance spectroscopy (
31
P NMR) is 
advantageous due to its decent spectrum and facile interpretation. The progression of the 
reaction is evidenced by the consumption of the starting TCEP 
31
P NMR signal at 17.6 
ppm and the concomitant formation of phosphonium product with 
31
P NMR signal at 
37.4 ppm (Figure 4-1B and Figure 4-2). Analysis of NMR signal integration indicated 
the second order rate constant of 1,4-addition determined was 0.060 ± 0.01 M
-1
 s
-1
 
(Figure 4-1B). It is notable, moreover, that after overnight reaction there is no detectable 
phosphine oxide byproduct observed, suggesting the stability of TCEP in aqueous 
condition adopted (Figure 4-2). Additionally, a parallel time course experiment using 
1
H 
NMR was performed. The depletion of the sp2 proton signal of acrylamide at 6.35-6.10 
ppm and 5.83-5.74 ppm were monitored (Figure 4-1C) and the kinetic analysis inferred 
a second order rate constant of 0.067 ± 0.002 M
-1
 s
-1
, that is in consistent with that of 
31
P 
NMR at the same condition. The determined second-order rate constants are comparable 
to those of the Staudinger ligation (k = 0.002 M
-1
 s
-1
) and the copper-free 
dibenzocyclooctyne–azide cycloaddition (k = 0.0565 M-1 s-1), two reactions that have 
been well-endorsed for bioconjugation in live cells. In comparison to the antecedent 1,4-
addition with thiol nucleophile, it is more kinetically favored with phosphine, 
approximately 20 times better, at the same pH. This promoted reaction rate will be a 
merit whenever live cell labeling is needed. Since there is no electrophilic residue of 
twenty canonical amino acids inventory, implementation of electrophilic functional 
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group such as acrylamide onto proteins will be beneficial, granting a unique chemical 
handle for programmable site-specific bioconjugation. 
Acrylamide has recently been introduced into proteins in the form of N

-acryloyl-
L-lysine (AcrK) and p-acrylamido-L-phenylanaline.
26, 125
 We took a step further to 
examine if TCEP-acrylamide chemistry can be transplanted and employed in the protein 
modification. Using an evolved pyrrolysyl-tRNA synthetase and cognate tRNA pair, our 
group previously reported the genetic incorporation of AcrK into super folder green 
fluorescence proteins (sfGFPAcrK) and demonstrated the protein bioconjugation with 
diverse reaction types including protein PEGylation via thiol nucleophilic 1,4-addition, 
albeit the reactivity is low.
26
 Same protocol was followed to recombinantly produce 
sfGFPAcrK which has an acrylamide displayed at the Ser2 position. TCEP (2 mM) was 
incubated with sfGFPAcrK (50 uM) in a Tris-HCl buffer (pH 6.8 or pH 8.8) at 37 
o
C for 
1h. 37 
o
C was used to elevate the reaction rate. Following buffer exchange to remove 
excessive phosphine, the product was subjected to electrospray ionization mass 
spectroscopy (ESI-MS) analysis. Except a minor peak of unmodified protein (27762 
Da), a major detected peak (28013 Da) agrees well with the calculated labeling adduct 
(28012 Da) (Figure 4-3). Moreover, due to the intrinsic acidity of TCEP phosphine in 
water (pKa = 7.6), the phosphine reactivity/ nucleophilicity is pH dependent. This was in 
consistent with our observation of reaction conversion at different pH, approximately 
80% and 90% modification for pH 6.8 and pH 8.8, respectively (Figure 4-3). 
Additionally, we previously demonstrated thiol 1,4-addition to acrylamide of the same 
protein using -mercaptoethanol. In compare to phosphine, -mercaptoethanol modifies 
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the protein much slower, giving roughly 50% conversion at 37
o
C, pH 8.8 and 8h 
incubation.
26
 Therefore, attributed to the high selectivity, phosphine-acrylamide 1,4-
addition is not only compatible with protein bioconjugate, but more importantly, the 
improved kinetics grants a much practical and sensible protocol of biological 
applications. 
 
 
Figure 4-3. Electrospray ionization mass spectroscopy (ESI-MS) analysis of 
acrylamide-containing super green fluorescence protein (sfGFPS2AcrK) modified with 
TCEP via nucleophilic 1,4-addition. (A) The reaction scheme. SfGFPAcrK was treated 
with TCEP in Tris-HCl buffer at 37
o
C for one hour. After buffer exchange, the product 
was then subjected to ESI-MS. (B) Stacked MS spectra of original and TCEP-treated 
sfGFPS2AcrK protein at different pH. Black trace indicates the untreated sfGFPAcrK 
protein (calculated: 27764 Da; found: 27762 Da). Blue trace and pink trace indicate 
TCEP treated sfGFPAcrK under buffers of pH 8.8 and pH 6.8, respectively, giving the 
TCEP conjugated product (calculated: 28012 Da; found: 28013 Da). 
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Figure 4-4. (A) Synthetic scheme of phosphine probes. (B) Bioorthogonal fluorescence 
labeling of the sfGFPS2AcrK protein with phosphine-dansyl probe 5a. (c) Streptavidin 
blotting of the sfGFPAcrK protein modified with phosphine-biotin probe 5b. 
 
Since phosphine and acrylamide form a favorable bioorthogonal reaction pair, to 
further extend the use of reaction in biochemical interrogation, we proceeded further to 
design and synthesize functionalized phosphine probes (Figure 4-4A). Briefly, utilizing 
A
B C
5a (              ) 5b (              )
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TCEP as scaffold, TCEP was first methyl-triesterified, followed by treatment of borane 
tetrahydrofurane solution to form a phosphine-borane complex in order to reinforce 
phosphine’s ambient stability. Stoichiometric hydrolysis of the triester afforded the 
mono-acid-di-ester phosphine-borane intermediate 3. The accessible free acid was 
conjugated with choice of reporters such as fluorophore or biotin using simple amide 
coupling. Finally, decomplexation of borane by 1,4-diazabicyclo[2.2.2]octane afforded 
the phosphine 5a as a dansyl fluorescence probe and 5b as a biotin probe (Figure 4-4).  
With 5a in hand, we proceeded to demonstrate fluorescent protein labeling on the 
genetically encoded acrylamide. sfGFPAcrK (70 uM) was incubated with probe 5a (2 
mM) in Tris-HCl buffer (pH 7.5) at room temperature (rt) for 5h. After fully denatured, 
the resulting protein was subjected to SDS-PAGE analysis. In-gel fluorescence detected 
appreciable signal where the detected area agrees well with the protein band after 
Coomassie blue staining (Figure 4-4B). However, sfGFP protein without AcrK 
incorporated did not show any positive signal under the same labeling condition (Figure 
4-4B). Interestingly, the mobility of 5a-modified sfGFPAcrK on SDS-PAGE is slightly 
higher, migrating farer than that of AcrK-free sfGFP. This may due to the contribution 
from additional positive charge derived from the formation of phosphonium product 
after 1,4-addtion. Similarly, biotin probe 5b was incubated with sfGFPAcrK. Followed 
by buffer exchange and SDS-PAGE, the resulting proteins were transferred onto a 
nitrocellulose membrane. After sequential treatment of blocking reagent and 
streptavidin-HRP, the membrane was subjected to chemiluminescent detection. As 
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expected, the sfGFPAcrK shows detectable signal, whereas sfGFP without AcrK 
incorporated doesn’t (Figure 4-4C). 
With the demonstration of the phosphine-acrylamide 1,4-addition for protein 
labeling in vitro, we then proceeded to test this reaction to label AcrK of proteins in live 
cells. Two previously constructed plasmids pEVOL-pylT-PrKRS and pETDuet-
OmpXTAG were used to transform E. coli BL21 cells to express an E. coli outer 
membrane protein OmpX with AcrK incorporated at its extracellular domain 
(OmpXAcrK). Plasmid pEVOL-pylT-PrKRS carried genes for PrKRS and tRNACUA and 
plasmid pETDuet-OmpXTAG contained a gene coding OmpX with an AAAXAA (A 
denotes alanine and X denotes an amber mutation) insertion between two extracellular 
residues 53 and 54. The expression of the protein was performed in LB medium 
supplemented with 1 mM IPTG and 5 mM AcrK afforded OmpXAcrK overexpression 
(Figure 4-4B). Incubating the lysate of cells expressing OmpXAcrK with 5a (3 mM) at 
rt for 7h led to a detectable fluorescent band in a SDS-PAGE gel that corresponded well 
with the Coomassie blue stained OmpXAcrK in the same gel. While many proteins in 
the lysate were present at higher expression levels, in-gel fluorescence imaging showed 
that only the expressed OmpXAcrK could be specifically labeled, giving virtually no 
discernible background. Following the successful cell lysate labeling, experiments were 
conducted to fluorescently label living cells with 5a by incubating the PBS-washed E. 
coli that overexpressed OmpXAcrK with 5a (4 mM) at rt for 1h. The cells were then 
washed with an isotonic saline solution and subjected to confocal microscopy imaging. 
E. coli cells expressing OmpXAcrK showed strong fluorescence (Figure 4-4C). 
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Nonetheless, cells grown in the absent of AcrK were barely fluorescent which may due 
to auto-fluorescence from the cell at the detection wavelength.   
 
 
 
 
Figure 4-5. (A) Fluorescent labeling of E. coli OmpX-AcrK with phosphine probe 5a.  
(B) Labeling OmpX-AcrK in a cell lysate with phosphine probe 5a. The second lane 
shows control without OmpX-AcrK expressed. (C) Epifluororescent cell imaging of the 
cells  
 
 
A
B C
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Figure 4-6. Metabolic incorporation of the acrylamide sugar and glycoprotein labeling 
of whole cell lysate. (A) The structural of native monosaccharide GalNAc (per-O-
acetylated form) and non-native monosaccharide surrogates with azide, GalNAz (per-O-
acetylated) or with acrylamide, GalNAcr (per-O-acetylated).  (B) HEK293T whole cell 
lysate labeling on the acrylamide glycoprotein using the phosphine probe 5b. The 
control (Ctrl) represents the whole cell lysate from the HEK293T without Ac4GalNAcr 
provided. 
 
Lastly, to evaluate if phosphine-acrylamide can serve as general chemical 
reporter pair for extended applications, we chose to demonstrate metabolic incorporation 
of sugar acrylamide and labeling. This state-of-the-art chemical biology methodology 
involves two steps, metabolic labeling of glycans with a functionalized monosaccharide 
surrogate followed by labeling of probe via bioorthogonal reaction, allows the detection 
of specific glycoconjugate on cells or the selective capture of glycoproteins from cell 
lysates. It was reported previously that the unnatural monosaccharide N-
A B
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azidoacetylgalactosamine (GalNAz) can be utilized by cells as a substitute for its natural 
counterpart N-acetylgalactosamine (GalNAc). Acrylamide is structurally highly 
resembled to acetamide, by the same token we speculated the acrylamide version of 
GalNAc, N-acryloylgalactosamine (GalNAcr), will be a granted mimic, seamlessly 
integrated into the monosaccharide incorporation machinery. Therefore, per-O-
acetylated N-acryloylgalactosamine (Ac4GalNAcr), acetylated precursor of GalNAcr, 
was synthesized. HEK293T cell were incubated with Ac4GalNAcr at a concentration of 
50 uM for 36h or 60h. The cells were then washed, lysed and the cell lysates were 
reacted with 5b (3 mM) for 1h. Followed by buffer exchange and SDS-PAGE, the 
proteins were transferred onto a nitrocellulose membrane. After sequential treatment of 
blocking reagent and streptavidin-HRP, the membrane was subjected to 
chemiluminescent detection. The labeling of the probe shows stronger signal at the 
acrylamide sugar supplemented cells in comparison with that of control cells without 
sugar. Moreover, with longer incubation of the acrylamide sugar, there is slightly 
reduced signal observed, and this might be due to the medium thiol gradually scavenges 
the acryloyl functionality. 
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Conclusion 
To recap, we report a new click type reaction which makes use of 
trialkylphosphine and acrylamide to undergo nucleophilic 1,4-addtion in aqueous buffer. 
Trialkylphosphine reacts with -unsaturated alkene preferentially to give 
phosphonium product. Comparing to thiol nucleophilic 1,4-addtion, kinetics analysis of 
the phosphine nucleophilic 1,4-addition indicates about twenty time faster reaction rate 
under the same condition. Use a biocompatible tris(2-carboxyethyl)phosphine as 
nucleophile, the acrylamide containing sfGFP is specifically labeled labeling which fall 
in live well with the kinetics studies. Given several advantages of acrylamide including 
small in size and stable in the cellular context, acrylamide and phosphine is ideal 
chemical reporter pair for bioconjugate applications. We designed the TCEP based 
fluorescence and biotin probes and demonstrated the site-specific protein labeling in 
vitro, in the cell lysate and on the bacteria. Moreover, to illustrate the phosphine-
acryladmide 1,4-addition can generalized to other biomolecule applications, metabolic 
acrylamide incorporation and labeling were carried out. This reaction presents a new 
click labeling protocol which is specific and biocompatible and can be potentially used 
as an excellent alternative tool for in vivo protein labeling and biochemical 
investigations. 
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Experimental Section 
General experimental  
All reactions involving moisture sensitive reagents were conducted in oven-dried 
glassware under an argon atmosphere. Anhydrous solvents were obtained through 
standard laboratory protocols. Analytical thin-layer chromatography (TLC) was 
performed on EMD Millipore silica gel 60 F254 plates. Visualization was accomplished 
by UV irradiation at 254 nm or by staining with ninhydrin (0.3% w/v in glacial acetic 
acid/n-butyl alcohol 3:97). Flash column chromatography was performed with flash 
silica gel (particle size 32-63 m) from Dynamic Adsorbents Inc (Atlanta, GA).  
Proton and carbon NMR spectra were obtained on Varian 300 and 500 MHz 
NMR spectrometers. Chemical shifts are reported as  values in parts per million (ppm) 
as referenced to the residual solvents: chloroform (7.27 ppm for 
1
H and 77.23 ppm for 
13
C) or water (4.80 ppm for 1H). A minimal amount of 1,4-dioxane was added as the 
reference standard (67.19 ppm for 
13
C) for carbon NMR spectra in deuterium oxide, and 
a minimal amount of sodium hydroxide pellet or concentrated hydrochloric acid was 
added to the NMR sample to aid in the solvation of amino acids which have low 
solubility in deuterium oxide under neutral conditions. 
1
H NMR spectra are tabulated as 
follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet), number of protons, and coupling constant(s). Mass 
spectra were obtained at the Laboratory for Biological Mass Spectrometry at the 
Department of Chemistry, Texas A&M University. 
 120 
 
Chemical synthesis 
 
 
Scheme 4-2. Synthesis of Phosphine Probes 5a and 5b 
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Synthesis of Phosphine Probes 5a and 5b – Scheme 4-2 
Synthesis of compound-1b: Tricarboxyethylphosphine hydrochloride (TCEP-
HCl, 2.0 g, 2.08 mmol) was stirred with 2.0 mg of sulfonic acid resin (Amberlyst) in 20 
mL methanol at room remperature for 2 h minutes. The resin was then removed by 
filtration and the filtrates, containing a mixture of mono-, di- and tri-methyl ester, were 
fractionated by flash chromotography (2-3% MeOH in DCM) to give compound -1 as 
colorless oil (0.794 mg, 34%). 
1
HNMR (CDCl3, 300 MHz): δ 3.70 (s, 9H), 2.56 (t, 6H, 
J= 9.0 Hz), 2.03-1.92(m, 6H).  
Synthesis of compound-2: The compound 1b (0.7 g, 2.39 mmol) was dissolved 
in dry THF in a flame-dried round bottom flask under an argon atmosphere. The solution 
was cooled to 0 
o
C and borane-THF (1.0 M in THF, 2.87 mL, 2.87 mmol) was added 
slowly. The reaction was stirred at 0 
o
 C for 45 min and then at room temperature for an 
additional 1.5 h. The solvent was removed under reduced pressure, and the residue was 
purified by flash chromatography (2-5% MeOH in DCM). The phosphine-borane 
complex 2 was isolated as a clear oil (0.293 g, 40%). 
1
HNMR (CDCl3, 300 MHz): δ 
3.69 (s, 9H), 2.55 (t, 6H, J= 9.0 Hz), 2.00-1.91(m, 6H).  
Synthesis of compound-3: The compound 2 (0.250 g, 0.81 mmol) was dissolved 
in dry THF/water (2:1) (18 ml) in a flame-dried round bottom flask under an argon 
atmosphere. The Lithium hydroxide (0.017 g, 0.408 mmol) was added slowly. The 
reaction was stirred at room temperature for 15 min. The reaction mixture was quenched 
with 1 M HCl then extraction with ethyl acetate (2x20 mL). The organic layer was dried 
over Na2SO4 and filtered. The solvent was removed under reduced pressure, and the 
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residue was purified by flash chromatography (2-6% MeOH in DCM). The mono-acid 
phosphine-borane complex 3 was isolated as a clear oil along with tri-ester and tri-acid 
compounds (0.071 g, 30%). 
1
HNMR (CDCl3, 300 MHz): δ 3.64 (s, 6H), 2.56-2.47 (m, 
6H) 1.96-1.87(m, 6H).  
Synthesis of compound-6: To cold (5 
o 
C) solution of D (+) Biotin (2.5.0 g, 
10.25 mmol) in DMSO (10 ml) triethylamine (1.65 mL, 12.5 mmol) was added followed 
after 5 min stirring by isobutylchloroformate (1.3 mL, 20 mmol) in 2.5 mL dioxane. The 
viscous mixture was then stirred at 5 
o
C for 30 min. A solution of 3-(tert-
butyloxycarbonylamino)propane (1.75 g, 10 mmol) and triethylamine (1,35 mL, 10 
mmol) in 10 mL dioxane was then added dropwise to the mixture. The cooling bath was 
removed and stirring continued for 4h. During this process, the solidification of the 
reaction medium was gradually observed. Cold water (30 mL) was added and the 
compound 4 was isolated by filtration, washed twice with cold water (5 mL) and dried 
(3.2 g, 80%).  
1
HNMR (CDCl3, 300 MHz): δ 6.58-6.68 (brs, 1H), 6.18-6.22 (brs, 1H), 
5.33-3.40 (brs, 1H), 4.98-5.01(brs, 1H), 4.53 (q, 1H, J = 3.3 Hz), 4.34 (t, 1H, J = 4.5 Hz), 
3.28-3.18 (m, 2H), 3.17-3.16(m, 2H), 2.92(dd, 1H, J = 3, 7.5 Hz), 2.73(dd, 2H, J = 3.3, 
11.1 Hz), 2.25-2.23 (m, 2H), 1.68-1.48 (m, 8H), 1.44 (s, 9H). 
13
NMR (CDCl3, 75 MHz): 
δ 14.9, 172.4, 163.1, 77.9, 61.5, 59.6, 55.8, 38.0, 36.5, 35.6, 33.9, 30.1, 28.6, 28.5, 28.4, 
25.7, 24.9.  
Synthesis of compound-7: To cold (5 
o 
C) solution of 4 (3 g, 7.5 mmol), in 10 
mL methylene chloride trifluroacetic acid (7 mL) was added and the solution was 
vigorously stirred for 2h at rt (monitoring by TLC). After completion, the solution was 
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evaporated in vacuo and washes with Et2O until crystallization occurred (2.3 g, 75%).  
1
HNMR (CD3OD, 300 MHz): δ 4.44-4.52(m, 1H), 4.28-4.32 (m, 1H), 3.23-3.33 (m, 
1H), 3.18-3.21 (m, 1H), 2.94-2.90 (m, 2H), 2.70 (d, 1H, J = 7.8 Hz), 2.32 (t, 1H, J = 4.2 
Hz), 2.25 (t, 1H, J = 4.5 Hz), 1.82-1.62 (m, 6H), 1.51-1.42 (m, 2H). 
Synthesis of compound-4b: To the compound 3 (0.060 g, 0.205 mmol) in DMF 
solution was added EDC.HCl (0.062 g, 0.328 mmol) and DMAP  (0.0025 g, 0.025 
mmol) in ice both and the mixture was stirred for 10-15 minutes. The amine salt 
compound  7 (0.084 g, 0.203 mmol) in anhydrous DMF was added to the above mixture 
dropwise and followed by addition of DIPEA (0.045 mL, 0.246 mmol) dropwise in ice 
bath. The mixture was warmed to room temperature and stirred for 16 hours. The solvent 
was evaporated under reduced pressure and extracted with ethyl acetate. The organic 
layer was washed with brine, dried over sodium sulfate, concentrated and purified by 
chromatography (2-3% MeOH/DCM) to give desired product 4b (0.053 g, 45%). 
1
HNMR (CDCl3, 300 MHz): δ 7.09 (t, 1H, J = 3.3 Hz), 6.81 (t, 1H, J = 6.6 Hz), 6.57 (s, 
1H),  5.71 (s, 1H), 4.54-4.58 (m,1H), 4.35-4.48 (m, 1H), 3.69 (s, 6H), 3.35-3.201 (m, 
4H), 3.15-3.16 (m, 1H), 2.89 (dd. 1H, J = 3.3, 10.2 Hz), 2.71  (d, 1H, J = 7.5 Hz), 2.59-
2.54 (m, 4H), 2.46-2.41 (m, 2H), 2.22-2.20 (m, 4H), 2.01-1.93(m, 6H), 1.72-1.61 (m, 
6H), 1.46-1.41 (m, 2H). 
13
CNMR (CDCl3, 75 MHz): δ 174.0, 172.8, 172.6, 171.5, 
164.0, 61.7, 60.2, 55.7, 52.2, 52.1, 40.6, 36.5, 36.2, 35.7, 29.3, 29.1, 28.0, 27.9, 27.4, 
25.5, 18.9, 18.7, 18.6, 18.6, 18.3. 
Synthesis of compound-8: To a solution of tert-butyl (3-aminopropyl)carbamate 
(0.64 g 3.71 mmol) and DIPEA (169 mL, 9.19 mmol) in anhydrous CH2Cl2 (15 mL) was 
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added dansyl chloride (1g, 3.71 mmol) in CH2Cl2 (10 mL) dropwise over 10 min. The 
solution was stirred at room temperature for another 2 h. After the removal of solvent, 
the residue was purified by silica gel column chromatography (hexanes/EtOAc 8:2) to 
give pure compound 8 (1.2 g, 83%). 
1
HNMR (CDCl3, 300 MHz): δ 8.56 (d, 1H, J = 8.4 
Hz), 8.36 (d, 1H, J = 8.4 Hz), 8.26 (dd, 1H, J = 1.2, 4.2 Hz), 7.62-7.50 (m, 2H), 7.21 (d, 
1H, J= 7.2 Hz), 5.73 (brs, 1H), 4.57 (brs, 1H), 3.11 (q. 2H, J = 3.3, 12.3 Hz), 2.93 (q. 
2H, J = 6.6, 13.2 Hz), 2.91 (s, 6H), 1.51-1.49 (m, 2H), 1.37 (s, 9H).  
Synthesis of compound-9:  8 (1.0 g, 2.94 mmol) was added to a flask and then 
added HCl (1.47 mL, 4.0 M in Dioxane). The resulting mixture was stirred at room 
temperature overnight. The white solid was collected via filtration and dried under high 
vacuum to give amino acid 9 (0.541 g, 65% yield). 
1
HNMR (CD3OD, 300 MHz): δ 
8.91 (d, 1H, J= 8.7 Hz), 8.62 (d, 1H, J = 8.6 Hz), 8.41 (d, 1H,J = 7.2 Hz), 8.12 (d, 1H, J 
= 6.8 Hz), 7.95-7.87 (m, 2H), 3.50 (s, 6H), 3.03-2.99 (m, 4H),1.89-186 (m, 2H). 
Synthesis of compound-4a To the  compound 3 (0.050 g, 0.171 mmol) in DMF 
solution was added EDC.HCl (0.052 g, 0.273 mmol) and DMAP  (0.0020 g, 0.0171 
mmol) in ice both and the mixture was stirred for 10-15 minutes. The amine salt 
compound  9 (0.058 g, 0.171 mmol) in anhydrous DMF was added to the above mixture 
dropwise and followed by addition of DIPEA (0.037 mL, 0.205 mmol) dropwise in ice 
bath. The mixture was warmed to room temperature and stirred for 16 hours.  The TLC 
assay was showing a new fluorescent spot after 16 hours. Water was added to quench the 
reaction and extracted with ethyl acetate. The organic layer was washed with brine, dried 
over sodium sulfate, concentrated and purified by chromatography (50% EA/Hexane) to 
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give desired product 4a (0.06 g, 65%). 
1
HNMR (CDCl3, 300 MHz): δ 8.55 (d, 1H, J= 
5.1 Hz), 5.30 (d, 1H, J = 5.1 Hz), 8.26 (d, 1H, J = 4.2 Hz), 7.60-7.52 (m, 2H), 7.21 (d, 
1H, J = 1.5 Hz), 6.01 (brs, 1H), 5.66 (brs, 1H), 3.70 (s, 6H), 3.27 (q, 2H, J = 3.9, 7.5 Hz),  
2.92 (q, 2H, J = 3.9, 5.7 Hz), 2.60 (s, 6 H), 2.56-2.58 (m, 4H), 2.37-2.42 (m, 2H), 1.98-
1.94 (m, 6H), 1.61-1.56 (m, 2H). 
13
CNMR (CDCl3, 75 MHz): 172.7, 172.6, 171.7, 
151.9, 134.9, 130.4, 129.8, 129.4, 129.2, 128.4, 123.2, 118.7, 115.2, 52.2, 52.1, 45.4, 
40.1, 36.3, 29.3, 29.1, 27.3, 18.8, 18.6, 18.5, 18.3.  
 
 
Scheme 4-3 Synthesis of Acrylamide Monosaccharide Ac4GalNAcr 
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Synthesis of Acrylamide Monosaccharide Ac4GalNAcr (14) – Scheme 4-3 
Synthesis of compound 12: To a solution of D-Glactosamine hydrochloride (0.5 
g, 2.32 mmol) in a freshly prepared aqueous solution of 1 M NaOH (4.65 mL, 4.65 
mmol) under stirring was added p-anisaldehyde (0.379 mL, 2.79 mmol). After a short 
time crystallization began. Then the mixture was refrigerated off and washed with cold 
water, and followed by a mixture of 1:1 EtOH: Et2O to give N-protected compound 11 
(0.423 g, 65%). This intermediate product 11 (0.4 g, 1.42 mmol) was added successively 
to a cooled (ice-water) mixture of Pyrindine (1.52 mL) and Ac2O (2.71 mL). A catalytic 
amount of DMAP was added and the mixture was stirred in ice-bath for 1 hour and then 
at room temperature overnight. The solution was poured into 100 mL of ice-water. The 
precipitated white product was filtered, washed with cold water and dried give 
compound 2 with  (0.398, 60%). %). 
1
HNMR (CD3Cl3, 300MHz): δ 8.18 (s, 1H), 7.66 
(d, 2H, J = 7.8 Hz), 6.92 (d, 2H, J = 7.8 Hz), 5.95 (d, 1H, J = 8.4 Hz), 5.45 (t, 1H, J = 9.6 
Hz), 5.17 (t, 1H, J= 9.6 Hz), 4.38 (dd, 1H, J = 4.5, 12.3 Hz) 4.14 (dd, 1H, J = 9.0, 12.3 
Hz), 4.02-3.97 (m, 1H), 3.86 (s, 3H), 3.47 (dd, 1H, J = 8.4, 9.6 Hz), 2.12 (s, 3H), 2.11 (s, 
3H), 2.06 (s, 3H), 1.90 (s, 3H). 
Synthesis of compound 13: Concentrated hydrochloric acid was carefully added 
in an acetone solution of 12 (0.35 g, 0.75 mmol) kept at 0 °C in an ice bath to reach pH 
5.The precipitate formed was filtered and washed with acetone to afford 13 (0.23g,  
80%). 
1
HNMR (CD3OD, 300 MHz): δ 5.89 (d, 1H, J = 8.7 Hz), 5.39 (dd, 1H, J = 9, 10.2 
Hz), 5.12 (t, 1H, J = 9.9 Hz), 4.32 (dd, 1H, J = 4.5, 12.6 Hz), 4.12 (dd, 1H, J = 2.1, 12.6 
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Hz), 4.04-4.08 (m, 1H), 3.64 (dd, 1H, J = 9.0, 10.5 Hz), 2.22 (s, 3H), 2.12 (s, 3H), 2.06 
(s, 3H), 2.05 (s, 3H).  
Synthesis of compound 14:  Et3N (0.15 mL, 1.04 4 mmol) was added to a 
stirred solution of 13 (0.2 g, 0.522 mmol). The solution was cooled to 0 °C, and acryloyl 
chloride (0.046 mL, 0.522 mmol) was added dropwise. The reaction mixture was stirred 
overnight at room temperature. The solution was concentrated in vacuo and purified on 
silica gel chromatography (hexanes 100% to hexanes/EtOAc = 1/1) to afford 14 as a 
light brown color solid (0.136 g, 65%).  
1
HNMR (CD3Cl3, 300MHz): δ 6.31 (d, 1H, J = 
1.2 Hz), 6.25-5.94 (m, 1H), 5.82-5.92 (brs, 1H), 5.76-5.8 (m, 2H), 5.26-5.10 (m, 2H), 
4.43 (dd, J = 3.5, 10.5 Hz), 4.20 (ABq, 2H, J = 2.1, 10.2 Hz), 3.88-3.84 (m, 1H), 2.12 (s, 
3H), 2.12 (s, 3H),  2.07 (s, 3H), 2.04 (s, 3H). 
13
CNMR (CD3Cl3, 75MHz): δ 171.2, 170.6, 
169.3, 165.6, 130.2, 127.3, 92.4, 72.7, 68.1, 61.8, 52.5, 20.8, 20.6, 20.6, 20.5. 
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CHAPTER V  
GENETICALLY ENCODED PERFLUORINATED PHENYLALANINES FOR 
PROBING BIOLOGICAL CATION- INTERACTIONS 
 
Introduction 
Site-Specific introduction of fluorine labels into proteins is a powerful tool for 
investigating protein conformational changes and interactions.
70, 126, 127
 The remarkable 
utility of using fluorine substitution as ideal probes mostly due to the unique properties 
of fluorine element, given its unprecedented combination of small size, low polarity and 
the strongest electronegativity among all elements.
128
 In other words, the fluorine 
substitution allows the most inductive perturbation to the neighboring moiety but 
maintain the smallest spatial impact on the host. Therefore, it has been developed into an 
increasingly popular strategy in studying noncovalent protein interactions, including - 
stacking between aromatic amino acids as well as polar- interactions between aromatic 
amino acids and cation/anion.
129, 130
 These interactions are highly relevant to biological 
activities such as protein folding, protein-protein association and protein-ligand 
recognition. To this end, two methods are commonly used to introduce fluorinated 
ncAAs which involves semisynthesis or metabolic incorporation via endogenous 
translational machinery.
126-129
 However, semisynthesis suffers from low yield and 
limitation of protein size. Metabolic incorporation is impeded by background 
incorporation from canonical amino acids and low yield due to toxicity of fluorinated 
ncAAs. Development of methodology for programmable fluorinated amino acids 
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incorporation into protein is eminently desirable. Herein, we report the genetically 
incorporation of pentafluorophenylalanine into proteins in Escherichia coli using a 
polyspecific pyrrolysyl-tRNA synthetase (PylRS) mutant. Further engineering of the 
synthetase to optimize the incorporation efficiency, a serious perfluorinated 
phenylalanines were introduced into proteins site-specifically. To study the protein 
cation- interaction between chromodomain and trimethylated lysine on a histone 
peptide, the M-phase phorsphoprotein 8 was expressed with pentafluorophenylalanine 
incorporated at the ligand binding cage. The results reveal cation- interaction is 
interrupted by the fluorine substitution, leading to abolish of the ligand binding. 
Incorporation of these fluorinated phenylalanine noncanonical amino acids expands the 
availability of fluorine probes for studying biological noncovalent biological events.  
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Results and Discussion 
We have previously reported a polyspecific PylRS mutant (PylRS-
N346A/C348A), coupled with tRNACUA
Pyl
, is able to genetically incorporate a wide variety 
of para-, meta- and ortho- substituted phenylalanine derivatives at amber mutation sites 
of a protein that brings the size of the substrate inventory of this enzyme close to 60.
70, 74, 
114, 115, 122, 131, 132
 PylRS(N346A/C348A) displays high activities toward these 
noncanonical amino acids (ncAAs) while remaining relative orthogonality toward 
canonical amino acids. Accordingly, to incorporate fluorinated phenylalanines into 
proteins, particularly pentafluoro-L-phenylalanine (ncAA-1), we sought to employ 
PylRS(N346A/C348A) to mediate the genetic incorporation. To test this assumption, we 
used a previously generated ncAA incorporation and super green fluorescent protein 
(sfGFP) expression strain, BL21(DE3) transformed to contain the plasmids of synthetase 
and tRNA (pEVOL-PylT-PylRS(N346A/C348A)) as well as a plasmid of sfGFP with S2 
amber mutation reporter (pET-sfGFPS2TAG), for ncAA-1 incorporation.
115
 Following 
medium shift protocol, we grown the cell in LB until OD600 equals to one. After 
removed the medium, washed with isotonic saline, the pellet was resuspended in GMML 
medium supplemented with 0.2% arabinose, 1 mM IPTG, 5 mM ncAA-1 and incubated 
at 37
o
C for 20h to induce sfGFP mutant expression. The ncAA-1 incorporation 
efficiency is evaluated based on fluorescence intensity of the medium-free cell pellet. In 
compared to the control expression without providing any ncAA in the medium, indeed, 
the ncAA1-1 is able to serve as a substrate of PylRS(N346A/C348A), though the 
efficiency is not great (Figure 5-1). While the hydrogen and fluorine atoms have similar 
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size, the pentafluorophenylalanine hoards the small inequality from each fluorine 
substitution, resulting to overall discrimination against phenylalanine for the synthetase. 
However, in considering of other perfluorophenylalanine ncAAs with fewer fluorine 
substitutions, PylRS(N346A/C348A) may be inadequate to offer efficient incorporation. 
Therefore, optimization of the synthase is desirable for extending the 
perfluorophenylalanine inventory. The crystal structure of a PylRS(N348A/C348A) 
analogy mutant OMeRS in complex with O-methyltyrosine reveals the synthetase active 
site configuration coordinating with phenylalanine analogue.
133
 Figure 5-2 presents the 
active site structure of this enzyme-substrate complex superimposed on the wild-type 
PylRS with pyrrolysyl-AMP bound. The N346A is a key mutation that allows the 
synthetase to select phenylalanine analogues.
74
 Whereas other residues around the 
binding pocket don’t stringently confine the substrate orientation. On the other words, by 
engineering the residues around the binding pocket against ncAA-1, the synthetase will 
ideally better accommodate the fluorinated ncAAs, in turn promotes the incorporation 
efficiency. 
 
 
Figure 5-1. Small scale ncAA-1 incorporation and sfGFP mutant expression test.  
5 mM 13 mM 1- ncAA
N346A,C348S N346A,C348APylRS mutant
ncAA
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Figure 5-2. Superimposed structures of the OmeRS complex with O-methyltyrosine and 
the PylRS complex with pyrrolysine-adenosylmonophosphate (Pyl-AMP).  
 
In order to evolve aaRS mutants that present better substrate specificity, directed 
evolution has proven to be an effective approach, where standard protocols have been 
established for each newly targeted ncAA of interest.
85
 However, the whole evolution 
protocol is lengthy, normally takes several weeks to finish repeated selections. In the 
contrary, the rationally designed PylRS(N346A/C348A) mutate has broad substrate 
scope.
70, 74, 114, 115, 131
 The N346 residue of PylRS behaves as key discriminator for 
selecting lysine derivatives as substrates, whereas the N346 mutation abolishes the 
selectivity and allows a variety of phenylalanine/tyrosine derivatives to be incorporated. 
The polyspecificity of the PylRS(N346A/C348A) mutant is convenient to introduce new 
ncAAs into proteins, bypassing the tedious evolution steps. Nonetheless, the mutant 
itself encounters bottleneck to further improve its enzymatic efficiency toward those 
poor ncAA substrates due to the incorporation of canonical amino acid phenylalanine. 
N346
C348
Pyl-AMP
OMeY
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This background incorporation outcompetes the PylRS(N346A/C348A) uptake of the 
ncAA substrate, resulting to inefficient or no convergence after each round of directed 
evolution. Although it is not practical to evolve a mutant based on PylRS-
N346A/C348A, engineering of the mutant catalytic pocket provide a means to fine-tune 
the specificity to an ncAA substrate. Thereby, to further optimize the incorporation 
efficiency toward ncAA-1, a screening strategy was applied. Briefly, we constructed an 
active-site mutant library of the mmPylRS gene with randomization at single active site 
residue, where the N346A mutant was intentionally retained to ensure accommodation 
of phenylalanine analogues. This single site library in pBK plasmid together with 
another selection plasmid pY+ was used to transform the Top10 E. coli strain. pY+ 
plasmid contains genes encoding  pylT, type I chloramphenicol acetyltransferase with an 
amber mutation at D112 and green fluorescent protein (GFPuv) with an amber mutation 
at Q204. The library-containing cell was plated on GMML plate with 1% LB then single 
colonies were randomly selected and inoculated to LB medium on 96-well plates. After 
incubating the plates at 37
o
C for 3h, the cell in each well was dotted onto the screening 
plates containing chloramphenicol (Cm) and with or without ncAA-1 (Figure 5-3). Both 
cell viability and fluorescence intensity were evaluated during the screening process. 
The candidates displayed low background incorporation as well as strong fluorescence 
were collected, duplicated, plasmid-extracted, and subjected to DNA sequencing. 
Among various constructed single-site libraries, the randomization at C348 site appeared 
positive response toward ncAA-1 supplemented in the medium, where the library 
converges to a C348S mutant after screening procedure (Figure 5-3). 
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Figure 5-3. Single site randomization library screening experiment for the PylRS 
mutant optimization.  
 
The afforded PylRS mutant with N346A/C348A double mutations was 
subsequently cloned into an optimized pEVOL vector under contraol of an araBAD 
promoter to afford plasmid pEVOL-pylT-PylRS(N346A/C348S)  that also contain a 
tRNACUA
pyl
 gene under proK promoter. Transforming BL21(DE3) cells that contained a 
reporter plasmid pET-sfGFPS2TAG with pEVOL-PylRS(N346A/C348S)  afforded cell 
strain for further protein expression. PET-sfGFPS2TAG has a His-tagged sfGFP gene 
that contains an amber mutation at its S2 position and is under control of a IPTG-
inducible T7 promoter.
26
 Growing cells in LB medium, after medium shift to GMML 
supplemented with 0.2% arabinose, 1 mM IPTG, and 3 mM of ncAA-1resulted in the 
overexpression of sfGFP, indicated by the strong fluorescence after 20h protein 
expression. When ncAA-1 is absent, only a small amount of sfGFP could be observed 
(Figure 5-1). Evidenced by stronger fluorescent signal, the protein expression of ncAA-
A B
C
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1 dependent sfGFP expression using pEVOL-pylT-PylRS(N346A/C348S) is slightly 
better than that of using previously reported pEVOL-PylRS(N346A/C348A) plasmid 
under the same expression condition (Figure 5-1), indicating PylRS(N346A/C348S) is 
more specific to ncAA-1 . This observation is also in line with our assumption that the 
screening approach is capable of assisting synthetase-ncAA pair optimization. For 
further characterization of the ncAA-1 genetic incorporation into sfGFP, the cell was 
lysed and the lysate was subjected to Ni-NTA affinity purification. After buffer 
exchange, purified protein was further analyzed by electrospray ionization mass 
spectrometry (ESI-MS) that showed the expected molecular weights of sfGFP with 
ncAA-1 incorporated (calculated 27,819 DA; found 27,817 Da) (Figure 5-4C and Table 
5-1).  
 
Table 5-1. ESI-MS characterization of sfGFP variants incorporated with different 
fluorinated phenylalanine ncAAs (ncAA 1-6). 
 
ncAA Calculated Mass (Da) Observed Mass (Da) 
1 27819 27817 
2 27801 27799 
3 27783 27783 
4 27765 27763 
5 27765 27763, 
(27782, 27800, 27818, 27836, 
27845, 27871, 27891, 27911) 
6 27765 27765, 
(27800, 27835, 27871, 27907, 
27932, 27965, 28004) 
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Figure 5-4. (A) Structures of perfluorophenylalanine ncAAs 1-6. (B) Site-specific 
incorporation of ncAA 1-6 into sfGFP at the S2 site. The N/A indicates no ncAA was 
supplemented in the medium. (C) Deconvoluted ESI-MS of sfGFPS2 mutants 
incorporated with ncAAs 1-6. 
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C
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With the success on pentafluorophenylalanine incorporation, we went further to 
explore the possibility if other fluorine-substituted phenylalanine analogues are able to 
mediate the ncAA incorporation into proteins. Synthesized or commercially available 
ncAAs including 2, 3, 4, 5-tetrafluoro-L-phenylalanine (ncAA-2, gift from Prof. Jianmin 
Gao, Boston College), 3,4,5-trifluoro-L-phenylalanine (ncAA-3), 2, 3-difluoro-L-
phenylalanine (ncAA-5), 3, 4-difluoro-DL-phenylalanine (ncAA-6), and 3, 5-difluoro-L-
phenylalanine (ncAA-4) were provided in the expression medium. Following similar 
expression protocol with the same cell strain, after protein expression, purification and 
buffer exchange, the afforded proteins were analyzed by ESI-MS (Figure 5-4 and Table 
5-1). The MS of the proteins supplemented with ncAA-2 or ncAA-3 agree well with 
theoretical molecular weights, indicating the incorporation of tetra- and tri-fluorine 
substituted phenylalanines. However, when the medium provided with ncAA-5 or 
ncAA-6, two difluorophenylalanine isomers, both ESI-MS of the purified proteins show 
numerous peaks, where each peak differs from roughly 34 Da, indicating multiple 
difluorophenylalanines are incorporated into sfGFP (Figure 5-4 and Table 5-1). While 
there are in total of twelves phenylalanines in one sfGFP, the multiple 
difluorophenylalanines incorporation may result from disincorporation of ncAA-5 or 
ncAA-6 to the original phenylalanine sites. Since E. coli endogenous phenylalanyl-
tRNA synthetase (PheRS) has known to mischarge the p-fluorophenylalanine, little 
perturbation of difluorine substitutions with high concentration ncAAs provided in the 
medium may contribute to the mischarge of ncAA-5 and -6 on the tRNA
Phe
. 
Interestingly, when anther isomer 3,5-difluorophenylalanine (ncAA-4) was provided in 
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the medium, after protein expression, purification and ESI-MS analysis, the MS 
spectrum showed only single protein product, where the observed molecular weight 
agrees well with that of single difluorophenylalanine incorporated sfGFP (Figure 5-4 
and Table 5-1). We assume that the 3,5-difluorine substitution is bulkier than the other 
isomers, effectively precluding ncAA-4 being mischarged to the tRNA
Phe
 by endogenous 
PheRS, leading to site-specific incorporation of ncAA-4 into sfGFP. This result further 
expands the perfluorophenylalanine arsenal that can be used for biophysical studies.  
The genetic incorporation of ncAA-1-4 offers an array of perfluorinated 
phenylalanine probes and enables stepwise change the electron distribution of the 
aromatic system on phenylalanine. With this tool set in hand, we proceeded to apply it in 
the investigation of cation- interactions between chromodomain and trimethyllysine. A 
chromodomain is a protein structural domain of about 40-50 amino acid residues 
commonly found in proteins associated with the remodeling and manipulation of 
chromatin. Chromodomains are highly conserved methylated histone lysine recognition 
modules that share a common ancestral fold with two to four well-conserved aromatic 
residues coordinating the methylated lysine. The aromatic residues form a “cage” and 
binds to the methylated lysine generally believed through the noncovalent cation- 
interactions. The M-phase phosphoprotein 8 (MPP8) is a methyl-H3K9-binding protein. 
MPP8 was found mediating the E-cadherin gene silencing and synergistically promotes 
tumor cell motility and invasion.
134
 E-cadherin gene is a key regulator of tumor cell 
growth and transition. When MPP8 bind to methylated H3K9, the resulting complexes 
recruit methyltransferases and methylate E-cadherin gene, in term to repress the gene 
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function.
134
 The MPP8 chromodomain comprises of F59, W80, Y83 aromatic cage and 
binds tightly with trimethylated H3K9 (H3K9me3) at 0.3 uM of dissociation constant 
(Figure 5-5A).
135
 We sought to perturb this binding behavior by substituting the F59 
residue to ncAA-1. The perfluorination inverts the electronic property of the 
phenylalanine  system and we predict that the affinity between trimethyllysine and 
MPP8 will be abolished.  
 
 
 
Figure 5-5. (A) The structure of H3K9 trimethyllysine peptide-bound M-phase 
phorphoprotein 8 chromo domain (MPP8CD). (B) Binding of H3-K9Me3 to wild-type 
MPP8CD or MPP8CD mutant incorporated with ncAA-1 as determined by fluorescence 
polarization assay. 
 
 
 
A B
 140 
 
To this end, we constructed an expression plasmid which contains the gene under 
control of araBAD promoter to express the fusion protein of human MPP8 
chromodomain (MPP8CD, residues 55-116) with C-terminal small ubiquitin-like 
modifier-6xHis (SUMO-6xHis) in which the F59 of MPP8CD gene was mutated to TAG 
amber codon (pBAD-MPP8CDF59TAG-SUMO). Top10 E. coli strain was transformed 
to contain aforementioned pBAD-MPP8CDF59TAG-SUMO and pEVOL-PylT-PylRS-
N346A-C348S for protein expression. The ncAA-1 incorporation and protein expression 
follows medium shift protocol. Briefly, the cell was grown in LB until the DO600 reach 
to one. After removing the LB, the cell pellet was washed with isotonic saline for two 
times and resuspended in GMML medium supplemented with 0.2% arabinose, 2.5 mM 
ncAA-1 to induce MPP8SUMO mutant expression. The protein expression was 
conducted at 37
o
C for 20h. After collecting the cells, the cell was lysed and subjected to 
purification procedures including Ni-NTA affinity and Q-sepharose iox-exchange 
purification to afford the fusion protein MPP8CDF59-1-SUMO. Wild-type MPP8CD-
SUMO was expressed as a control protein using similar pBAD plasmid without the in-
frame amber codon and expressed in LB medium with the same purification protocol. 
H3K9 trimethyllysine peptide (FAM-ARTKQTAR(KMe3)STGGKAY-NH2, H3K9Me3) 
was synthesized with N-terminal end fluorescein modification and C-terminal end 
amidation. Fluorescence polarization assays were carried out to determine the binding 
between H3KMe3 and MPP8CD in phosphate buffer (pH 7.5) and 50 mM NaCl. At 
25
o
C, specific binding was observed between wild-type MPP8CD-SUMO and 
H3K9Me3 peptide at a dissociation constant of 1.01 uM (Figure 5-5B) that is consistent 
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with literature reported binding constant at the degree of order.
135, 136
 However, when the 
ncAA-1 incorporated MPP8CD-SUMO was applied, the binding with H3K9Me3 peptide 
is significantly dropped, given more than 200 uM dissociation constant (Figure 5-5B). 
Given the similarity in size and shape as well as the greater hydrophobicity of the 
petntafluorophenylalanine in comparing with phenylalanine, the factors that substantially 
weaken the binding may be attributed by the inductive effect from the aromatic  
system. This observation clearly demonstrates the essential nature of the cation- 
component to binding of the lysing-methylated H3 tail to chromodomains. 
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Conclusion 
In summary, we reported the genetic incorporation of an array of perfluorinated 
phenylalanine ncAAs including penta-, tetra-, tri-, and di-fluorophenylalanine into 
proteins using an optimized PylRS(N346A/C348S)- tRNACUA
Pyl
 pair. The fluorine 
substitution has the minimum structural influence to a molecule but contributes 
significant electronic perturbation due to fluoride’s unrivaled electronegativity. 
Phenylalanine is involved in a variety of biological noncovalent associations and plays 
critical role in many protein ligand recognitions in living system. The incorporation of a 
series of fluorinated phenylalanines has greatly expanded the probe inventory for 
studying these biological -interactions. Using this incorporation protocol, we generated 
pentafluorophenylalanine-incorporated MPP8 chromodomain protein. The perturbation 
resulted from the fluorine substitutions significantly lower the association between the 
trimethylated H3K9 peptide, essentially rescinding the cation- interaction. This 
observation can provide the insight of quantifying contribution from cation- interaction 
in the protein-ligand association event. This method also offers the opportunity to further 
investigate other biological -systems of specific biomolecelar recognition. 
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Experimental Section 
Polysepcific PylRS mutant optimization: single-site library construction and library 
screening  
Library Construction 
The plasmid pBK-PylRS(N346A)  was derived from pBK-MmPylRS plasmid 
reported previously.
74, 85
 
The single site randomization was achieved through Phusion DNA polymerase 
(NEB, Ipswich, MA, USA) based site-directed mutagenesis protocol with pBK-
PylRS(N346A) as template and two synthesized degenerated primers (IDT, Coralville, 
IA, USA): YJL055 (5’- NNKCAGATGGGATCGGGATGTACAC -3’) and YJL056 (5’- 
GAAGTTCAGCATGGTAAACTCTTCGAGGTGTTC -3’) where N=A/C/T/G; T, 
K=G/T; M=C/A. The afforded PCR product was phosphorylated with T4 PNK, ligated 
with T4 DNA ligase and heat-inactivation of the enzyme before transformation. 
 
Library Screening 
This single site library in pBK plasmid together with another selection plasmid 
pY+ was used to transform the Top10 E. coli strain. pY+ plasmid contains genes 
encoding  pylT, type I chloramphenicol acetyltransferase with an amber mutation at 
D112 and green fluorescent protein (GFPuv) with an amber mutation at Q204.
85
 The 
library-containing cell was plated on GMML plate with kanamycin (Kan, 50 μg/mL) and 
tetracycline (Tet, 25 μg/mL) plus 1% LB then single colonies were randomly selected 
and inoculated to LB medium with kanamycin (Kan, 50 μg/mL) and tetracycline (Tet, 25 
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μg/mL) on 96-well plates. After incubating the plates at 37oC for 3h, the cell in each well 
was dotted onto the screening plates containing chloramphenicol (Cm) (68 μg/mL), Kan 
(50 μg/mL), Tet (25 μg/mL) and with ncAA-1. The plates without ncAA-1 serve as the 
control. Plates were incubated at 37
o
C. Both cell viability and fluorescence intensity 
were evaluated during the screening process. The clones with strong fluorescence on the 
NAAcontaining plate and low viability and fluorescence on the control plate were 
selected as the active clones and were amplified from the corresponding wells in the 96-
well plate. The pBK plasmid of the active clones was isolated and sequenced. Most of 
the active clones were converged to contain N346A/C348A mutations. 
 
sfGFP-ncAA mutants protein expression and purification 
pEVOL-pylT-PylRS(N346A/C348S) Construction 
The pEVOL-PylT-PylRS(N346A/C348S)  plasmid was derived from the 
pEVOL-PylT plasmid reported previously.
74
 The PylRS(N346A/C348S) gene were PCR 
amplified from the identified pBK-PylRS(N346A/C348S) plasmids using primers 
pEVOL-PylRS-SpeI-F (5’-gaggaaactagtatggataaaaaaccactaaacactctg-3’) and pEVOL-
PylRS-SalI-R (5’-tgatggtcgactcacaggttggtagaaatcccgtt-3’). The PCR product was 
digested by SpeI and SalI restriction enzymes, and ligated to a similarly digested 
pEVOLPylT plasmid. 
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Protein Sequence of sfGFP: 
MASKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKL
PVPWPTLVTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTY
KTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNFNSHNVYITADKQKNGI
KANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLSKDPNEKR
DHMVLLEFVTAAGITHGMDELYKGSHHHHHH 
*The NCAA incorporation site is highlighted in red. 
 
Incorporation of Perfluorinated ncAAs into sfGFP 
A previously reported protocol was followed to genetically incorporate ncAA-1 –
ncAA-6 into sfGFP.
70, 74, 115
 Briefly, E. coli BL21(DE3) cells were cotransformed with 
pET-PylT-sfGFPS2TAG and pEVOL-PylT-PylRS(N346A/C348S). The transformed 
cell was used to inoculate the LB media and was grown at 37°C with agitation until the 
OD600 reached 1.0-1.2. Then the cells were pelleted and washed with isotonic saline or 
PBS buffer (x3). After medium shift to a minimal medium (GMML) supplemented with 
1 mM IPTG, 0.2% arabinose, and one of desired ncAA (3 mM), the cells were incubated 
at 37
o
C with agitation for 20h. ncAAs were purchased from commercial sources or 
synthesized in the lab which were used without further purification. After centrifugation, 
the cell pellet was resuspended in ice cold lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 
10 mM imidazole, pH 8.0) and lysed by sonication. The lysate was centrifuged (10000 g, 
4
o
C, 1h) and the supernatant subjected to Ni-NTA affinity chromatography according to 
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manufacturer’s protocol. The supernatant was incubated with Ni-NTA resin (Qiagen) 
(2h, 4
o
C). The slurry was then loaded to a column and the protein-bound resin was 
washed with washing buffer (50 mM NaH2PO4, 300 mM NaCl, 45 mM imidazole, pH 
8.0) followed by eluting the bound protein with elution buffer (50 mM NaH2PO4, 300 
mM NaCl, 250 mM imidazole, pH 8.0). The eluted protein was buffer-exchanged to 
Tris-HCl buffer (50 mM, pH 7.4) and concentrated using an Amicon Ultra-15 
Centrifugal Filter (10 kD MWCO, Millipore). The quality of the purified protein was 
analyzed by SDS-PAGE and ESI-MS. The sfGFP concentration was quantified by UV 
absorbance at 485 nm using literature reported extinction coefficient 8.33x10
4
 M
-1
 cm
-1
. 
 
Expression and purification of MPP8CD-SUMO-6xHis proteins 
DNA Sequence of MPP8CD 
5’-
atgggcgaagacgtgttcgaagtagagaagatcctggacatgaagaccgaaggcggtaaagttctgtacaaagtgcgctgga
aaggctatacttctgacgatgacacctgggaaccagagatccatctggaagattgtaaagaagttctgctggaatttcgcaagaa
gattgccgagaacaaagctaaa- 3’ 
 
MPP8CD-SUMO Expression Vector Construction 
The codon optimized MPP8 chromo domain (MPP8CD) gene was synthesized 
by Epoch (Epoch Life Science, Sugar Land, TX, USA). The MPP8CD gene was PCR 
amplified from the synthetic construct using primers YJL057 (5’-CCACCATG 
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GGCGAAGACGTGTTCGAAGTAG-3’) and YJL058 (5’-AACCATGGC 
ACCTTGGAAATACAGGTTCTCTTTAGC-3’). A pET28-SUMO-6xHis plasmid (a 
gift from Prof. C. Hilty, Department of Chemistry, Texas A&M) was digested with NcoI 
restrict enzyme. The digested site was ligated with the aforementioned NcoI-digested 
PCR product using T4-DNA ligase to aford pET28b-MPP8CD-SUMO-6xHis.  
The MPP8CD-SUMO-6xHis gene was PCR amplified from the template plasmid 
pET28b-MPP8-SUMO-6xHis using primers YJL057 (5’- CCACCATG 
GGCGAAGACGTGTTCGAAGTAG-3’) and YJL094 (5’-
GATCCTGCAGTTAGTGGTGGTGGTGGTGGTG 
ACCACCAATCTGTTCTCTGTGAGCC-3’). Amplified PCR product was inserted into 
a pBAD plasmid downstream of an araBAD promoter using NcoI and PstI sites to 
generate pBAD-MPP8CD-SUMO-6xHis.  
 
Protein Sequence of MPP8CD-SUMO-6xHis: 
MGEDVFEVEKILDMKTEGGKVLYKVRWKGYTSDDDTWEPEIHLEDCKEVLLE
FRKKIAENKAKELSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTP
LRRLMEAFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGG
HHHHHH 
*The underline highlights the MPP8 chromo domain sequence (MPP8CD) and ncAA 
incorporation site is marked in red. 
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Incorporation of Perfluorinated ncAAs into sfGFP 
The purification protocol was modified from the sfGFP-ncAA expression and 
purification. E. coli strain Top10 were transformed with plasmids pBAD-
MPP8CDF59TAG-SUMO-6xHis and pEVOL-pylT-PylRS(N346A/C348S) or pEVOL-
pylT-PylRS(N346A/C348A). The transformed cell was used to inoculate the LB media 
and was grown at 37°C with agitation until the OD600 reached 1.0-1.2. Then the cells 
were pelleted and washed with isotonic saline or PBS buffer (x3). After medium shift to 
a minimal medium supplemented with 1 mM IPTG, 0.2% arabinose, and 3 mM ncAA-1, 
the cells were incubated at 37
o
C with agitation for 20h.  
After centrifugation, the cell pellet was resuspended in ice cold lysis buffer (50 
mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by sonication. The 
lysate was centrifuged (10000 xg, 4
o
C, 1h) and the supernatant subjected to Ni-NTA 
affinity chromatography according to manufacturer’s protocol. The supernatant was 
incubated with Ni-NTA resin (Qiagen) (2h, 4
o
C). The slurry was then loaded to a 
column and the protein-bound resin was washed with washing buffer (50 mM NaH2PO4, 
300 mM NaCl, 45 mM imidazole, pH 8.0) followed by eluting the bound protein with 
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). The 
eluted protein was buffer-exchanged to Tris-HCl buffer (50 mM, pH 7.4) and 
concentrated using an Amicon Ultra-15 Centrifugal Filter (10 kD MWCO, Millipore). 
The quality of purified protein was analyzed by SDS-PAGE.  
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To further improve the quality of protein, the buffer exchanged MPP8CD was 
subjected to FPLC mounted with a QSepharose HP column, where the M88P was eluted 
at roughly 37% NaCl concentration of buffer B (20 mM TrisHCl pH 8, 1 M NaCl; buffer 
A contains the same composition without NaCl). The collected fractions were dialyzed 
to a FP assay buffer containing 50 mM potassium phosphate pH 8.0, 25 mM NaCl and 
concentrated. Protein concentration was determined by absorbance spectroscopy using 
predicted extinction coefficient (280 = 15470 M
-1
 cm
-1
, MW = 19640.12). 
 
Fluorescence polarization binding assays 
Fluorescence polarization (FP) was performed on a BioTek Synergy H1 plate 
reader by setting it on automatic gain and 100 flashes. FP binding assays were performed 
under conditions of 50 mM potassium phosphate pH 8.0, 25 mM NaCl and in the 
presence of 100 nM fluorescein-labeled peptide. A series dilution of protein was 
prepared in the nanomolar-millimolar concentration range on a black solid bottom 96-
well plate. Fluorescence polarization (P) values were converted to anisotropy (A) values 
by the equation A = 2P/(3 - P). Binding curves were analyzed by non-linear least-squares 
fitting of the raw fluorescence polarization data. Data were fitted using the equation A = 
Af + (Ab – Af)([protein]/(KD + [protein])), where Af and Ab represent the anisotropy of 
the free and bound peptides, respectively.
137
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General experimental and chemical synthesis 
All reactions involving moisture sensitive reagents were conducted in oven-dried 
glassware under an argon atmosphere. Anhydrous solvents were obtained through 
standard laboratory protocols. Analytical thin-layer chromatography (TLC) was 
performed on EMD Millipore silica gel 60 F254 plates. Visualization was accomplished 
by UV irradiation at 254 nm or by staining with ninhydrin (0.3% w/v in glacial acetic 
acid/n-butyl alcohol 3:97). Flash column chromatography was performed with flash 
silica gel (particle size 32-63 m) from Dynamic Adsorbents Inc (Atlanta, GA).  
Proton and carbon NMR spectra were obtained on Varian 300 and 500 MHz 
NMR spectrometers. Chemical shifts are reported as  values in parts per million (ppm) 
as referenced to the residual solvents: chloroform (7.27 ppm for 
1
H and 77.23 ppm for 
13
C) or water (4.80 ppm for 
1
H). A minimal amount of 1,4-dioxane  was added as the 
reference standard (67.19 ppm for 
13
C) for carbon NMR spectra in deuterium oxide, and 
a minimal amount of sodium hydroxide pellet or concentrated hydrochloric acid was 
added to the NMR sample to aid in the solvation of amino acids which have low 
solubility in deuterium oxide under neutral conditions. 
1
H NMR spectra are tabulated as 
follows: chemical shift, multiplicity (s = singlet, bs = broad singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet), number of protons, and coupling constant(s). Mass 
spectra were obtained at the Laboratory for Biological Mass Spectrometry at the 
Department of Chemistry, Texas A&M University. 
Pentafluoro-L-phenylalanine (ncAA-1), 3,4,5-trifluoro-L-phenylalanine (ncAA-
3), 2,3-difluoro-L-phenylalanine (ncAA-5) and 3,4-difluoro-L-phenylalanine (ncAA-6) 
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were purchased from ChemImpex Inc. (Wood Dale, IL, USA). All obtained ncAAs were 
subjected to the protein expression without further treatment.  
2,3,4,5-Tetrafluoro-L-phenylalanine (ncAA-2) is a gift from Prof. Jianmin Gao ( 
Department of Chemistry, Boston College). The synthesis procedure was published 
previously. 
138
 The ncAA-2 was used as obtained without further treatment. 
3,5-Difluoro-L-phenylalanine (ncAA-4) was purchased from CombiBlocks Inc. 
(San Diego, CA, USA). It was subjected to the protein expression without further 
treatment. 
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CHAPTER VI  
CONCLUDING REMARKS AND FUTURE OUTLOOK 
 
In this study, we reported the genetic incorporation of a variety of ncAAs into 
proteins using genetic code expansion approach with wild-type or evolved PylRS-
tRNACUA
Pyl
 pair. In order to incorporate these novel ncAAs, deviated from previous 
directed evolution procedure, we demonstrate a small library screen based strategy 
which is deviated from previous reported directed evolution approach. It allowed quick 
optimization and fine-tuning the PylRS-ncAA pair, effectively promote the 
incorporation efficiency. These introduced ncAAs contains novel protein modifications, 
including native protein posttranslational modification (lysine crotonylation, 
propionylation and butyrylation), bioorthogonal chemical reports (acryloyllysine, long 
chain unstrained alkene ncAAs) and biophysical probes (perfluorinated phenylalanines). 
While the overall emphasis of research is focused on methodology development, the 
utilization of developed protocol for biologically significant applications, from both 
fundamental research to translational science and clinical application, have not yet 
comprehensively explored. Genetic code expansion enables the synthesis of proteins 
with defined and homogeneous protein with up to now more than 100 functionalities, 
substantially promoting the ability of controlling biomolecular intracellular activity, 
though not thoroughly. Backtracking to 10 years ago when alanine-scanning site-
directed mutagenesis is the unparalleled protocol for biochemistry studies, nonetheless, 
there are increasing numbers of research adopting ncAA chemical biology approach. 
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Because of the uniqueness and selectivity, the ncAA method become a targeted research 
methodology can be envisioned.  
For the development of genetically encoded acrylamide functionality, the 
incorporation of AcrK has provided diverse application opportunities. Acrylamide has 
unprecedented combination of small size and reactivity. Our studies show that the 
acrylamide moiety is stable in cellular condition for recombinant protein expression. The 
Acrk incorporated protein is able to undergo many-faceted bioconjugation reactions. For 
example, radical polymerization allows AcrK-containing protein immobilized into a 
hydrogel. Thiol 1,4-addition on protein acrylamide can provide site specific PEGylation 
to increase therapeutic protein stability. Moreover, AcrK is considered as lysine 
acetylation and propionylation PTM surrogate. In combining with the demonstrated 
bioorthogonal reactions, such as 1,3-dipolar cycloaddition with nitrile imine, the AcrK 
incorporation into histons can be developed as a chemical biology probe for epigenetics 
investigation with a high throughput manner.  
Besides short-chain acylations, proteins in cells also undergo long-chain 
acylations. The development of using unstrained alkene as chemical reporter, in coupled 
with tetrazine DAinv chemistry, provides an easy accessible methodology to address this 
question. Similar to the AcrK incorporation, this chemical antibody sort of PTM 
detection can further modified to high throughput fluorescence protocol.  
Following the research line of acrylamide incorporation, the developed novel 
phosphine nucleophilic 1,4-addition is a great improvement of its thiol predecessor, 
essentially allowing to the practical in vivo protein labeling. Phosphine reacts with 
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acrylamide very selective and in a decent reaction rate which are two key features of 
ideal click reaction pairs. This development further extends the available tool in the click 
chemistry inventory. The application of using phosphine and acrylamide pair also can be 
found on other biomolecule or metabolite research. 
Lastly, the site-specific incorporation of fluorine-containing noncanonical amino 
acid probes into proteins was also developed. Fluorine is referred as “magic bullet” in 
medicinal organic chemistry and biochemistry and is uniquely in the protein with barely 
structural perturbation. Phenylalanine is involved in a variety of biological noncovalent 
associations and plays critical role in many protein ligand recognitions in living system. 
The incorporation of a series of fluorinated phenylalanines has greatly expanded the 
probe inventory for studying these biological -interactions. The site-incorporation of 
perfluorinated probes is an invaluable tool for the study of noncovalent protein 
interactions as well as the application on protein designs. 
Overall, the collective work presented in this dissertation has improved our 
knowledge and competency of manipulating site-specific protein modifications with 
native biological PTMs and handy chemical/ biophysical probes. The developments 
substantially expand available chemical biology tools for comprehensive applications. 
The established protocols will help in the future design of probes and strategies on 
studying significant biological questions. 
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